{"meta":{"query_hash":"1e57ce0a9843","filters":{"venue":"European Journal Of Haematology"},"cohort_total":183,"direct_labels_cover":0,"predictions_cover":183,"exported":183,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1e57ce0a9843","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Journal+Of+Haematology"},"results":[{"id":"W11553269","doi":"10.1034/j.1600-0609.2001.067001056.x","title":"Fisheries management evaluation: a case study of the British Columbia groundfish fisheries","year":2008,"lang":"en","type":"dissertation","venue":"European Journal Of Haematology","topic":"Marine and fisheries research","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Groundfish; Fishery; Fisheries management; Fisheries science; Bycatch; Business; Fish <Actinopterygii>; Fishing; Biology","score_opus":0.027903666116209258,"score_gpt":0.26287988905615145,"score_spread":0.2349762229399422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W11553269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76564205,0.000054288554,0.0000020407447,0.000054751206,0.0006183439,0.00051382656,0.0000029332325,0.0000059031827,0.23310588],"genre_scores_gemma":[0.9706005,0.00021522607,0.00013963209,0.00005500544,0.00007335153,0.000017606486,0.000013332897,0.00005271097,0.028832667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995716,0.0015646361,0.0010391942,0.00029326236,0.0011161106,0.00027079892],"domain_scores_gemma":[0.99820095,0.000059029495,0.0010149915,0.00046368942,0.00017126251,0.0000900692],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011791609,0.0001857382,0.00058777333,0.00004530007,0.0006218133,0.00033108916,0.0008518731,0.000067719586,0.008635187],"category_scores_gemma":[0.00015010122,0.0001963115,0.00019291836,0.0003296411,0.00034955493,0.00022482908,0.00038700574,0.0005473913,0.00001736787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016877516,0.0009857325,0.43718374,0.00026053513,0.00051105605,0.18220946,0.008370235,0.000015979267,0.000004470766,0.0000017257129,0.26998994,0.10029836],"study_design_scores_gemma":[0.0034483061,0.0021031867,0.56157756,0.0002142512,0.000671711,0.20916642,0.07250777,0.000035198846,0.0000070869937,0.00012982667,0.1495337,0.00060499716],"about_ca_topic_score_codex":0.009290908,"about_ca_topic_score_gemma":0.13609771,"teacher_disagreement_score":0.20495844,"about_ca_system_score_codex":0.00009354253,"about_ca_system_score_gemma":0.000057618214,"threshold_uncertainty_score":0.9973063},"labels":[],"label_agreement":null},{"id":"W1494952166","doi":"10.1111/j.1600-0609.2011.01725.x","title":"The cellular and molecular mechanisms for neutropenia in Barth syndrome","year":2011,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Biology; Myeloid; Apoptosis; Progenitor cell; Molecular biology; Cell biology; Myeloid leukemia; Transfection; Cancer research; Mitochondrion; Haematopoiesis; U937 cell; Cell culture; Stem cell; Biochemistry; Genetics","score_opus":0.010293353384232918,"score_gpt":0.20196479087540822,"score_spread":0.1916714374911753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1494952166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98847026,0.003244286,0.0069363886,0.00015901252,0.00012269757,0.00012235978,0.00000184968,0.0000016117153,0.00094155344],"genre_scores_gemma":[0.99702346,0.0001758605,0.0025780573,0.0001390256,0.0000112657835,0.000002629383,0.000002417523,0.000020792091,0.00004651718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991972,0.00019505112,0.00026782314,0.00012417033,0.000045552308,0.0001702413],"domain_scores_gemma":[0.9995859,0.000012175637,0.0001536089,0.00014420337,0.000047008318,0.000057073805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000359269,0.00009836038,0.00017575132,0.000036896567,0.000057652134,0.000011529554,0.00018244589,0.00003099672,0.0000046041273],"category_scores_gemma":[0.000035029512,0.0000665303,0.00007124556,0.00002895033,0.000067107,0.0000034589827,0.00006297293,0.000067531786,0.0000035320418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004063425,0.0023494482,0.015772693,0.00022208657,0.002656663,0.06857858,0.0018832816,0.00004099255,0.77626914,0.09225343,0.0045044688,0.03140579],"study_design_scores_gemma":[0.019817285,0.01449329,0.018853107,0.00014362208,0.0004681867,0.038423747,0.0011189056,0.000052736545,0.838599,0.025489677,0.041536584,0.0010038345],"about_ca_topic_score_codex":0.0000016009936,"about_ca_topic_score_gemma":0.000007032157,"teacher_disagreement_score":0.06676375,"about_ca_system_score_codex":0.0000022344134,"about_ca_system_score_gemma":0.000019993002,"threshold_uncertainty_score":0.2713027},"labels":[],"label_agreement":null},{"id":"W1572717899","doi":"10.1111/j.1600-0609.2011.01629.x","title":"Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?","year":2011,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Karyotype; Cytogenetics; Biology; Chromosome; Multiple myeloma; Genetics; Leukemia; Somatic evolution in cancer; Plasma cell leukemia; Cancer research; Cancer; Pathology; Immunology; Gene; Medicine","score_opus":0.0699727070098944,"score_gpt":0.2965551187885002,"score_spread":0.22658241177860583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572717899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830017,0.009010727,0.00009253399,0.0006526815,0.00028133532,0.00018614801,0.000020504638,0.000014067761,0.0067403154],"genre_scores_gemma":[0.99131,0.005761983,0.0016459133,0.00014464397,0.00007890799,0.000003338945,0.0000357068,0.00003901933,0.0009805015],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975099,0.00075531384,0.0008057797,0.00021796672,0.00023137622,0.00047965668],"domain_scores_gemma":[0.9987514,0.00015266016,0.0003936126,0.00018884534,0.000213796,0.00029966177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006065403,0.00021785415,0.0006432675,0.0003263899,0.000059514117,0.000024470328,0.00024437753,0.00009408914,0.00071378367],"category_scores_gemma":[0.0001782706,0.00017227835,0.00017041272,0.00009672014,0.00024177319,0.00019187349,0.00009296868,0.00051319523,0.0003086619],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012873698,0.0057528974,0.6174003,0.0017214057,0.002690008,0.22858298,0.010241021,0.000040324296,0.064318836,0.0038456365,0.018617509,0.033915382],"study_design_scores_gemma":[0.1033406,0.020313106,0.16141415,0.0034598701,0.0007894639,0.122869655,0.00848395,0.00088130654,0.49674487,0.0016274642,0.078392535,0.0016830212],"about_ca_topic_score_codex":0.00001166373,"about_ca_topic_score_gemma":0.00001137103,"teacher_disagreement_score":0.45598614,"about_ca_system_score_codex":0.0001280405,"about_ca_system_score_gemma":0.00026050763,"threshold_uncertainty_score":0.7815431},"labels":[],"label_agreement":null},{"id":"W1572992859","doi":"10.1111/j.1600-0609.2005.00461.x","title":"Transformation in the use of radiation therapy of Hodgkin lymphoma: New concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT)","year":2005,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Comprehensive Cancer Network","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Randomized controlled trial; Lymph node; Oncology; Radiology; Internal medicine","score_opus":0.08705444835431066,"score_gpt":0.333600224076648,"score_spread":0.24654577572233738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572992859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16309445,0.83130765,0.003109559,0.0016249893,0.000036324782,0.0007976384,0.000013671143,0.000004593614,0.000011143421],"genre_scores_gemma":[0.3208695,0.67830396,0.00048638487,0.00027733578,0.000020149531,0.000004026667,0.000022180022,0.000014083226,0.0000023824734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978385,0.00088579074,0.0008625739,0.00015398429,0.0001482095,0.00011096989],"domain_scores_gemma":[0.9982097,0.00046020545,0.001005173,0.00014503876,0.00010017095,0.00007969329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005345206,0.00020260995,0.0010770163,0.0003110754,0.000039467068,0.000025391319,0.000080484184,0.000056970657,0.000004067357],"category_scores_gemma":[0.00010803096,0.00012913335,0.00009756658,0.00016265461,0.000068653564,0.00015456742,0.000010343099,0.00012326032,3.9950814e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017699225,0.00017254634,0.0013123029,0.00019262485,0.000175187,0.00012982753,0.0027233069,0.0000075995863,0.000023595625,0.00000855148,0.0007081016,0.9943694],"study_design_scores_gemma":[0.050432824,0.0065576946,0.39018357,0.019383306,0.0030798656,0.06416274,0.0009460003,0.003458886,0.0015633187,0.00011587958,0.45888165,0.0012342582],"about_ca_topic_score_codex":0.000024357616,"about_ca_topic_score_gemma":0.0000024247258,"teacher_disagreement_score":0.9931351,"about_ca_system_score_codex":0.00006251548,"about_ca_system_score_gemma":0.0001475115,"threshold_uncertainty_score":0.52659047},"labels":[],"label_agreement":null},{"id":"W1576118523","doi":"10.1111/j.1600-0609.2011.01602.x","title":"Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients","year":2011,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; University of Alberta","funders":"","keywords":"Carfilzomib; Multiple myeloma; Oncology; Variation (astronomy); Alkaline phosphatase; Medicine; Internal medicine; Chemistry; Lenalidomide; Biochemistry; Enzyme","score_opus":0.04353107053041077,"score_gpt":0.26935986516702304,"score_spread":0.22582879463661226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1576118523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987272,0.00016215508,0.000031795993,0.00015492711,0.00006522649,0.0004236406,0.000047673337,0.000013157196,0.00037423667],"genre_scores_gemma":[0.99851173,0.000054025648,0.00104785,0.000062117986,0.000028228436,0.000007638914,0.000040276063,0.000040648672,0.00020746792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976076,0.0008923418,0.00063017866,0.00020829025,0.0003022564,0.00035937218],"domain_scores_gemma":[0.9985658,0.00016243305,0.00045565845,0.00024052798,0.00030555594,0.00027001664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005454899,0.00020681931,0.00058014266,0.00036259447,0.00007337008,0.000010294575,0.00011901553,0.000044462966,0.00019665703],"category_scores_gemma":[0.0007527745,0.00014130409,0.00009927276,0.00020887524,0.00007542864,0.00012627922,0.000036583195,0.00020254836,0.0001066109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053513538,0.0045388364,0.8425303,0.000034912086,0.00085610483,0.09030312,0.004629501,0.000006542194,0.0011910304,0.000008223971,0.00012177643,0.0022660908],"study_design_scores_gemma":[0.029173598,0.0076609887,0.95131135,0.00029206733,0.00014558027,0.0021279927,0.000114400325,0.000062264815,0.008798631,0.0000039514175,0.00019101996,0.00011817338],"about_ca_topic_score_codex":0.00006797302,"about_ca_topic_score_gemma":0.000045069835,"teacher_disagreement_score":0.10878101,"about_ca_system_score_codex":0.0002781396,"about_ca_system_score_gemma":0.00013177947,"threshold_uncertainty_score":0.57622135},"labels":[],"label_agreement":null},{"id":"W1582036651","doi":"10.1111/j.1600-0609.2005.00464.x","title":"Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?","year":2005,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; ABVD; Disease; Radiation therapy; Randomized controlled trial; Lymphoma; Chemotherapy; Stage (stratigraphy); Oncology; Intensive care medicine; Internal medicine; Surgery; Vincristine; Cyclophosphamide","score_opus":0.1503753029679155,"score_gpt":0.3515405477591824,"score_spread":0.20116524479126693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1582036651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035025973,0.96287274,0.00008529881,0.00056859903,0.000115913914,0.0012604481,0.00003423835,0.000006226565,0.000030584433],"genre_scores_gemma":[0.014196826,0.9834906,0.0014428254,0.00052092155,0.000101716774,0.000013796829,0.000011073065,0.00009608413,0.00012615033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728787,0.00056224776,0.0013185027,0.00025055886,0.00030845407,0.0002723556],"domain_scores_gemma":[0.9956264,0.001469546,0.0020068835,0.00047698367,0.00031851296,0.00010166377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060630956,0.00038074524,0.0024454608,0.0002589885,0.000042799384,0.000023120725,0.00030208766,0.00008745249,0.00006389644],"category_scores_gemma":[0.00026951145,0.00018540063,0.0005191741,0.0002070951,0.000121354205,0.00011804151,0.00004601,0.0001888989,0.000010902116],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010749367,0.0009244895,0.017449683,0.0037503506,0.0016508446,0.0021082328,0.00036319473,0.000005247592,1.2903318e-7,0.000018375436,0.0016389698,0.9710156],"study_design_scores_gemma":[0.010490531,0.0022018233,0.029896682,0.036127437,0.0020637717,0.0019038933,0.000029486191,0.000007013842,0.000009483538,5.3895343e-7,0.9170643,0.00020500505],"about_ca_topic_score_codex":0.0000110892925,"about_ca_topic_score_gemma":0.000005616164,"teacher_disagreement_score":0.97081053,"about_ca_system_score_codex":0.00024796574,"about_ca_system_score_gemma":0.0004905321,"threshold_uncertainty_score":0.7560418},"labels":[],"label_agreement":null},{"id":"W1794399453","doi":"10.1111/j.1600-0609.2005.00463.x","title":"How to define intermediate stage in Hodgkin's lymphoma?","year":2005,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stage (stratigraphy); Medicine; Internal medicine; Multivariate analysis; Population; Oncology; Lymphoma; Prospective cohort study; Proportional hazards model; Biology","score_opus":0.019069780225030735,"score_gpt":0.26287488639337947,"score_spread":0.24380510616834875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1794399453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97696316,0.0009248461,0.00018716419,0.017519576,0.00023743202,0.00012835259,0.0000030769017,0.000012869601,0.004023509],"genre_scores_gemma":[0.9937011,0.00012534017,0.0033225077,0.0018646795,0.00025065872,0.0000020962095,0.0000021573078,0.000028670122,0.00070279354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861467,0.00024272004,0.0005248629,0.0001589916,0.00018010437,0.00027863486],"domain_scores_gemma":[0.99910027,0.00007884423,0.0002552528,0.00020611827,0.00009557477,0.0002639709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045996736,0.00015881337,0.0005820779,0.00035846568,0.000020919366,0.000026350328,0.00015588096,0.000028013525,0.000085063024],"category_scores_gemma":[0.00022599203,0.000115150804,0.00013505104,0.00014421382,0.000048632857,0.000099397046,0.00006876389,0.00010492223,0.00023389523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019383525,0.0033676832,0.25475046,0.00016541914,0.0005500876,0.25789812,0.0038777695,0.00009998518,0.001847333,0.0024568138,0.026216473,0.44683152],"study_design_scores_gemma":[0.016031737,0.0030029176,0.589809,0.0005243222,0.000150554,0.034326676,0.00039659985,0.000028658518,0.00649452,0.000024995696,0.34895235,0.00025771002],"about_ca_topic_score_codex":0.000003084919,"about_ca_topic_score_gemma":0.000023144004,"teacher_disagreement_score":0.44657382,"about_ca_system_score_codex":0.00020067526,"about_ca_system_score_gemma":0.00011737672,"threshold_uncertainty_score":0.46957135},"labels":[],"label_agreement":null},{"id":"W1844789861","doi":"10.1034/j.1600-0609.2003.00049.x","title":"Complex interaction of Hb Hekinan [α27(B8) Glu–Asp] and Hb E [β26(B8) Glu–Lys] with a deletional α‐thalassemia 1 in a Thai family","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Associated Medical Services","funders":"Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; National Science and Technology Development Agency","keywords":"Thalassemia; Chemistry; Medicine; Genetics; Molecular biology; Biology","score_opus":0.019009262736221357,"score_gpt":0.2544439669909967,"score_spread":0.23543470425477533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1844789861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840094,0.0021560374,0.0007649557,0.0012647946,0.00021287616,0.00015361208,0.0000022209488,0.000011532309,0.011424598],"genre_scores_gemma":[0.99753493,0.00043970635,0.0014409034,0.0004398457,0.00004002831,9.318759e-7,0.0000043761943,0.00003651892,0.00006275982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977903,0.0005994919,0.0008513473,0.00020839172,0.00026276062,0.00028773246],"domain_scores_gemma":[0.9987925,0.00008511066,0.0005677833,0.00016952008,0.00021246506,0.00017257777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069107645,0.00020883011,0.0007239096,0.00036918584,0.000055617253,0.000013099528,0.000113483446,0.00008317613,0.000087218126],"category_scores_gemma":[0.00019988691,0.0001514543,0.00011352564,0.0002639655,0.0002450185,0.00011340473,0.000034711247,0.000652937,0.000017666038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013271398,0.004976344,0.70444936,0.0023825855,0.0027654492,0.11824984,0.012962065,0.0015240946,0.072209954,0.01683823,0.02238533,0.027985336],"study_design_scores_gemma":[0.028553793,0.008848764,0.54492646,0.0051911473,0.0007418441,0.32881472,0.013203613,0.00087406323,0.002436702,0.0005378631,0.064977475,0.0008935648],"about_ca_topic_score_codex":0.000014868813,"about_ca_topic_score_gemma":0.000015910313,"teacher_disagreement_score":0.21056488,"about_ca_system_score_codex":0.00004977321,"about_ca_system_score_gemma":0.0001507109,"threshold_uncertainty_score":0.61761266},"labels":[],"label_agreement":null},{"id":"W1875763950","doi":"10.1111/j.1600-0609.2005.00458.x","title":"Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long‐term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy","year":2005,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Disease; Medicine; Quality of life (healthcare); Foundation (evidence); Developing country; Gerontology; Intensive care medicine; Pediatrics; Environmental health; Family medicine; Pathology; Economic growth; Political science; Nursing","score_opus":0.042623741761769154,"score_gpt":0.32552792253056484,"score_spread":0.2829041807687957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1875763950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953599,0.0016289847,0.00028317588,0.0017215819,0.00029605484,0.00017140787,0.000012563145,0.000005097664,0.00052124565],"genre_scores_gemma":[0.9989704,0.000244623,0.0003486907,0.00014922142,0.00019148838,0.0000012280067,0.00003490931,0.000016500204,0.000042959597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972857,0.00067413674,0.0013386008,0.00021160241,0.00035409688,0.00013586311],"domain_scores_gemma":[0.99745095,0.00042563915,0.0013776654,0.0003193442,0.0002870815,0.00013934233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016870641,0.00014376789,0.0005807424,0.00012917937,0.00003682858,0.000015597552,0.00015016164,0.000033838583,0.000054671116],"category_scores_gemma":[0.0021318947,0.000099357574,0.00012114172,0.00012607411,0.00013131744,0.000103534294,0.00006811722,0.00016469174,0.0000043718946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012150664,0.0006052405,0.9791163,0.00006895246,0.00034125408,0.0030249024,0.000521655,0.000081935934,0.00029489194,0.000063343294,0.00024096761,0.014425468],"study_design_scores_gemma":[0.0022952273,0.000111963556,0.99518055,0.0004851464,0.00016078452,0.0006444367,0.00009818983,0.000046269703,0.00067356543,0.00001965969,0.00021002813,0.00007420495],"about_ca_topic_score_codex":0.00025588955,"about_ca_topic_score_gemma":0.00018496852,"teacher_disagreement_score":0.0160642,"about_ca_system_score_codex":0.00012790949,"about_ca_system_score_gemma":0.0002450871,"threshold_uncertainty_score":0.4051684},"labels":[],"label_agreement":null},{"id":"W1896961192","doi":"10.1111/j.1600-0609.2010.01419.x","title":"Effective ex vivo expansion of hematopoietic stem cells using osteoblast‐differentiated mesenchymal stem cells is CXCL12 dependent","year":2010,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Stem cell; Mesenchymal stem cell; Ex vivo; Cell biology; CD34; CD38; Haematopoiesis; Cord blood; Biology; Cytokine; Chemokine; Bone marrow; Immunology; In vivo; Inflammation","score_opus":0.018893009431150867,"score_gpt":0.2565551116369715,"score_spread":0.23766210220582062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1896961192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862634,0.00019773672,0.010223838,0.0001036753,0.0016821701,0.0006249934,0.000017531653,0.000032666783,0.00085398764],"genre_scores_gemma":[0.99748546,0.000045099365,0.0019506537,0.00009048182,0.00013318207,0.000001634663,0.0000018371801,0.00010038766,0.00019128769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953985,0.0012495371,0.0017385876,0.0003953308,0.0007334061,0.00048464016],"domain_scores_gemma":[0.9967441,0.000474746,0.0013692428,0.0005117363,0.0005237693,0.00037639035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015185833,0.00041226653,0.0014235091,0.00048053835,0.00008632377,0.000026554972,0.00034314484,0.00018169441,0.0004533811],"category_scores_gemma":[0.000020527526,0.00033531408,0.00037977495,0.00023854269,0.00021422977,0.000151326,0.00008500738,0.0008774257,0.00013867833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005408832,0.00024845486,0.0015244869,0.0010718605,0.00027329125,0.0063590007,0.0037695784,0.00003722039,0.9850043,0.000064134794,0.00020072998,0.0009060539],"study_design_scores_gemma":[0.0037306575,0.00087309803,0.0007470011,0.0011108466,0.00064727146,0.029751591,0.0012374962,0.00040152326,0.96112907,0.000014929995,0.00010612733,0.00025036468],"about_ca_topic_score_codex":0.00000603402,"about_ca_topic_score_gemma":0.000003036926,"teacher_disagreement_score":0.023875212,"about_ca_system_score_codex":0.000054227934,"about_ca_system_score_gemma":0.00016981272,"threshold_uncertainty_score":0.9999099},"labels":[],"label_agreement":null},{"id":"W1905318784","doi":"10.1111/j.1600-0609.2009.01357.x","title":"BCR‐ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients","year":2009,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Myeloid leukemia; Chromosomal translocation; clone (Java method); Immunology; Population; Biology; Immune system; ABL; Leukemia; Cancer research; Tyrosine kinase; Medicine; Receptor; Gene; Genetics","score_opus":0.008542085462240891,"score_gpt":0.23313671559384858,"score_spread":0.2245946301316077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1905318784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929762,0.0028106074,0.00012660076,0.00096293254,0.00029205126,0.00024491284,0.000009785266,0.000018819737,0.0025580742],"genre_scores_gemma":[0.9974155,0.0011583903,0.00071716367,0.00028587962,0.00013810037,6.3580336e-7,0.000014612108,0.000040797448,0.00022894637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975718,0.0005051134,0.0009501776,0.00027858472,0.0002461876,0.00044812122],"domain_scores_gemma":[0.99885774,0.00011210172,0.00041145494,0.00027472898,0.00010382057,0.00024017872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005648711,0.00027634721,0.0009071794,0.000332313,0.000055867553,0.000017202077,0.00021178034,0.00007970564,0.00014441878],"category_scores_gemma":[0.000057948615,0.00022563836,0.00013168146,0.00019115546,0.00013018896,0.00012927216,0.000034766905,0.00062862516,0.00006777949],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053010904,0.0009962807,0.018916281,0.00029560228,0.0009082667,0.25727436,0.007950858,0.0002078539,0.66707236,0.000338115,0.0022884125,0.03845053],"study_design_scores_gemma":[0.040111996,0.008337463,0.5629038,0.0032809984,0.0006820541,0.12203169,0.00022661472,0.00025146018,0.25881636,0.00012373328,0.0026211825,0.00061264547],"about_ca_topic_score_codex":0.000012402369,"about_ca_topic_score_gemma":0.000006966016,"teacher_disagreement_score":0.5439875,"about_ca_system_score_codex":0.0011553414,"about_ca_system_score_gemma":0.00056449673,"threshold_uncertainty_score":0.9201265},"labels":[],"label_agreement":null},{"id":"W1965573028","doi":"10.1111/ejh.12338","title":"Early lymphocyte recovery at 28 d post‐transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts","year":2014,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Cumulative incidence; Lymphocyte; Transplantation; Donor lymphocyte infusion; Hematopoietic stem cell transplantation; Gastroenterology; Leukemia; Myeloid; Incidence (geometry); Haematopoiesis; Stem cell; Biology","score_opus":0.004312094474801542,"score_gpt":0.18298448789232943,"score_spread":0.17867239341752789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965573028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603313,0.000121132965,0.0019100854,0.00004458095,0.00012570547,0.0004240074,0.00019063879,0.000016133741,0.0011345561],"genre_scores_gemma":[0.9976946,0.00045887148,0.001578982,0.000055202912,0.000023745495,0.0000020975313,0.000039101298,0.0000785456,0.000068848574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630094,0.0010744708,0.0013681024,0.00032392604,0.0005788907,0.00035366937],"domain_scores_gemma":[0.99736625,0.00023019993,0.0013766447,0.0003398381,0.0004766749,0.00021039254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007633266,0.00033673583,0.001235188,0.0003762737,0.00004609932,0.0000062567674,0.00023379445,0.00011003574,0.00003775161],"category_scores_gemma":[0.000014787517,0.00023727516,0.00017920483,0.00025551146,0.00022691434,0.00015543615,0.000013903778,0.0004323857,0.0000070978444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10035373,0.0011395029,0.8054896,0.00238807,0.0028914125,0.013112479,0.026939346,0.00049809465,0.046262357,0.000017026401,0.000047034722,0.0008613266],"study_design_scores_gemma":[0.04588229,0.02229711,0.71462727,0.005589183,0.004196446,0.019590052,0.00032466772,0.0001059573,0.18694623,0.0000055608257,0.00002120813,0.00041405216],"about_ca_topic_score_codex":0.00003199551,"about_ca_topic_score_gemma":0.000014180024,"teacher_disagreement_score":0.14068387,"about_ca_system_score_codex":0.00012900073,"about_ca_system_score_gemma":0.00029591672,"threshold_uncertainty_score":0.96758},"labels":[],"label_agreement":null},{"id":"W1967630686","doi":"10.1034/j.1600-0609.2003.00146.x","title":"Shwachman–Diamond syndrome with late‐onset neutropenia and fatal acute myeloid leukaemia without maturation: a case report","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neutropenia; Medicine; Myeloid leukaemia; Bone marrow; Chemotherapy; Myeloid; Congenital Neutropenia; Leukemia; Internal medicine; Gastroenterology","score_opus":0.006528774815631207,"score_gpt":0.22411312398542887,"score_spread":0.21758434916979766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967630686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594086,0.0014225199,0.00041554787,0.00014533699,0.000120975485,0.00011331498,0.000009779977,0.00000608368,0.0018255999],"genre_scores_gemma":[0.996605,0.000108904125,0.002618101,0.0001419709,0.000029934574,0.0000018434864,0.000027776869,0.000037693877,0.00042876718],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99868864,0.00030662544,0.00042323358,0.0002622487,0.00010112452,0.00021814548],"domain_scores_gemma":[0.99906963,0.000009068927,0.00039710524,0.0002666718,0.000108729546,0.00014880316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000275438,0.00020537042,0.00035675353,0.00006458003,0.00011187127,0.000041028303,0.000107814776,0.00005900346,0.000018150547],"category_scores_gemma":[0.000035071134,0.00015054132,0.00007022983,0.00006473001,0.000142371,0.000016781449,0.000051003302,0.00016596678,0.000010265381],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042763987,0.00012358009,0.021051371,0.000021329332,0.0007200008,0.97284335,0.00010521841,0.000013492546,0.0031065813,0.000062524894,0.0012327927,0.0002920931],"study_design_scores_gemma":[0.0021861612,0.0011712881,0.003436697,0.000023433076,0.00021476916,0.98297185,0.0000941804,0.0000019364088,0.0056442777,0.000023478715,0.0040579084,0.00017405022],"about_ca_topic_score_codex":0.0000037329082,"about_ca_topic_score_gemma":0.000022203883,"teacher_disagreement_score":0.017614674,"about_ca_system_score_codex":0.0000064275882,"about_ca_system_score_gemma":0.000087070366,"threshold_uncertainty_score":0.6138897},"labels":[],"label_agreement":null},{"id":"W1967872782","doi":"10.1111/j.1600-0609.2004.00396.x","title":"Hemoglobin oxygen saturation discrepancy using various methods in patients with sickle cell vaso‐occlusive painful crisis","year":2005,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dartmouth General Hospital; Dalhousie University; University of Saskatchewan","funders":"","keywords":"Pulse oximetry; Vaso-occlusive crisis; Oxygen–haemoglobin dissociation curve; Medicine; Limits of agreement; Hemoglobin; Internal medicine; Anesthesia; Oxygen saturation; Hemoglobinopathy; Oxygen; Gastroenterology; Cardiology; Sickle cell anemia; Nuclear medicine; Disease; Chemistry","score_opus":0.008543875382826622,"score_gpt":0.27051220799579273,"score_spread":0.2619683326129661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967872782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810362,0.0010669003,0.012895433,0.001607778,0.00020684295,0.0002528296,0.0000020246196,0.000018375507,0.0029136422],"genre_scores_gemma":[0.9056287,0.00006727903,0.09331322,0.0007905985,0.00009149542,4.1792757e-7,0.000006713699,0.00004763885,0.000053944954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739856,0.0009565674,0.0008475229,0.00021511545,0.00024613048,0.0003360986],"domain_scores_gemma":[0.99865377,0.00007564411,0.0005990547,0.00022676615,0.00026797756,0.00017676395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008896759,0.00021692233,0.0006412527,0.00029883225,0.000081252234,0.000018496528,0.00014571624,0.00008467699,0.00007925123],"category_scores_gemma":[0.00013180038,0.00015077465,0.0001321355,0.00029233674,0.00007760747,0.0001786276,0.0000603843,0.000556002,0.000026492015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017218955,0.01296256,0.5960369,0.0016567789,0.0028113278,0.06391239,0.05178041,0.022527969,0.018186962,0.0012559769,0.026368113,0.18528166],"study_design_scores_gemma":[0.12199258,0.019979337,0.6527648,0.004002443,0.0047534793,0.055923596,0.019300934,0.011709037,0.015898447,0.00079531956,0.08892719,0.0039528385],"about_ca_topic_score_codex":0.000013435614,"about_ca_topic_score_gemma":0.0000065599643,"teacher_disagreement_score":0.18132882,"about_ca_system_score_codex":0.00011914927,"about_ca_system_score_gemma":0.00013291113,"threshold_uncertainty_score":0.61484116},"labels":[],"label_agreement":null},{"id":"W1972576558","doi":"10.1111/ejh.12041","title":"A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia","year":2012,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Waterloo; McMaster University","funders":"Canadian Institutes of Health Research; Amgen Canada; Mitacs; Canada Research Chairs","keywords":"Medicine; Bone marrow; Immune thrombocytopenia; Confidence interval; Megakaryocyte; Biopsy; Internal medicine; Pathology; Platelet; Gastroenterology","score_opus":0.020301579440618923,"score_gpt":0.25755128357753115,"score_spread":0.23724970413691224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972576558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667233,0.00044305684,0.000015172526,0.00008261824,0.00008707491,0.00030438934,0.0000014573092,0.000004096758,0.0023898245],"genre_scores_gemma":[0.99938273,0.00001209402,0.00048702606,0.000042674543,0.0000143294355,0.0000010876711,0.000005882502,0.000021040885,0.000033135122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986002,0.0003049296,0.0006095256,0.00007978008,0.00021743521,0.00018813192],"domain_scores_gemma":[0.9990996,0.000041830397,0.00046428124,0.00016395414,0.0001462736,0.00008406374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043864653,0.00011210361,0.0008361654,0.00026862137,0.0000251735,0.0000033363585,0.00007774089,0.000019668654,0.000045246215],"category_scores_gemma":[0.000052299725,0.00007589748,0.000047843732,0.00016791525,0.0000514811,0.00013788804,0.00003792599,0.00018377138,0.0000144722135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010325453,0.00888127,0.97832924,0.000043666736,0.00028556766,0.007326766,0.0021176352,0.0000018728808,0.00020098487,0.000022374468,0.000093847,0.0016642236],"study_design_scores_gemma":[0.016564915,0.0033394494,0.9764451,0.00010303358,0.00017363773,0.0026688185,0.0004868523,5.265022e-7,0.000091394795,0.000004256344,0.00006118114,0.00006087275],"about_ca_topic_score_codex":0.000004719916,"about_ca_topic_score_gemma":0.0000054155194,"teacher_disagreement_score":0.01553237,"about_ca_system_score_codex":0.000031766584,"about_ca_system_score_gemma":0.00003856448,"threshold_uncertainty_score":0.30950093},"labels":[],"label_agreement":null},{"id":"W1986010889","doi":"10.1111/ejh.12052","title":"Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta‐analysis and clinical characterization","year":2012,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Dermatology Foundation; Dermatology Foundation; American Society of Hematology","keywords":"Nilotinib; Dasatinib; Medicine; Rash; Incidence (geometry); Internal medicine; Tyrosine-kinase inhibitor; Adverse effect; Dermatology; Myeloid leukemia; Imatinib; Cancer","score_opus":0.0988586204046646,"score_gpt":0.3572264443656417,"score_spread":0.2583678239609771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986010889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013468398,0.9851069,0.00018176228,0.0003856609,0.00018223978,0.00053218834,0.0000203058,0.000015599819,0.00010698203],"genre_scores_gemma":[0.009281563,0.9888556,0.0009712556,0.00015397108,0.00040683197,0.0000050877243,0.000102306745,0.000092149865,0.00013125448],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99468756,0.0028985848,0.0015560241,0.00032606322,0.00025633292,0.00027545443],"domain_scores_gemma":[0.9961351,0.00068186776,0.002308379,0.0003970995,0.00016266707,0.00031487053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022006761,0.0004462042,0.004553707,0.00039572135,0.000088003886,0.000029894698,0.00016950905,0.00013516012,0.00010395262],"category_scores_gemma":[0.00019121736,0.0002104277,0.0010155129,0.00038092525,0.0003568336,0.00009755687,0.00011841455,0.00086830126,0.000025213187],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024587917,0.0004867246,0.005692035,0.0058424203,0.37923938,0.01090297,0.0005021005,3.090645e-7,0.00000508341,0.000031139512,0.00029736178,0.5967546],"study_design_scores_gemma":[0.0020713743,0.0005664185,0.0037336976,0.0008814806,0.54393464,0.020452825,0.000030797684,0.000004848182,0.0000018147826,3.5061657e-7,0.42810497,0.00021678588],"about_ca_topic_score_codex":0.0000026519483,"about_ca_topic_score_gemma":0.00000551621,"teacher_disagreement_score":0.5965378,"about_ca_system_score_codex":0.00006037177,"about_ca_system_score_gemma":0.00025785936,"threshold_uncertainty_score":0.8580992},"labels":[],"label_agreement":null},{"id":"W1990211195","doi":"10.1111/j.1600-0609.2007.00903.x","title":"Analysis of 6q deletion in Waldenstrom macroglobulinemia","year":2007,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Research; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Waldenstrom macroglobulinemia; Macroglobulinemia; Fluorescence in situ hybridization; Interphase; Cytogenetics; Biology; Pathology; Multiple myeloma; Chromosome; Medicine; Immunology; Genetics; Gene; Lymphoma","score_opus":0.01728273097224054,"score_gpt":0.3187438329478327,"score_spread":0.30146110197559217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990211195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917423,0.0005118941,0.0028382349,0.00035274297,0.00010351217,0.00007173795,0.0000013876404,0.00000592675,0.0043722657],"genre_scores_gemma":[0.99733585,0.000078446035,0.0022802453,0.000113749156,0.000083410494,1.1737275e-7,0.0000046802043,0.000017493829,0.00008602931],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9977507,0.0003045288,0.001127508,0.00013453553,0.0003746556,0.00030804373],"domain_scores_gemma":[0.99861276,0.00022094933,0.00046288324,0.0002422312,0.00030001838,0.00016118614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028120282,0.000102797225,0.00079069595,0.001215957,0.000014389553,0.0000043438913,0.00019543935,0.000048936305,0.00019470087],"category_scores_gemma":[0.0004748627,0.00008300277,0.0002512846,0.0009365609,0.00015337962,0.000041702242,0.00005857777,0.00035103416,0.000028518592],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009272738,0.0015111567,0.3592518,0.0007648816,0.006949236,0.50763184,0.004474259,0.0025269678,0.040206455,0.0014934663,0.004926429,0.06099077],"study_design_scores_gemma":[0.06330595,0.003691085,0.6889854,0.0010574908,0.0049741697,0.18187271,0.0022418485,0.013528569,0.03088087,0.00011432859,0.00879176,0.0005558082],"about_ca_topic_score_codex":0.000032783057,"about_ca_topic_score_gemma":0.000050884846,"teacher_disagreement_score":0.3297336,"about_ca_system_score_codex":0.001155154,"about_ca_system_score_gemma":0.00073931424,"threshold_uncertainty_score":0.33847547},"labels":[],"label_agreement":null},{"id":"W1990418413","doi":"10.1111/ejh.12455","title":"How we manage <scp>JAK</scp> inhibition in allogeneic transplantation for myelofibrosis","year":2014,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Discontinuation; Janus kinase; Transplantation; Tofacitinib; Hematopoietic stem cell transplantation; Adverse effect; Stem cell; Constitutional symptoms; Internal medicine; Immunology; Oncology; Cytokine; Disease; Bone marrow","score_opus":0.04522550680314516,"score_gpt":0.30919926107075374,"score_spread":0.2639737542676086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990418413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031340613,0.98944974,0.0035572562,0.0011725125,0.0004039918,0.0013185424,0.000051964827,0.000019079169,0.00089287385],"genre_scores_gemma":[0.0037000165,0.99263495,0.0024824436,0.00015823664,0.00035726916,0.000060691975,0.00019978941,0.00011237762,0.00029420533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653053,0.0011607079,0.0013402045,0.00036542155,0.00024118247,0.00036197095],"domain_scores_gemma":[0.9971964,0.0008402591,0.0013722698,0.00023214874,0.00017432348,0.00018463284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009364534,0.00048100037,0.0030107014,0.000767736,0.000060697585,0.000050695046,0.00013105845,0.00017609193,0.000011446267],"category_scores_gemma":[0.00027317353,0.00034183357,0.0008239519,0.00021099098,0.00007283673,0.00009994792,0.00002375166,0.0004514201,0.00004960477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017905762,0.0008373254,0.00039172714,0.08384733,0.0018751486,0.046049915,0.00093869324,0.000007608166,0.000039638217,0.002175838,0.011824666,0.85183305],"study_design_scores_gemma":[0.0029294046,0.0014950095,0.00031153942,0.02313253,0.0027275588,0.030449696,0.000048125497,0.0000026028831,0.00012609089,0.00005721562,0.93859315,0.00012708352],"about_ca_topic_score_codex":6.646216e-7,"about_ca_topic_score_gemma":0.000009150557,"teacher_disagreement_score":0.9267685,"about_ca_system_score_codex":0.00011552595,"about_ca_system_score_gemma":0.0001228138,"threshold_uncertainty_score":0.9999034},"labels":[],"label_agreement":null},{"id":"W1993056188","doi":"10.1034/j.1600-0609.2002.02802.x","title":"Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22)","year":2002,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Fulminant; Medicine; Lysis; Immunology","score_opus":0.01763568963201568,"score_gpt":0.22722290478281376,"score_spread":0.2095872151507981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993056188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850223,0.0015037955,0.0003044196,0.0022275096,0.00020203114,0.00018256073,0.000002988432,0.000029658588,0.010524745],"genre_scores_gemma":[0.9951664,0.00025705987,0.0025411905,0.00048528265,0.000081915656,0.00000232318,0.0000049558253,0.000080615064,0.0013802507],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9965885,0.0007272413,0.001281318,0.00034444756,0.00046528887,0.00059318414],"domain_scores_gemma":[0.9980624,0.000113852155,0.000770476,0.00047053403,0.00021001388,0.00037273203],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001031808,0.0003538975,0.0016226252,0.0008003264,0.000075432225,0.000022450135,0.00040959168,0.000073793395,0.0009445501],"category_scores_gemma":[0.00017492054,0.00024483245,0.00028763223,0.00066553213,0.00020755445,0.00013788076,0.000081799306,0.0008100002,0.00049729616],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053868396,0.00061992544,0.02925862,0.0001708658,0.0008483789,0.9543545,0.0010561463,0.00003292554,0.0058906763,0.00021629526,0.0033361826,0.003676752],"study_design_scores_gemma":[0.005203316,0.0030718136,0.049698558,0.0005587325,0.00084753707,0.9353879,0.00021577635,0.00008135687,0.0013126028,0.00008275847,0.0032015748,0.0003380854],"about_ca_topic_score_codex":0.000007489933,"about_ca_topic_score_gemma":0.000009469785,"teacher_disagreement_score":0.02043994,"about_ca_system_score_codex":0.00015675314,"about_ca_system_score_gemma":0.00007739886,"threshold_uncertainty_score":0.9999687},"labels":[],"label_agreement":null},{"id":"W1997971414","doi":"10.1034/j.1600-0609.2001.066005347.x","title":"Cyclosporin A in the treatment of refractory immune thrombocytopenia purpura in children","year":2001,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Adverse effect; Methylprednisolone; Splenectomy; Refractory (planetary science); Autoimmune thrombocytopenia; Platelet; Gastroenterology; Regimen; Internal medicine; Salvage therapy; Immune thrombocytopenia; Surgery; Chemotherapy; Spleen","score_opus":0.017566489034681883,"score_gpt":0.2725336860001401,"score_spread":0.2549671969654582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997971414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991019,0.004406905,0.0000049606597,0.0008386623,0.000060980372,0.00023290963,0.0000014379173,0.0000031268146,0.003431992],"genre_scores_gemma":[0.99588,0.0038056718,0.00012963389,0.000079413076,0.000032736578,0.0000014443169,0.000005265785,0.00001563095,0.000050183644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854434,0.00035237498,0.0006696988,0.0001048874,0.00013960646,0.00018911656],"domain_scores_gemma":[0.9993208,0.00005506344,0.00033083465,0.00021442506,0.000035683817,0.000043207347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003603143,0.00013237409,0.0008006624,0.00021608091,0.000017617263,0.0000045981274,0.00015781978,0.000028839728,0.000058642127],"category_scores_gemma":[0.000029738178,0.00007588693,0.00012949428,0.00018959031,0.00006972467,0.000055165583,0.000012054818,0.00017108668,0.000024306744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010101123,0.004551025,0.82520473,0.000014416247,0.00032417962,0.14556631,0.0027595733,0.00001010362,0.00070760574,0.0001108451,0.00013969369,0.019601373],"study_design_scores_gemma":[0.007511293,0.0028178864,0.92202353,0.000101798956,0.00008672626,0.06415684,0.00032906365,0.0000023120576,0.00021716453,0.00006531935,0.0026257196,0.000062354506],"about_ca_topic_score_codex":0.000055027387,"about_ca_topic_score_gemma":0.000027302765,"teacher_disagreement_score":0.096818775,"about_ca_system_score_codex":0.000054449352,"about_ca_system_score_gemma":0.000045489356,"threshold_uncertainty_score":0.30945793},"labels":[],"label_agreement":null},{"id":"W2001492984","doi":"10.1034/j.1600-0609.2000.90069.x","title":"Flow cytometric analysis of defensins in blood and marrow neutrophils","year":2000,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Bone marrow; Flow cytometry; Myeloid; Granulocyte; Biology; Molecular biology; Immunology; Myeloperoxidase; Alkaline phosphatase; Chemistry; Inflammation; Biochemistry; Enzyme","score_opus":0.009413831502153126,"score_gpt":0.20826294157902994,"score_spread":0.1988491100768768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001492984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533707,0.0026138157,0.00005769262,0.00016310926,0.00010814898,0.00003498825,0.000013979711,0.0000055990677,0.0016655837],"genre_scores_gemma":[0.9983332,0.0008459352,0.00042609658,0.000102165366,0.00001545285,1.0447117e-7,0.000005497821,0.000012532046,0.0002589703],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983809,0.0005986254,0.0006372074,0.00013693288,0.000027802032,0.00021853454],"domain_scores_gemma":[0.9993004,0.00014708505,0.0003296555,0.00013544815,0.00006282441,0.000024538527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004648623,0.0001266133,0.00078181806,0.0011387916,0.000041927084,0.000007813322,0.00017102067,0.00006155247,0.0007813065],"category_scores_gemma":[0.000057142275,0.00010520603,0.00018774801,0.0007152443,0.00027867762,0.00008410257,0.000038242873,0.0002784364,0.000036560385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001968889,0.0015839657,0.17255464,0.00015968968,0.011519687,0.013761742,0.003756162,0.0037540442,0.72238934,0.0010717066,0.004492593,0.06298755],"study_design_scores_gemma":[0.013372607,0.0036215691,0.8047336,0.00042048533,0.008122613,0.060778197,0.0012207374,0.00014952155,0.091853134,0.00022527274,0.014398404,0.0011038727],"about_ca_topic_score_codex":0.00001611047,"about_ca_topic_score_gemma":0.0000145162685,"teacher_disagreement_score":0.63217896,"about_ca_system_score_codex":0.000006290715,"about_ca_system_score_gemma":0.000020507794,"threshold_uncertainty_score":0.8554758},"labels":[],"label_agreement":null},{"id":"W2003806098","doi":"10.1111/j.1600-0609.2007.00913.x","title":"Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome)","year":2007,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bleeding diathesis; Bernard–Soulier syndrome; Platelet disorder; Splenectomy; Surgery; Internal medicine; Platelet","score_opus":0.01492468069202792,"score_gpt":0.2779179364442399,"score_spread":0.262993255752212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003806098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554069,0.0011185774,0.0007703754,0.0003841749,0.00026547152,0.00017156276,0.0000026670552,0.000008910543,0.041871354],"genre_scores_gemma":[0.9936568,0.0001528563,0.005315461,0.00018644627,0.000032599128,3.9970425e-7,0.0000040870423,0.000028113876,0.00062319444],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99860245,0.00014036868,0.00067450816,0.00013013155,0.00021599211,0.00023652587],"domain_scores_gemma":[0.9991734,0.000041932544,0.00033144638,0.00018290778,0.00013486057,0.00013547398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006419153,0.00015078644,0.00074493967,0.00016915723,0.000043604985,0.000005557127,0.00014681743,0.000031268977,0.00030951848],"category_scores_gemma":[0.000018304854,0.00010912304,0.0001530824,0.00012453466,0.00012875546,0.000075327225,0.00006109199,0.00020663363,0.00010016256],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074481545,0.000626776,0.003949436,0.00021851729,0.0014359688,0.9816314,0.0007274448,0.0000051085362,0.0010281159,0.0008005773,0.0023723207,0.006459508],"study_design_scores_gemma":[0.014290918,0.0049226764,0.20603323,0.0011253905,0.00094016595,0.7486039,0.0038026667,0.000008979481,0.007468283,0.0001447197,0.01233421,0.0003248635],"about_ca_topic_score_codex":0.000002370042,"about_ca_topic_score_gemma":0.0000019502731,"teacher_disagreement_score":0.23302752,"about_ca_system_score_codex":0.00003166098,"about_ca_system_score_gemma":0.000030031624,"threshold_uncertainty_score":0.44499084},"labels":[],"label_agreement":null},{"id":"W2010787620","doi":"10.1034/j.1600-0609.2001.00503.x","title":"Bronchiolitis obliterans organizing pneumonia in a patient with chronic myelogenous leukemia developing after initiation of interferon and cytosine arabinoside","year":2001,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Saskatoon Medical Imaging; Saskatchewan Cancer Agency","funders":"","keywords":"Bronchiolitis obliterans organizing pneumonia; Medicine; Bronchiolitis obliterans; Chronic myelogenous leukemia; Pneumonia; Discontinuation; Leukemia; Gastroenterology; Lung; Pathology; Internal medicine; Lung transplantation","score_opus":0.0076239092973383014,"score_gpt":0.21233338178641742,"score_spread":0.20470947248907911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010787620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508566,0.0024505577,0.0012463705,0.00046902674,0.00008919791,0.00012577952,0.00000410441,0.0000072864427,0.00052202336],"genre_scores_gemma":[0.9984536,0.00043548096,0.0007223045,0.0002588132,0.00008837788,0.0000014475866,0.0000046897644,0.000029000512,0.000006273623],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99858165,0.00023037818,0.00068769907,0.00014741873,0.00013533638,0.00021750583],"domain_scores_gemma":[0.9992367,0.000036852492,0.00033998373,0.00010914006,0.00017911405,0.00009822912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019439077,0.00014702928,0.0004796275,0.00027061545,0.000027861754,0.000011566459,0.000070824666,0.00003377694,0.000025110141],"category_scores_gemma":[0.00004239548,0.000114740295,0.000057768677,0.00015667509,0.00008350119,0.00013351107,0.000044777116,0.00023473545,0.0000036060367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05817324,0.0008390587,0.29322055,0.0037424625,0.0007589571,0.41778737,0.019999126,0.0002238484,0.15532479,0.0015384436,0.00012948098,0.048262656],"study_design_scores_gemma":[0.006647588,0.029685643,0.64091444,0.012614418,0.00039412666,0.30135038,0.0008063285,0.00024220184,0.005253604,0.000103746774,0.0014849332,0.0005025921],"about_ca_topic_score_codex":0.000016823276,"about_ca_topic_score_gemma":0.000027409991,"teacher_disagreement_score":0.3476939,"about_ca_system_score_codex":0.00024450006,"about_ca_system_score_gemma":0.00025717917,"threshold_uncertainty_score":0.46789733},"labels":[],"label_agreement":null},{"id":"W2025533780","doi":"10.1111/ejh.12491","title":"Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation","year":2014,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation; Celgene","keywords":"Medicine; Refractory (planetary science); Internal medicine; Multiple myeloma; Gastroenterology; Clinical endpoint; Adverse effect; Chromosomal translocation; Dexamethasone; Clinical trial; Surgery; Biology","score_opus":0.029760721526495826,"score_gpt":0.311031236984917,"score_spread":0.2812705154584212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025533780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982443,0.000029082466,0.00046755478,0.00008778298,0.00004982869,0.00076565094,0.0000039898823,0.000012197218,0.00033961248],"genre_scores_gemma":[0.9978446,0.0000085893325,0.00190923,0.000040561186,0.000037454498,0.000005772877,0.000012051955,0.000050703115,0.000091045265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971849,0.0009934906,0.0007946264,0.00022440657,0.0005186769,0.00028394695],"domain_scores_gemma":[0.99817896,0.00024290277,0.00059934787,0.0003181063,0.00042997868,0.00023071567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068449334,0.00020601679,0.00086321175,0.0003851226,0.000046990535,0.000008849286,0.0001641307,0.00003383333,0.00007183653],"category_scores_gemma":[0.00045408163,0.00010459754,0.000045840094,0.0002620851,0.00013055463,0.00013920417,0.000019144025,0.00036159996,0.000011629984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10272968,0.012330272,0.8508988,0.0001238813,0.00041194895,0.007232039,0.002134569,0.000012564567,0.00021096965,0.0000028369882,0.00006163513,0.0238508],"study_design_scores_gemma":[0.2229108,0.12150124,0.6496,0.0007766026,0.00022886856,0.0021614851,0.001194573,0.0002524713,0.0007392824,0.0000012170931,0.00044244807,0.00019095483],"about_ca_topic_score_codex":0.000017577364,"about_ca_topic_score_gemma":0.00024879663,"teacher_disagreement_score":0.20129876,"about_ca_system_score_codex":0.00004377321,"about_ca_system_score_gemma":0.00016427635,"threshold_uncertainty_score":0.42653638},"labels":[],"label_agreement":null},{"id":"W2026357830","doi":"10.1111/j.1600-0609.2004.00348.x","title":"Recommendations on haematological criteria for the diagnosis of epoetin‐induced pure red cell aplasia","year":2004,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"Albert-Ludwigs-Universität Freiburg; University Health Network","keywords":"Pure red cell aplasia; Medicine; Erythropoietin; Anemia; Epoetin alfa; Intensive care medicine; Disease; Rare disease; Internal medicine; Bone marrow; Erythropoiesis; Aplasia; Pediatrics","score_opus":0.1319050324320348,"score_gpt":0.37397484038988393,"score_spread":0.24206980795784913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026357830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011407596,0.9864525,0.0006718433,0.007212942,0.0013568305,0.001411378,0.000056878755,0.0000210548,0.0016757783],"genre_scores_gemma":[0.011063878,0.9861989,0.0020104216,0.00020411714,0.00029877384,0.00003531801,0.00004560602,0.00009822912,0.000044766686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614507,0.001062591,0.0019503067,0.00029937227,0.00023800228,0.00030467493],"domain_scores_gemma":[0.9959939,0.001392009,0.0017066583,0.0004658417,0.00027626246,0.00016528966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012816302,0.00041151632,0.002979243,0.00030903044,0.00014045936,0.000019186042,0.00048110908,0.00022889192,0.0002754225],"category_scores_gemma":[0.00045366422,0.00022321944,0.0012422932,0.0002275216,0.0001300109,0.000038788166,0.00006023892,0.001017458,0.000035515746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089818164,0.0029372831,0.00006655568,0.05144931,0.002100547,0.013478623,0.0005129827,0.000002404965,0.000042153697,0.003604741,0.040798694,0.88410854],"study_design_scores_gemma":[0.002623592,0.0029854581,0.000036350582,0.02595248,0.0043834955,0.030170944,0.00006667251,0.0000011166253,0.00016075483,0.0001064768,0.9332899,0.00022276423],"about_ca_topic_score_codex":0.0000010488739,"about_ca_topic_score_gemma":0.000001094326,"teacher_disagreement_score":0.8924912,"about_ca_system_score_codex":0.000041543935,"about_ca_system_score_gemma":0.00023129043,"threshold_uncertainty_score":0.91026247},"labels":[],"label_agreement":null},{"id":"W2035074950","doi":"10.1046/j.0902-4441.2004.00168.x","title":"Clinicopathological correlations of TIMP‐1 and TIMP‐2 in Hodgkin's lymphoma","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society","keywords":"Lymphoma; Nodular sclerosis; Immunostaining; Pathology; Medicine; Immunohistochemistry; Hodgkin lymphoma; Matrix metalloproteinase; Non-Hodgkin's lymphoma; Connective tissue; Internal medicine","score_opus":0.013220676770787386,"score_gpt":0.24358121841907357,"score_spread":0.23036054164828618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035074950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120796,0.0014357592,0.0030808584,0.000066765606,0.00019337492,0.000056837172,0.0000027113542,0.0000019471045,0.0039538043],"genre_scores_gemma":[0.99711794,0.00018606117,0.0024509283,0.00013370604,0.000052355186,5.4940347e-7,0.0000027814815,0.000011861965,0.000043839285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985016,0.0006726129,0.0004994005,0.00012902622,0.000063986714,0.0001333579],"domain_scores_gemma":[0.9994031,0.000028937726,0.0003029602,0.00013303537,0.00006551278,0.00006642739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008752238,0.00008945473,0.00025736255,0.000078121215,0.000023276452,0.000004601434,0.000110377594,0.00006762209,0.000026903188],"category_scores_gemma":[0.00040330176,0.00007414747,0.000065658474,0.000053564156,0.0001009853,0.000004918424,0.000048136015,0.00009900692,0.000008218558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069803745,0.0009362736,0.05362591,0.000082914885,0.00011394844,0.007534989,0.00036746872,0.00009458503,0.9014186,0.017416833,0.0060209637,0.01168945],"study_design_scores_gemma":[0.010856855,0.009126516,0.0506162,0.0002816458,0.00013761721,0.060393326,0.0004976984,0.000071591894,0.80368847,0.0046047308,0.058972202,0.00075315876],"about_ca_topic_score_codex":3.6814788e-7,"about_ca_topic_score_gemma":8.31168e-7,"teacher_disagreement_score":0.09773016,"about_ca_system_score_codex":0.0000037778939,"about_ca_system_score_gemma":0.000052636187,"threshold_uncertainty_score":0.30236462},"labels":[],"label_agreement":null},{"id":"W2035077408","doi":"10.1111/j.1600-0609.2009.01230.x","title":"Rivaroxaban – an oral, direct Factor Xa inhibitor – lessons from a broad clinical study programme","year":2009,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bayer HealthCare; Bayer","keywords":"Rivaroxaban; Medicine; Dosing; Atrial fibrillation; Stroke (engine); Intensive care medicine; Apixaban; Venous thromboembolism; Internal medicine; Warfarin; Thrombosis","score_opus":0.39316658425784345,"score_gpt":0.5020525776786479,"score_spread":0.1088859934208044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035077408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015360305,0.97703034,0.0000653988,0.0011271145,0.0026341279,0.0019899437,0.00003215938,0.00012892444,0.0016316606],"genre_scores_gemma":[0.0070253224,0.9844033,0.0019128034,0.00022468569,0.0055316407,0.0000014417409,0.0000956417,0.00016912042,0.0006360532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901079,0.005064881,0.003341205,0.0005537786,0.0004892599,0.00044295687],"domain_scores_gemma":[0.9952601,0.00055846607,0.0026938503,0.00067980506,0.00028800365,0.00051973225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023160558,0.0005948569,0.0057532624,0.0005067215,0.00009335583,0.000094576026,0.0005506545,0.00019922316,0.00019061536],"category_scores_gemma":[0.0012883203,0.0003980918,0.0014968684,0.00035368156,0.00012992401,0.00016630217,0.00017112088,0.0011095351,0.00026359365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018270763,0.00039537833,0.004108841,0.0005844197,0.0014885525,0.009268863,0.00014489167,1.2415636e-7,3.1779066e-7,0.000026143705,0.004226668,0.9795731],"study_design_scores_gemma":[0.0023982183,0.0039033892,0.003457047,0.0028877996,0.0044853087,0.0013934842,0.00012527102,8.6172275e-7,3.739183e-7,0.000010058262,0.98099744,0.00034074314],"about_ca_topic_score_codex":0.000006201934,"about_ca_topic_score_gemma":0.000007125329,"teacher_disagreement_score":0.9792324,"about_ca_system_score_codex":0.00006264889,"about_ca_system_score_gemma":0.00030758028,"threshold_uncertainty_score":0.9998471},"labels":[],"label_agreement":null},{"id":"W2040290774","doi":"10.1111/ejh.12475","title":"Economic evaluation of arsenic trioxide compared to all‐trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada","year":2014,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal","funders":"Lundbeck Canada","keywords":"Acute promyelocytic leukemia; Arsenic trioxide; Medicine; Internal medicine; Refractory (planetary science); Cost effectiveness; Oncology; Retinoic acid; Arsenic","score_opus":0.01786673555841948,"score_gpt":0.2675080334715705,"score_spread":0.249641297913151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040290774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577737,0.0005250113,0.0027261267,0.00020615716,0.00018293755,0.0003056295,0.0000140877155,0.0000011995013,0.00026146852],"genre_scores_gemma":[0.99820966,0.00013753395,0.0014056076,0.00007944999,0.00006771252,0.000008591298,0.00003614221,0.000022151005,0.00003317608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998263,0.0004305582,0.0007984245,0.00018314333,0.00015425339,0.0001706251],"domain_scores_gemma":[0.9988901,0.000042534753,0.0005816871,0.00019003057,0.00022586071,0.0000697821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008859702,0.00013979874,0.0004908522,0.00008411449,0.000016711998,0.0000036414885,0.00021980598,0.000043081454,0.000021173148],"category_scores_gemma":[0.000083193234,0.0001247031,0.00014246577,0.000042056843,0.000055926288,0.000004616197,0.0000132871855,0.000045164204,0.0000011417972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002715937,0.00012783169,0.0037652864,0.00016880715,0.00074131635,0.000067561356,0.00037385357,0.009067292,0.97477245,0.00012969479,0.001840117,0.006229858],"study_design_scores_gemma":[0.010115598,0.0019722397,0.0024517057,0.00007801052,0.0002275348,0.0005711097,0.00010620271,0.0016159518,0.97429514,0.00010322748,0.00829238,0.00017090596],"about_ca_topic_score_codex":0.0008119589,"about_ca_topic_score_gemma":0.0072061843,"teacher_disagreement_score":0.00745134,"about_ca_system_score_codex":0.00044984627,"about_ca_system_score_gemma":0.002173992,"threshold_uncertainty_score":0.5085245},"labels":[],"label_agreement":null},{"id":"W2041638907","doi":"10.1034/j.1600-0609.2002.01523.x","title":"The comprehensive care of sickle cell disease","year":2002,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Disease; Multidisciplinary approach; Health care; General partnership; Quality of life (healthcare); Sickle cell anemia; Family medicine; Medical emergency; Intensive care medicine; Nursing; Internal medicine","score_opus":0.030223638538953244,"score_gpt":0.28715183198898747,"score_spread":0.2569281934500342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041638907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001803544,0.9881732,0.0000108809345,0.00022704792,0.00057256065,0.00029165324,0.000012973532,0.000008217244,0.01052312],"genre_scores_gemma":[0.0008481558,0.9981519,0.00007047947,0.00007379432,0.00012979514,7.915604e-7,0.000008852872,0.000068126006,0.0006480904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997061,0.0009825048,0.0013072366,0.00015364694,0.00024115764,0.0002544505],"domain_scores_gemma":[0.99719703,0.00026248343,0.0014852142,0.00040098553,0.00038623056,0.00026806313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021439084,0.00028948378,0.0020258843,0.00016693964,0.00009623431,0.000010101337,0.000365416,0.000094549665,0.00008164437],"category_scores_gemma":[0.00012357325,0.00015061196,0.0009772901,0.00016253712,0.00031035425,0.000019575225,0.000089221976,0.0008843106,0.00015551878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011181779,0.00017394334,0.000015712794,0.03434673,0.0005949362,0.033278562,0.00051891437,0.000004600535,7.575292e-7,0.00012419728,0.020285549,0.9105443],"study_design_scores_gemma":[0.0007166554,0.0003425758,0.000009322577,0.008628721,0.0019825548,0.009022275,0.0005152742,0.0000010890119,8.3688263e-7,0.000003971686,0.97865695,0.00011977068],"about_ca_topic_score_codex":4.5005072e-7,"about_ca_topic_score_gemma":1.2024499e-7,"teacher_disagreement_score":0.9583714,"about_ca_system_score_codex":0.00003270547,"about_ca_system_score_gemma":0.00026676452,"threshold_uncertainty_score":0.61417776},"labels":[],"label_agreement":null},{"id":"W2042482546","doi":"10.1111/ejh.12382","title":"Transient myeloproliferative disorder in neonates without Down syndrome: case report and review","year":2014,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Trisomy; Down syndrome; Myeloproliferative Disorders; Medicine; Population; Aneuploidy; Pathology; Trisomy 8; Disease; Pediatrics; Immunology; Chromosome; Cytogenetics; Genetics; Biology","score_opus":0.015522874665339048,"score_gpt":0.2970291577226387,"score_spread":0.2815062830572997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042482546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728183,0.012290807,0.001023356,0.010600772,0.00008762732,0.00033164464,9.971498e-7,0.000011075364,0.0028353808],"genre_scores_gemma":[0.99367905,0.0030700152,0.0017881278,0.0011494625,0.00004916098,0.0000028112688,0.0000028658565,0.000034806646,0.0002236893],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9972478,0.0010537128,0.0009601733,0.00022307075,0.00023817965,0.000277054],"domain_scores_gemma":[0.9987648,0.00014942605,0.00035201843,0.00025246665,0.00024507052,0.00023622002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028492804,0.0001687328,0.0009357627,0.00025187034,0.000048901074,0.000011414315,0.00011407006,0.000036769405,0.00008845124],"category_scores_gemma":[0.0010613406,0.000117873366,0.00008857516,0.00020087934,0.00020864431,0.00008904623,0.000055899283,0.000670613,0.000027264943],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015880032,0.0000706773,0.013159237,0.0006855969,0.00008115944,0.9752561,0.00047919666,0.0000026997957,0.00007262727,0.00008194229,0.001798362,0.008153637],"study_design_scores_gemma":[0.0023607528,0.00072834245,0.011435037,0.0015960352,0.00009963816,0.96835476,0.00013411988,0.000081316866,0.00003893183,0.000025804826,0.015041686,0.00010356721],"about_ca_topic_score_codex":0.00001110741,"about_ca_topic_score_gemma":0.000016309203,"teacher_disagreement_score":0.02086072,"about_ca_system_score_codex":0.000056489862,"about_ca_system_score_gemma":0.00015859569,"threshold_uncertainty_score":0.48067364},"labels":[],"label_agreement":null},{"id":"W2044636425","doi":"10.1111/j.1600-0609.2009.01257.x","title":"Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma","year":2009,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Celgene","keywords":"Lenalidomide; Salvage therapy; Dexamethasone; Refractory (planetary science); Multiple myeloma; Medicine; Oncology; Internal medicine; Thalidomide; Chemotherapy","score_opus":0.050451942893496096,"score_gpt":0.30919838829429025,"score_spread":0.25874644540079417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044636425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967211,0.00053151575,0.000024655674,0.001735828,0.000039199767,0.0005673575,0.0000017000441,0.000014911078,0.0003637511],"genre_scores_gemma":[0.9972895,0.0003178057,0.0017678727,0.00027348573,0.000020201756,0.0000048548854,0.000012286292,0.000046140074,0.00026790262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683976,0.0011218563,0.0008821027,0.00028945733,0.00041358246,0.00045323416],"domain_scores_gemma":[0.99830186,0.0005852908,0.0004556453,0.00026861572,0.00017613487,0.00021247781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009390756,0.0002606594,0.0009120556,0.00078230747,0.000050729333,0.000025569054,0.00016973012,0.00007679437,0.00008809113],"category_scores_gemma":[0.0007186443,0.00015793706,0.00005923945,0.00044184082,0.00010203166,0.0002693266,0.000031103198,0.00077594817,0.000054750773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055579633,0.0020981939,0.8182455,0.000038109945,0.00011112765,0.11641855,0.0015991679,0.00016750387,0.0015719102,0.000019467449,0.00020114282,0.003949726],"study_design_scores_gemma":[0.056452595,0.011611582,0.9179518,0.00094578654,0.000023281455,0.0083869,0.00014937884,0.0003890766,0.0029124285,0.0000084090925,0.0009939333,0.00017483253],"about_ca_topic_score_codex":0.000058308808,"about_ca_topic_score_gemma":0.0017133023,"teacher_disagreement_score":0.108031645,"about_ca_system_score_codex":0.00029852585,"about_ca_system_score_gemma":0.00013164568,"threshold_uncertainty_score":0.64404863},"labels":[],"label_agreement":null},{"id":"W2047446466","doi":"10.1111/j.1600-0609.2007.00985.x","title":"Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study","year":2007,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Toronto General Hospital","funders":"","keywords":"Deferasirox; Medicine; Myelodysplastic syndromes; Internal medicine; Tolerability; Adverse effect; Gastroenterology; Rash; Creatinine; Deferiprone; Prospective cohort study; Anemia; Deferoxamine; Thalassemia","score_opus":0.01761672658062096,"score_gpt":0.28468205114405354,"score_spread":0.26706532456343257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047446466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516,0.000098289216,0.0026114464,0.0002772615,0.000066937384,0.000968794,0.000009177105,0.000011984943,0.00079610053],"genre_scores_gemma":[0.99777067,0.000006950547,0.0018206232,0.00013436201,0.000030084955,0.0000021976912,5.9221685e-7,0.00005819852,0.00017633465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996882,0.0010643377,0.0008097919,0.0002842841,0.0006120903,0.00034745157],"domain_scores_gemma":[0.9977691,0.00066773256,0.00036797996,0.0002489086,0.0005967861,0.00034946765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028418277,0.00021571848,0.0007751939,0.00066280336,0.00007350692,0.0000100971465,0.00018514425,0.000046635072,0.00006526141],"category_scores_gemma":[0.00091916305,0.00014481659,0.00006894027,0.00037889963,0.00021661093,0.0001000487,0.000084663756,0.0005958718,0.000021343061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055008817,0.0010432956,0.9018182,0.00006184723,0.00067934615,0.027296407,0.012169406,0.000011171381,0.0010461966,0.00008610106,0.00009919073,0.0006800227],"study_design_scores_gemma":[0.010659042,0.017729314,0.95852244,0.00024368193,0.00023417018,0.00873396,0.0026975842,0.0000024141439,0.0008900538,0.000015223717,0.0001348071,0.0001373338],"about_ca_topic_score_codex":0.000007898169,"about_ca_topic_score_gemma":0.000021310745,"teacher_disagreement_score":0.056704216,"about_ca_system_score_codex":0.00017159471,"about_ca_system_score_gemma":0.00019153458,"threshold_uncertainty_score":0.5905449},"labels":[],"label_agreement":null},{"id":"W2055097184","doi":"10.1111/j.1600-0609.2009.01370.x","title":"Kasabach–Merritt phenomenon: a single centre experience","year":2009,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Vincristine; Surgery; Retrospective cohort study; Kasabach–Merritt syndrome; Platelet; Hypofibrinogenemia; Fibrinogen; Hemangioma; Internal medicine; Gastroenterology; Chemotherapy; Cyclophosphamide","score_opus":0.022267041532408393,"score_gpt":0.2623355091877568,"score_spread":0.2400684676553484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055097184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581796,0.0014548827,0.0001990674,0.0029411793,0.00017764025,0.00007006053,8.959261e-7,0.000017425842,0.036959272],"genre_scores_gemma":[0.9969216,0.000049992363,0.0014941118,0.0010495832,0.000089541936,1.1626027e-7,0.0000022583665,0.000014838019,0.0003779458],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989293,0.00013701961,0.00041752975,0.0001254123,0.00015230672,0.00023841912],"domain_scores_gemma":[0.99931204,0.000020591218,0.0002480774,0.00015253366,0.000088042936,0.00017873326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013641569,0.00012905122,0.0004933436,0.000106536645,0.000047017773,0.0000125384,0.00012144103,0.000022111039,0.0001771584],"category_scores_gemma":[0.000060512222,0.00009665795,0.00011634677,0.00009630645,0.00006415214,0.000084561776,0.000016200545,0.00016522143,0.0001234417],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015041181,0.0047892984,0.010131112,0.000065583394,0.00050705334,0.80854356,0.011601658,0.000011659541,0.01854435,0.001443903,0.018960759,0.12389696],"study_design_scores_gemma":[0.02700377,0.015958339,0.052610736,0.0010670379,0.00076192216,0.6244612,0.005004668,0.000065041306,0.012076467,0.0018204307,0.25822812,0.0009422579],"about_ca_topic_score_codex":4.6910512e-7,"about_ca_topic_score_gemma":4.915634e-7,"teacher_disagreement_score":0.23926738,"about_ca_system_score_codex":0.000028901019,"about_ca_system_score_gemma":0.000029617502,"threshold_uncertainty_score":0.39415967},"labels":[],"label_agreement":null},{"id":"W2055964741","doi":"10.1111/j.1600-0609.2006.00780.x","title":"Abnormality of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells in idiopathic thrombocytopenic purpura","year":2006,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Science Foundation of Tianjin City; National Natural Science Foundation of China; Peking Union Medical College; Academy of Medical Sciences","keywords":"Thrombocytopenic purpura; IL-2 receptor; Flow cytometry; Immunology; Medicine; Peripheral blood mononuclear cell; Immune system; Regulatory T cell; T cell; Biology; In vitro","score_opus":0.013561190154140009,"score_gpt":0.24098794668683668,"score_spread":0.22742675653269667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055964741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98869157,0.0029755477,0.00008964174,0.00067838945,0.00015921565,0.00029222676,0.000013217777,0.000024579002,0.007075607],"genre_scores_gemma":[0.998374,0.00023272108,0.00062661676,0.0002585446,0.00017273505,0.0000018799484,0.000012835424,0.000067357636,0.00025333557],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9957448,0.0010024977,0.0018663591,0.000346836,0.000476357,0.00056312076],"domain_scores_gemma":[0.9979882,0.00010631015,0.00091154175,0.0005350242,0.0002488409,0.00021003287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016123588,0.00036897152,0.0018480708,0.000473776,0.00007589158,0.000019196792,0.0003785639,0.00013336672,0.00019436948],"category_scores_gemma":[0.00010345522,0.00030006107,0.00038806017,0.00034382785,0.00030816434,0.00023188136,0.000111646965,0.0006842995,0.00015618642],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005623672,0.009641816,0.29042184,0.0025152527,0.0023472887,0.6035413,0.0057389275,0.022177285,0.011242661,0.004000442,0.033451404,0.009298096],"study_design_scores_gemma":[0.06421373,0.009421307,0.50456357,0.0053669414,0.0025874625,0.33808738,0.0036510518,0.004486714,0.038265746,0.003154771,0.02386749,0.0023338571],"about_ca_topic_score_codex":0.00004865574,"about_ca_topic_score_gemma":0.000010681335,"teacher_disagreement_score":0.26545393,"about_ca_system_score_codex":0.0001097482,"about_ca_system_score_gemma":0.00023936632,"threshold_uncertainty_score":0.99994516},"labels":[],"label_agreement":null},{"id":"W2061310836","doi":"10.1111/ejh.12232","title":"Cost‐effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the <scp>TAPS</scp> trial","year":2013,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Medical Research Council; NHS Blood and Transplant","keywords":"Medicine; Quality-adjusted life year; Disease; Blood transfusion; Cost effectiveness; Elective surgery; Quality of life (healthcare); Pediatrics; Surgery; Internal medicine","score_opus":0.022906171678882672,"score_gpt":0.26213035652600736,"score_spread":0.23922418484712468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061310836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634826,0.0009485324,0.0014599831,0.00013603564,0.00013080466,0.00085355307,0.000007769608,0.000004049384,0.00011101847],"genre_scores_gemma":[0.99952614,0.00013620713,0.00019521019,0.00007777196,0.0000279333,0.0000026748962,0.000006897514,0.000018825902,0.000008309732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718213,0.0015981074,0.00059717736,0.00016962449,0.00027128588,0.000181673],"domain_scores_gemma":[0.99815905,0.000741885,0.00041894786,0.00020807218,0.0003254289,0.00014663104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006023335,0.00014772222,0.00069426175,0.00021619766,0.00005765473,0.00001402195,0.00015905965,0.000038816153,0.0000607722],"category_scores_gemma":[0.0004484558,0.00007882702,0.00019204183,0.00051170675,0.0001587386,0.00015716313,0.000030337174,0.00034207702,0.0000073137353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087451255,0.00090649474,0.9767184,0.00007725876,0.0009285336,0.0008302326,0.0044287527,0.005556923,0.0009878089,0.000004385725,0.00011411226,0.0007019618],"study_design_scores_gemma":[0.026184939,0.001554004,0.9662374,0.0008351783,0.002391695,0.000026844757,0.0010592978,0.0011608852,0.0004680705,0.000008532375,0.000024446532,0.000048660437],"about_ca_topic_score_codex":0.00011670334,"about_ca_topic_score_gemma":0.000010483726,"teacher_disagreement_score":0.017439814,"about_ca_system_score_codex":0.00003601901,"about_ca_system_score_gemma":0.0001266305,"threshold_uncertainty_score":0.32144725},"labels":[],"label_agreement":null},{"id":"W2061727471","doi":"10.1111/ejh.12110","title":"Parathyroid hormone ablation alters erythrocyte parameters that are rescued by calcium‐sensing receptor gene deletion","year":2013,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Parathyroid hormone; Internal medicine; Endocrinology; Erythrocyte fragility; Receptor; Parathyroid hormone receptor; Hemoglobin; Chemistry; Hematocrit; Mean corpuscular volume; Population; Biology; Calcium; Hormone receptor; Medicine; Hemolysis","score_opus":0.03445272615461768,"score_gpt":0.2507992859222206,"score_spread":0.21634655976760292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061727471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97809225,0.0018375503,0.015333342,0.003283347,0.00070288894,0.00024906758,0.000004286031,0.0000470627,0.00045019208],"genre_scores_gemma":[0.98499143,0.0007101189,0.011353447,0.0022741137,0.00030576382,0.00000151373,0.000049757873,0.000059397167,0.00025447662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738556,0.0009200773,0.0007973383,0.0002738347,0.00025711858,0.00036609758],"domain_scores_gemma":[0.9980311,0.00013057771,0.0009272458,0.0002775757,0.00035218152,0.00028133238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052429026,0.00024607673,0.0007439539,0.00024751973,0.00012000221,0.00002973965,0.00012040283,0.000105560975,0.00012967126],"category_scores_gemma":[0.00020275169,0.00020065095,0.0002155597,0.00015955168,0.00018548204,0.00021669107,0.000038682243,0.0004992259,0.00052213913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008865859,0.0000953167,0.0004647451,0.00003194212,0.00016992193,0.0012330657,0.00029432643,0.00006470181,0.80641276,0.000011080198,0.18696383,0.003371707],"study_design_scores_gemma":[0.031491835,0.015666462,0.18286686,0.0011659295,0.0013722338,0.1396354,0.004907856,0.0032109295,0.46924296,0.0004447101,0.1476053,0.0023895418],"about_ca_topic_score_codex":0.000013034789,"about_ca_topic_score_gemma":0.0000010549044,"teacher_disagreement_score":0.33716983,"about_ca_system_score_codex":0.00008160591,"about_ca_system_score_gemma":0.00004803168,"threshold_uncertainty_score":0.8182308},"labels":[],"label_agreement":null},{"id":"W2062221225","doi":"10.1111/ejh.12059","title":"<scp>I</scp>gG4‐related disease with hypergammaglobulinemic hyperviscosity and retinopathy","year":2012,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Fludarabine; Pathology; Gastroenterology; Hyperviscosity syndrome; Cyclophosphamide; Internal medicine; Lymphoma; Multiple myeloma; Chemotherapy","score_opus":0.009421351465277705,"score_gpt":0.21201494887274835,"score_spread":0.20259359740747065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062221225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98097104,0.009453841,0.000053386626,0.0006044033,0.0003296952,0.0001370668,0.00000519059,0.000048323738,0.00839708],"genre_scores_gemma":[0.99789304,0.00031293818,0.00043320865,0.0005058953,0.00027379338,7.0064175e-7,0.000007827415,0.000055639885,0.000516979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980587,0.00045970723,0.00064156915,0.00017169575,0.00024886627,0.00041947444],"domain_scores_gemma":[0.9980147,0.00014841033,0.00045932506,0.00025047178,0.00019998942,0.0009271302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062217517,0.00023514114,0.0005786989,0.00018916065,0.000100924175,0.000017132472,0.00013913805,0.00005282912,0.000060871524],"category_scores_gemma":[0.00062561705,0.00016278935,0.000127665,0.00014703364,0.00025717437,0.00025365525,0.00006715863,0.0004913956,0.00014910953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013189251,0.00094462984,0.91439456,0.0005173552,0.0006651511,0.05518202,0.00199478,0.000023439798,0.0028947354,0.001781289,0.018388629,0.0018945144],"study_design_scores_gemma":[0.0070476914,0.0014246438,0.83735204,0.0009569133,0.001799651,0.109725334,0.0009445891,0.00006747515,0.0008658112,0.00008265651,0.03949885,0.0002343276],"about_ca_topic_score_codex":4.8336e-7,"about_ca_topic_score_gemma":1.1873437e-7,"teacher_disagreement_score":0.077042475,"about_ca_system_score_codex":0.000022214794,"about_ca_system_score_gemma":0.00011779614,"threshold_uncertainty_score":0.6638357},"labels":[],"label_agreement":null},{"id":"W2063408197","doi":"10.1111/ejh.12148","title":"Autoimmune hemolytic anemia in a teenager: a wolf in sheep's clothing","year":2013,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Autoimmune hemolytic anemia; Immunodeficiency; Immune dysregulation; Medicine; Autoimmunity; Immune system; Immunology; Malignancy; Anemia; Hemolytic anemia; Severe combined immunodeficiency; Pediatrics; Antibody; Internal medicine; Biology","score_opus":0.007066148431662144,"score_gpt":0.20567719187599423,"score_spread":0.19861104344433209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063408197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9640869,0.026461018,0.00013930682,0.0010665234,0.0008344591,0.00019161016,7.129625e-7,0.000027441356,0.0071920087],"genre_scores_gemma":[0.99878824,0.00016262392,0.000118688586,0.00038581082,0.000005349521,0.000003874162,0.0000044599706,0.00003500167,0.0004959753],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963884,0.001319745,0.0013812459,0.0002336677,0.000055751294,0.0006212231],"domain_scores_gemma":[0.9988688,0.00019491962,0.00053461443,0.00030406396,0.00008420455,0.000013354499],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014685921,0.00024605836,0.0007736049,0.0006626363,0.00009102099,0.000027827256,0.00067532616,0.00013291571,0.0008158293],"category_scores_gemma":[0.00029511788,0.00020999744,0.00016056169,0.00037458003,0.00030008217,0.0003011766,0.00014262588,0.0011569775,0.0012390654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010200838,0.0027832082,0.028004976,0.00035989148,0.0004113185,0.022436017,0.02974988,0.0011629643,0.7561606,0.0047625755,0.0056028645,0.14754558],"study_design_scores_gemma":[0.031291623,0.0021734748,0.7816412,0.0024136037,0.00014367794,0.071326055,0.015561632,0.00024246117,0.014874568,0.0027476766,0.07543865,0.0021454194],"about_ca_topic_score_codex":0.00011876691,"about_ca_topic_score_gemma":0.0000051648344,"teacher_disagreement_score":0.7536362,"about_ca_system_score_codex":0.000055819397,"about_ca_system_score_gemma":0.00009129659,"threshold_uncertainty_score":0.9995386},"labels":[],"label_agreement":null},{"id":"W2073782881","doi":"10.1034/j.1600-0609.2001.5790554.x","title":"VIII International Myeloma Workshop, Banff Springs Hotel, Banff, Alberta, Canada, 4–8 May 2001","year":2001,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Library science; Citation","score_opus":0.021366092669647382,"score_gpt":0.2802701939600759,"score_spread":0.2589041012904285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073782881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87480295,0.0003550955,0.0007480226,0.031260625,0.0012492094,0.00015756123,0.0000034492496,0.000020226518,0.091402896],"genre_scores_gemma":[0.97582614,0.00038388945,0.0020129366,0.003083446,0.0009090131,0.0000012761957,0.000010840681,0.000086820684,0.017685605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99678564,0.00047441488,0.0009996308,0.00030070715,0.00075431814,0.0006852603],"domain_scores_gemma":[0.9975716,0.00039272793,0.0004998823,0.00040698567,0.0005345462,0.0005942657],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011469132,0.0002716833,0.00072605093,0.00042335014,0.000097544915,0.00003982888,0.0007789578,0.00006773605,0.0029639911],"category_scores_gemma":[0.0011919815,0.0002273158,0.00019935709,0.00030156184,0.00019341207,0.00017187378,0.00022554376,0.0011334602,0.0003570138],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021330235,0.00023426383,0.057147164,0.000064549924,0.0008714346,0.31963983,0.00052427006,0.0000675631,0.0016961184,0.00045644894,0.60363096,0.0135343475],"study_design_scores_gemma":[0.0045981165,0.00036798717,0.049595177,0.00028856483,0.000118939206,0.25454086,0.00042896272,0.00023014306,0.00077969534,0.000025922001,0.68872744,0.00029821263],"about_ca_topic_score_codex":0.009774298,"about_ca_topic_score_gemma":0.028482463,"teacher_disagreement_score":0.10102325,"about_ca_system_score_codex":0.00055494974,"about_ca_system_score_gemma":0.0012838234,"threshold_uncertainty_score":0.99794745},"labels":[],"label_agreement":null},{"id":"W2086152189","doi":"10.1034/j.1600-0609.2003.02838.x","title":"Surface antigen expression and correlation with variable heavy‐chain gene mutation status in chronic lymphocytic leukemia","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Tays; Fondation pour la Recherche Médicale; Cancer Research Society","keywords":"Chronic lymphocytic leukemia; CD38; CD5; Antigen; Biology; IGHV@; Immunoglobulin D; Molecular biology; Surface Immunoglobulin; Immunophenotyping; CD23; CD20; Immunology; Antibody; Leukemia; B cell; Genetics; Immunoglobulin E","score_opus":0.015145554584080817,"score_gpt":0.2645746928100752,"score_spread":0.24942913822599436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086152189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98199207,0.0031335857,0.012399463,0.000045155408,0.0001244495,0.0002571342,0.0000011945166,0.00001608062,0.002030858],"genre_scores_gemma":[0.98889375,0.00046810997,0.01024835,0.00006527814,0.000050727336,9.880474e-7,0.0000068878103,0.00004643988,0.00021946651],"study_design_codex":"simulation_or_modeling","study_design_gemma":"case_report","domain_scores_codex":[0.9974381,0.0008306966,0.0006593791,0.00024737758,0.00036561597,0.00045883338],"domain_scores_gemma":[0.99877286,0.00019137646,0.00036560127,0.00023260519,0.00019664201,0.00024090326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014217669,0.00017993095,0.0005212913,0.00025283862,0.00009827998,0.000020145253,0.00009358927,0.00006985728,0.00008014934],"category_scores_gemma":[0.0003675398,0.00013812206,0.000038613125,0.0003223142,0.00015921127,0.00017624191,0.00005159152,0.0003586046,0.000019458164],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011999434,0.00043392504,0.03221453,0.0018908341,0.00068607915,0.17716856,0.011702127,0.4963101,0.2552944,0.0042721657,0.003481681,0.004546137],"study_design_scores_gemma":[0.18266289,0.011353612,0.014668327,0.0043415553,0.00034470772,0.45807272,0.0016564216,0.18202157,0.13098674,0.0006106932,0.012217542,0.0010632111],"about_ca_topic_score_codex":0.00008080416,"about_ca_topic_score_gemma":0.0000120814375,"teacher_disagreement_score":0.31428853,"about_ca_system_score_codex":0.017768623,"about_ca_system_score_gemma":0.01568748,"threshold_uncertainty_score":0.98989266},"labels":[],"label_agreement":null},{"id":"W2091177739","doi":"10.1034/j.1600-0609.2003.00115.x","title":"Aplastic anemia following administration of a tumor necrosis factor‐<i>α</i> inhibitor","year":2003,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Etanercept; Medicine; Rheumatoid arthritis; Tumor necrosis factor alpha; Aplastic anemia; Immunology; Infliximab; Blockade; Pancytopenia; Sepsis; Arthritis; Pathogenesis; Anemia; Internal medicine; Receptor; Bone marrow","score_opus":0.009230715432819073,"score_gpt":0.23251930186841183,"score_spread":0.22328858643559274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091177739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961284,0.0008793548,0.00086756126,0.000043455082,0.00031392084,0.000053366897,0.0000053548747,0.000002581996,0.001705997],"genre_scores_gemma":[0.9986539,0.000027570679,0.0011269434,0.00007333476,0.000040552517,5.4486884e-7,0.000005744375,0.000020080597,0.000051335068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989241,0.00026541518,0.00043286863,0.00012995194,0.00009881554,0.00014889955],"domain_scores_gemma":[0.999318,0.000018697034,0.00037147375,0.00013778423,0.000075471544,0.0000785434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001779407,0.00012240821,0.0002639502,0.000053442116,0.000038213107,0.000010246017,0.000115780196,0.00003468733,0.000020061912],"category_scores_gemma":[0.00018802682,0.00010395319,0.00021993143,0.000057019988,0.00004905185,0.0000062181093,0.000021906068,0.00008048938,0.0000076200313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013662847,0.0020215514,0.08640125,0.0002437732,0.0015999165,0.014265817,0.0005087391,0.000053407708,0.8809911,0.0011553541,0.0072104824,0.004182343],"study_design_scores_gemma":[0.0056877634,0.0048596435,0.0052329684,0.00012755526,0.0003246671,0.012013951,0.00025954004,0.0000024096587,0.95885235,0.00017020035,0.012104743,0.00036421648],"about_ca_topic_score_codex":6.474089e-7,"about_ca_topic_score_gemma":0.0000030007614,"teacher_disagreement_score":0.08116827,"about_ca_system_score_codex":0.0000046942496,"about_ca_system_score_gemma":0.00009679362,"threshold_uncertainty_score":0.4239088},"labels":[],"label_agreement":null},{"id":"W2130467588","doi":"10.1111/j.1600-0609.2010.01569.x","title":"Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)","year":2010,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deferiprone; Deferasirox; Medicine; Deferoxamine; Chelation therapy; Pregnancy; Pediatrics; Thalassemia; Intensive care medicine; Internal medicine","score_opus":0.008570325720383989,"score_gpt":0.21033629528513917,"score_spread":0.20176596956475518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130467588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85080105,0.0041296664,0.00016352364,0.13395,0.00047570316,0.00061972125,0.0000036463593,0.00003226918,0.00982441],"genre_scores_gemma":[0.9041364,0.002306347,0.004206149,0.08623147,0.0012504676,0.000015039697,0.000110031804,0.00049249723,0.0012515548],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969648,0.0006457167,0.0010152484,0.0003474213,0.0004991349,0.00052765105],"domain_scores_gemma":[0.99789494,0.00009711239,0.0012416526,0.00037460835,0.0002551839,0.00013652629],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00037105908,0.00045752502,0.0010788817,0.0005331714,0.00007511851,0.000029631185,0.00023908258,0.00069811195,0.00021221259],"category_scores_gemma":[0.000066989654,0.00027749361,0.00015815618,0.0002507526,0.00020624984,0.00013251706,0.000037888854,0.00734288,0.000033637076],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055312403,0.0009831013,0.060663644,0.0015837157,0.0012837922,0.69607157,0.0070254146,0.00015902994,0.0011780052,0.00002366572,0.17347571,0.0520211],"study_design_scores_gemma":[0.022981044,0.01520919,0.02008903,0.018955478,0.00080425007,0.42919713,0.00059946906,0.00003057921,0.0006661392,0.000025425015,0.49015582,0.0012864463],"about_ca_topic_score_codex":0.00000845719,"about_ca_topic_score_gemma":0.00001663884,"teacher_disagreement_score":0.3166801,"about_ca_system_score_codex":0.0000738032,"about_ca_system_score_gemma":0.00027188158,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W2140631301","doi":"10.1111/ejh.12496","title":"Various regimens for prophylactic treatment of patients with haemophilia","year":2015,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Haemophilia; Bleed; Arthropathy; Regimen; Venous access; Haemophilia A; Quality of life (healthcare); Surgery; Prophylactic treatment; Risk factor; Intensive care medicine; Pediatrics; Internal medicine; Pathology; Osteoarthritis","score_opus":0.09515856949178594,"score_gpt":0.3663581702857024,"score_spread":0.2711996007939165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140631301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030359763,0.99300903,0.000038676673,0.00016430093,0.00026112632,0.0021064626,0.00005340581,0.00001105629,0.0013199626],"genre_scores_gemma":[0.002209473,0.993246,0.0022794663,0.000012148518,0.00032041516,0.000021233924,0.00013465344,0.00016901965,0.0016075827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997063,0.0006647133,0.0011987945,0.00026889946,0.0004449046,0.00035967934],"domain_scores_gemma":[0.99656886,0.00020768018,0.0014770093,0.0004414777,0.0009696818,0.0003352741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005487395,0.00043054286,0.003697544,0.0004968525,0.000046099998,0.00001028522,0.00021839578,0.000116955,0.000030261006],"category_scores_gemma":[0.00015535377,0.00021462154,0.00066091964,0.00020525538,0.00020771558,0.000044998338,0.000034549,0.0002769302,0.000046847188],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021840804,0.003039882,0.0005153543,0.020504912,0.0033930156,0.018333642,0.00034831918,4.81239e-7,4.7388113e-7,0.000058002675,0.0025365755,0.94908524],"study_design_scores_gemma":[0.006990412,0.024147138,0.000058295136,0.004593075,0.004955904,0.009116735,0.000014920635,4.7108313e-7,0.000006027043,0.000017509017,0.94991255,0.00018698184],"about_ca_topic_score_codex":0.0000010429249,"about_ca_topic_score_gemma":4.7353242e-7,"teacher_disagreement_score":0.94889826,"about_ca_system_score_codex":0.0002603929,"about_ca_system_score_gemma":0.0011150782,"threshold_uncertainty_score":0.8752012},"labels":[],"label_agreement":null},{"id":"W2144684129","doi":"10.1111/j.0902-4441.2003.00209.x","title":"Effect of low‐dose warfarin on D‐dimer levels during sickle cell vaso‐occlusive crisis: a brief report","year":2004,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Dartmouth General Hospital; Dalhousie University; Royal University Hospital","funders":"","keywords":"D-dimer; Medicine; Warfarin; Hemoglobin; Fibrinogen; Internal medicine; Gastroenterology; White blood cell; Sickle cell anemia; Surgery; Anesthesia; Atrial fibrillation; Disease","score_opus":0.007920888680788114,"score_gpt":0.25495132378042434,"score_spread":0.24703043509963624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144684129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866293,0.001160702,0.00016361535,0.0012916164,0.00045918248,0.00022687326,0.0000020425682,0.000024372821,0.0100423],"genre_scores_gemma":[0.9988031,0.00012228217,0.0002673879,0.00038950527,0.00010730932,7.088728e-7,0.0000019816466,0.00005913575,0.00024862727],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974441,0.0005149888,0.0011080259,0.00024652874,0.00033979665,0.00034657787],"domain_scores_gemma":[0.998191,0.00010207364,0.00088893954,0.00037432672,0.00021196825,0.00023170366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011283879,0.0002510547,0.00095379737,0.00027603706,0.000081216764,0.000008360751,0.00018995485,0.00010079984,0.00009339588],"category_scores_gemma":[0.00036506206,0.00017831463,0.0003580861,0.00019170217,0.00014001143,0.00006761117,0.000086218985,0.00071613374,0.00011163807],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00760433,0.0023724537,0.0058394107,0.0034095875,0.0014373537,0.85370785,0.006130504,0.0044425796,0.10436204,0.00032132975,0.007267152,0.0031054057],"study_design_scores_gemma":[0.035800975,0.014877324,0.020815967,0.0033366296,0.0012694654,0.3345901,0.0012232476,0.000014100436,0.58382964,0.00012878397,0.0034932527,0.0006205156],"about_ca_topic_score_codex":0.000011685565,"about_ca_topic_score_gemma":5.6718534e-7,"teacher_disagreement_score":0.5191178,"about_ca_system_score_codex":0.00006061028,"about_ca_system_score_gemma":0.00015404509,"threshold_uncertainty_score":0.72714597},"labels":[],"label_agreement":null},{"id":"W2147225705","doi":"10.1111/j.1600-0609.2009.01344.x","title":"The prolyl‐hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia","year":2009,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genesis Pharma","keywords":"Plasma cell; Plasma cell leukemia; Monoclonal gammopathy of undetermined significance; Cancer research; Multiple myeloma; Methylation; Biology; Plasmacytoma; Epigenetics; Molecular biology; Immunology; Monoclonal; Biochemistry; Antibody; Monoclonal antibody","score_opus":0.0057936439824299545,"score_gpt":0.22146520820641952,"score_spread":0.21567156422398956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147225705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912154,0.005137907,0.00024634635,0.0015334203,0.00038724503,0.000098372475,0.0000049394544,0.0000036780602,0.0013726893],"genre_scores_gemma":[0.99623525,0.0023120658,0.00021848545,0.0006130452,0.00026930956,7.933783e-7,0.0000056138974,0.000017594924,0.0003278515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986569,0.00040080407,0.0004333473,0.00017982366,0.00010691314,0.00022215511],"domain_scores_gemma":[0.9992851,0.000035132165,0.0003380143,0.00017187199,0.00007794108,0.00009196399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005904514,0.00014229058,0.00025821538,0.00007037155,0.000081164166,0.000028459412,0.00019430018,0.00006499688,0.000006049518],"category_scores_gemma":[0.000105904204,0.00010506318,0.00006795465,0.00008440098,0.00008426974,0.000010441273,0.000041711544,0.00022862955,0.0000057249063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007500495,0.00007236509,0.00022922015,0.000011197697,0.00003750565,0.0001331694,0.00033493253,0.000021452828,0.9534022,0.000051169038,0.023114389,0.021842329],"study_design_scores_gemma":[0.002481514,0.00066322787,0.0025610893,0.000020153297,0.00003306113,0.0019870454,0.00012378079,0.000055382643,0.6350741,0.00007675243,0.35675395,0.00016994872],"about_ca_topic_score_codex":0.0000028325567,"about_ca_topic_score_gemma":0.000006805976,"teacher_disagreement_score":0.33363956,"about_ca_system_score_codex":0.000010347703,"about_ca_system_score_gemma":0.000060492723,"threshold_uncertainty_score":0.42843524},"labels":[],"label_agreement":null},{"id":"W2147721382","doi":"10.1111/j.1600-0609.2007.00951.x","title":"ITP: A new regulatory issue!","year":2007,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Citation; Library science; Computer science","score_opus":0.07279011603931608,"score_gpt":0.36313292119362506,"score_spread":0.290342805154309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147721382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020337972,0.9793006,0.0000959592,0.00018432998,0.00067948527,0.00023602812,0.0000026988725,0.000019612144,0.019277912],"genre_scores_gemma":[0.00002987898,0.99291444,0.0012807013,0.0002623448,0.00064391084,3.5581408e-7,0.000016451677,0.000108937544,0.0047429674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973578,0.00041704616,0.0013861627,0.00022443991,0.0002716347,0.00034290346],"domain_scores_gemma":[0.99773085,0.00011322542,0.0012704383,0.00037014263,0.000105557716,0.0004097985],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006918216,0.00039352285,0.003700467,0.00054012885,0.00003850015,0.000012987923,0.00027049077,0.00015249818,0.0004460803],"category_scores_gemma":[0.00012712182,0.00026334365,0.0008885355,0.00020500552,0.0000866596,0.00004740228,0.00006043563,0.00074773736,0.001299405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039104176,0.00010096253,0.000004741321,0.0023710732,0.0006917089,0.24256878,0.0000369317,3.4689315e-8,1.0500564e-7,0.00005177083,0.049703546,0.70443124],"study_design_scores_gemma":[0.0009907377,0.00038063666,0.000010591793,0.0072654453,0.0016314915,0.274317,0.000008913012,5.194241e-8,6.442463e-7,0.000016748798,0.715255,0.00012270591],"about_ca_topic_score_codex":0.0000014124897,"about_ca_topic_score_gemma":6.397193e-7,"teacher_disagreement_score":0.70430857,"about_ca_system_score_codex":0.00007176625,"about_ca_system_score_gemma":0.0005297198,"threshold_uncertainty_score":0.9999819},"labels":[],"label_agreement":null},{"id":"W2163945456","doi":"10.1111/ejh.12528","title":"Antibody binding to megakaryocytes <i>in vivo</i> in patients with immune thrombocytopenia","year":2015,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research; Mitacs; Amgen","keywords":"Megakaryocyte; Platelet; Immune thrombocytopenia; Bone marrow; Antibody; Medicine; In vivo; Immunology; Thrombocytopenic purpura; Immunoglobulin G; Immune system; Biology; Stem cell; Haematopoiesis","score_opus":0.015912926024002873,"score_gpt":0.2677094112327367,"score_spread":0.2517964852087339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163945456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394786,0.00026462597,0.000043444572,0.00045698803,0.00014205831,0.0001957484,0.0000023734995,0.0000063562316,0.004940555],"genre_scores_gemma":[0.998545,0.000017120656,0.0011186239,0.00020948183,0.000016202634,5.354783e-7,0.000008019148,0.000027691145,0.000057358367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986829,0.00019551077,0.0005216146,0.000137464,0.00020788562,0.000254609],"domain_scores_gemma":[0.9993185,0.000029709867,0.00021155982,0.00014323111,0.000115631934,0.0001813636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044377582,0.00014190818,0.00080167793,0.0003776232,0.000017345694,0.000011077445,0.00013169787,0.000023761462,0.000028645572],"category_scores_gemma":[0.0000961897,0.00009721215,0.000045632158,0.00026649583,0.000037251702,0.000121349156,0.00004771112,0.00020573947,0.00008265311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020240021,0.00079541095,0.91850394,0.000022095142,0.00010544324,0.07513871,0.00096983294,0.000035459278,0.0013770759,0.000030760548,0.00052799244,0.00046927482],"study_design_scores_gemma":[0.039011773,0.0073512783,0.9316865,0.0010921342,0.00012743864,0.013490009,0.000671951,0.000010160159,0.0028129474,0.000043428,0.0033775864,0.00032475454],"about_ca_topic_score_codex":0.000011117984,"about_ca_topic_score_gemma":0.000013558178,"teacher_disagreement_score":0.061648697,"about_ca_system_score_codex":0.000064476924,"about_ca_system_score_gemma":0.00007799683,"threshold_uncertainty_score":0.3964196},"labels":[],"label_agreement":null},{"id":"W2167996748","doi":"10.1034/j.1600-0609.2000.90070.x","title":"Granulocytopoiesis versus cytokine activities in peritoneal diffusion chamber cultures in the mouse","year":2000,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Norges Forskningsråd; Universitetet i Oslo; Cancer Research Society; F. Hoffmann-La Roche","keywords":"Granulocyte; Progenitor cell; Population; Cytokine; Haematopoiesis; Granulocyte macrophage colony-stimulating factor; Tumor necrosis factor alpha; Immunology; Endocrinology; Internal medicine; Colony-stimulating factor; Cyclophosphamide; Medicine; Andrology; Biology; Stem cell; Cell biology; Chemotherapy","score_opus":0.019645682048456913,"score_gpt":0.2876818523997717,"score_spread":0.2680361703513148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167996748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786265,0.00026407206,0.00000450447,0.002710887,0.00018145055,0.00009733262,0.0000018463214,0.000008493434,0.018104935],"genre_scores_gemma":[0.9983308,0.00049974857,0.00005081187,0.00044699328,0.00019474627,0.0000024891253,0.000001846766,0.00001655224,0.00045605088],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99862516,0.0005279712,0.00038641752,0.00010339067,0.00016741797,0.00018965213],"domain_scores_gemma":[0.99957323,0.00008277107,0.000108893226,0.00015371664,0.000029916215,0.000051446335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037884896,0.00011495809,0.0003648668,0.00016745125,0.000060972896,0.000016314649,0.00011819983,0.000029519053,0.0005171706],"category_scores_gemma":[0.000033337164,0.000070371156,0.00010444855,0.00018023339,0.000114269125,0.000095386626,0.000017913882,0.0004611662,0.00003535111],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06414667,0.007991131,0.20047276,0.0006797247,0.0009078956,0.3395615,0.09901746,0.001211046,0.11743062,0.004685568,0.07934143,0.0845542],"study_design_scores_gemma":[0.038666453,0.005640672,0.43874115,0.0005962683,0.00038950285,0.1431099,0.012394982,0.000039423656,0.012712746,0.00010482262,0.34691995,0.0006841203],"about_ca_topic_score_codex":0.000028371978,"about_ca_topic_score_gemma":0.00013611022,"teacher_disagreement_score":0.26757854,"about_ca_system_score_codex":0.00004481638,"about_ca_system_score_gemma":0.00003724776,"threshold_uncertainty_score":0.5662655},"labels":[],"label_agreement":null},{"id":"W2170126309","doi":"10.1111/ejh.12597","title":"Gender and <i><scp>BCR</scp>‐<scp>ABL</scp></i> transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia","year":2015,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; London Health Sciences Centre; Juravinski Hospital; McMaster University; Hamilton Health Sciences; Western University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Imatinib; Myeloid leukemia; Medicine; Internal medicine; Regimen; Oncology; Gastroenterology","score_opus":0.017623420847440594,"score_gpt":0.23667557265969524,"score_spread":0.21905215181225465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170126309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939227,0.002479525,0.00025710656,0.0001689781,0.00021143559,0.00082609174,0.000013011109,0.000042481148,0.0020786666],"genre_scores_gemma":[0.99655056,0.00007910151,0.0021417106,0.0004376658,0.00005630558,0.000009118205,0.00002512168,0.00014490505,0.00055550446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636704,0.0010189547,0.0008667148,0.00049129524,0.0005736871,0.0006822999],"domain_scores_gemma":[0.9972732,0.00031676202,0.000626806,0.00050036673,0.0005021207,0.0007807321],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073060644,0.0005279195,0.0011887535,0.00049754354,0.00006432215,0.000034906283,0.00022413828,0.00011516987,0.000012227775],"category_scores_gemma":[0.00065281213,0.00035956962,0.00009706216,0.00053853565,0.0001834661,0.00015733698,0.000057146357,0.00053821364,0.00010821084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027574336,0.003260381,0.67861325,0.00062377297,0.004610364,0.21720576,0.030287566,0.0057916697,0.0091903545,0.000098362194,0.019299086,0.0034451059],"study_design_scores_gemma":[0.1572796,0.06709495,0.6680668,0.002636728,0.0021612435,0.0452412,0.004524912,0.00028450158,0.009095421,0.000032900527,0.043105718,0.00047603922],"about_ca_topic_score_codex":0.000019489671,"about_ca_topic_score_gemma":0.000023484516,"teacher_disagreement_score":0.17196457,"about_ca_system_score_codex":0.0020531989,"about_ca_system_score_gemma":0.0018854719,"threshold_uncertainty_score":0.9998856},"labels":[],"label_agreement":null},{"id":"W2293040160","doi":"10.1111/ejh.12715","title":"Haemophilia in a real‐world setting: the value of clinical experience in data collection","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Novo Nordisk; Bayer; Baxter International; Pfizer","keywords":"Haemophilia; Data collection; Real world data; Value (mathematics); Medicine; Family medicine; Psychology; Medical education; Sociology; Pediatrics; Social science; Data science; Computer science","score_opus":0.19593758418557503,"score_gpt":0.4532271056941757,"score_spread":0.2572895215086006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293040160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801322,0.00018677385,0.000047309684,0.01481043,0.00023449899,0.00016491924,0.000001705106,0.000004201562,0.0044179186],"genre_scores_gemma":[0.9977452,0.0005847451,0.0005896948,0.00009252465,0.00013143162,9.3517656e-7,0.000001240994,0.000013875944,0.0008403507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965087,0.0016124848,0.0012184434,0.00018848803,0.00025528803,0.00021660759],"domain_scores_gemma":[0.99816954,0.000769406,0.00038722093,0.00047512836,0.00010322789,0.00009547079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042761676,0.00008896395,0.0005538564,0.00032944203,0.000028871016,0.00000440036,0.0004355806,0.0000339538,0.000069544796],"category_scores_gemma":[0.0018167207,0.00004149485,0.000079744925,0.00038228006,0.00032664082,0.00009618053,0.00017325851,0.00035686596,0.000020990632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011898263,0.0004367122,0.96047735,0.000041018986,0.0000671831,0.013779102,0.0011310767,0.0000015492025,0.0012594628,0.00034773743,0.005815952,0.015453017],"study_design_scores_gemma":[0.007995759,0.0010736084,0.9706385,0.0011538686,0.00005229084,0.0062435544,0.0005737705,0.0002670928,0.0016936073,0.00020477928,0.009997562,0.000105582265],"about_ca_topic_score_codex":0.000020616313,"about_ca_topic_score_gemma":0.00008571564,"teacher_disagreement_score":0.017612958,"about_ca_system_score_codex":0.000037254373,"about_ca_system_score_gemma":0.0002323006,"threshold_uncertainty_score":0.21749157},"labels":[],"label_agreement":null},{"id":"W2294841775","doi":"10.1111/ejh.12738","title":"Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Centers for Disease Control and Prevention; American Society of Hematology","keywords":"Medicine; Thrombosis; Factor V Leiden; Pulmonary embolism; Thrombophilia; Venous thrombosis; Prothrombin G20210A; Internal medicine; Gastroenterology; Pediatrics; Surgery","score_opus":0.034876827355871616,"score_gpt":0.27941912999946955,"score_spread":0.24454230264359794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294841775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964791,0.00018780013,0.0004944769,0.0017880648,0.00017030232,0.00025739113,0.00009606094,0.000014766534,0.00051202683],"genre_scores_gemma":[0.996611,0.00012621924,0.0030129428,0.00007730951,0.0000798824,0.0000014796094,0.000006675663,0.00003885965,0.000045607936],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9975907,0.00070062187,0.00091866206,0.00020502559,0.00039402503,0.00019095016],"domain_scores_gemma":[0.99791604,0.00011610421,0.00111399,0.0002801528,0.00038816626,0.0001855227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008009125,0.00020040074,0.00087307545,0.0003717862,0.00006994946,0.000017509832,0.00022216338,0.000061360864,0.00047921325],"category_scores_gemma":[0.00016862444,0.0001131906,0.00009487343,0.00010142018,0.00041911978,0.0004209074,0.0001066576,0.0002073036,0.0000073754322],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001193969,0.0016066413,0.80186105,0.00038664552,0.004527787,0.023730645,0.010070639,0.000005685224,0.13978027,0.0088002775,0.0002698385,0.0077665523],"study_design_scores_gemma":[0.012867589,0.008851455,0.32407165,0.0016077424,0.0009418342,0.43940184,0.0018933786,0.0000051848533,0.20717657,0.001380398,0.0014021451,0.0004002185],"about_ca_topic_score_codex":0.000008052168,"about_ca_topic_score_gemma":0.000008412003,"teacher_disagreement_score":0.4777894,"about_ca_system_score_codex":0.000016292002,"about_ca_system_score_gemma":0.000077543256,"threshold_uncertainty_score":0.52470493},"labels":[],"label_agreement":null},{"id":"W2296257365","doi":"10.1111/ejh.12734","title":"Measurement of liver iron concentration by superconducting quantum interference device biomagnetic liver susceptometry validates serum ferritin as prognostic parameter for allogeneic stem cell transplantation","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Ferritin; Serum ferritin; Quantum interference; Iron status; Liver transplantation; Medicine; Transplantation; Internal medicine; Gastroenterology; Cardiology; Superconductivity; Physics; Iron deficiency; Condensed matter physics; Anemia","score_opus":0.040351546373114534,"score_gpt":0.26357578812591853,"score_spread":0.223224241752804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296257365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775264,0.0060748635,0.015367621,0.00032616325,0.00022939204,0.00035676436,0.000020104348,0.000011411588,0.000087228305],"genre_scores_gemma":[0.9978984,0.00087553175,0.00097580405,0.00012474431,0.000046363573,0.0000030501587,0.0000068698355,0.000029716868,0.00003953132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978654,0.0006322729,0.0007661214,0.00019983905,0.0002750181,0.00026136325],"domain_scores_gemma":[0.9985796,0.0002657653,0.00045956872,0.00012623546,0.0004515519,0.00011723327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094547524,0.00017512446,0.00044696443,0.00014089688,0.00004164015,0.000013795864,0.00014948437,0.000052523486,0.00013349534],"category_scores_gemma":[0.00024671014,0.00011999477,0.00012440865,0.000089889334,0.00012854443,0.0001698686,0.000014903967,0.00010682242,0.000023059773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089907687,0.00034308434,0.0329285,0.0020759816,0.00006909886,0.00057606254,0.0013491556,0.0000022763547,0.94595134,0.00011632919,0.00048319672,0.01520589],"study_design_scores_gemma":[0.010134292,0.005785612,0.036453545,0.0018345303,0.0014099885,0.005540436,0.0020969294,0.00009533175,0.9355658,0.000044942433,0.00059505785,0.00044348484],"about_ca_topic_score_codex":0.000007594503,"about_ca_topic_score_gemma":0.0000032293467,"teacher_disagreement_score":0.020371936,"about_ca_system_score_codex":0.00002684653,"about_ca_system_score_gemma":0.00008634679,"threshold_uncertainty_score":0.48932448},"labels":[],"label_agreement":null},{"id":"W2300956547","doi":"10.1111/ejh.12581","title":"Optimising musculoskeletal care for patients with haemophilia","year":2015,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Grifols; Novo Nordisk; Biogen; Amgen; Pfizer; Swedish Orphan Biovitrum; CSL Behring","keywords":"Medicine; Haemophilia; Joint replacement; Haemophilia A; Arthropathy; Intensive care medicine; Population; Disease; Arthroplasty; Surgery; Physical therapy; Internal medicine; Osteoarthritis","score_opus":0.057802680824921696,"score_gpt":0.374179026491592,"score_spread":0.31637634566667033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300956547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002026481,0.9938217,0.00006654458,0.0001065677,0.00035093576,0.001190215,0.000028885466,0.000015847327,0.00239285],"genre_scores_gemma":[0.0005613626,0.9923956,0.005588476,0.000021409705,0.00060716947,0.000008331757,0.00024658506,0.00019838929,0.00037272397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714696,0.0006241499,0.0009773368,0.0002814168,0.0005459321,0.000424177],"domain_scores_gemma":[0.9967708,0.00015935146,0.00082449045,0.00034668072,0.0014631371,0.00043554368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074861664,0.0004150232,0.0029675583,0.000549805,0.000097821525,0.000026736881,0.00032265604,0.0001334646,0.000033208267],"category_scores_gemma":[0.00028548168,0.00022691311,0.0007970316,0.0002134411,0.00018057945,0.00007131746,0.000083935156,0.0006522063,0.00007679348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030938868,0.0002626648,0.00017619395,0.024526319,0.00097045203,0.010635442,0.00020849805,6.095584e-7,5.4548423e-8,0.00001560759,0.0032284595,0.9596663],"study_design_scores_gemma":[0.0036878039,0.0046213036,0.000021310087,0.012694041,0.0028284753,0.009015992,0.000075413634,3.88974e-7,4.7054672e-7,0.0000036007173,0.9668365,0.00021466386],"about_ca_topic_score_codex":2.5761577e-7,"about_ca_topic_score_gemma":2.5324766e-7,"teacher_disagreement_score":0.9636081,"about_ca_system_score_codex":0.00018782375,"about_ca_system_score_gemma":0.0008341572,"threshold_uncertainty_score":0.9253248},"labels":[],"label_agreement":null},{"id":"W2362147867","doi":"10.1111/ejh.12757","title":"The fludarabine, cytarabine, and granulocyte colony‐stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline‐based therapy for the treatment of acute myeloid leukemia for patients with pre‐existing cardiac disease","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Alberta","keywords":"Flag (linear algebra); Medicine; Cytarabine; Anthracycline; Fludarabine; Myeloid leukemia; Internal medicine; Granulocyte colony-stimulating factor; Regimen; Chemotherapy; Surgery; Gastroenterology; Oncology; Cyclophosphamide; Cancer","score_opus":0.03171977461410722,"score_gpt":0.3272721738273038,"score_spread":0.29555239921319654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2362147867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797183,0.00065809744,0.010333132,0.0061647994,0.00014620533,0.0026951206,0.00025054952,0.000014610423,0.000019186375],"genre_scores_gemma":[0.9924628,0.0013263659,0.0050564404,0.00042742374,0.00029805762,0.00007389645,0.000014433881,0.00010382855,0.00023673491],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776024,0.00039918162,0.00070138613,0.0003377725,0.00036495682,0.0004364873],"domain_scores_gemma":[0.99556005,0.0020600848,0.00070572324,0.00047594408,0.00086997706,0.00032823905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069247116,0.00030901423,0.00077326765,0.0001332098,0.0003233894,0.000035727648,0.00033500476,0.000037005037,0.000009158261],"category_scores_gemma":[0.00031333492,0.00012785394,0.00024243767,0.000121731005,0.0003637027,0.00012038532,0.000028148095,0.00013167647,0.0000012836031],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20241664,0.0014649834,0.2552656,0.00027004405,0.007867518,0.0007328671,0.010586642,0.0002715506,0.024210418,0.00021965244,0.0036755889,0.4930185],"study_design_scores_gemma":[0.1274596,0.09431534,0.659579,0.0012669204,0.0020065648,0.0003597801,0.0005567867,0.009186738,0.048132006,0.00023270235,0.0558621,0.0010424528],"about_ca_topic_score_codex":0.00001131109,"about_ca_topic_score_gemma":0.0000022993843,"teacher_disagreement_score":0.49197605,"about_ca_system_score_codex":0.00027845043,"about_ca_system_score_gemma":0.0003804375,"threshold_uncertainty_score":0.5213733},"labels":[],"label_agreement":null},{"id":"W2410461470","doi":"10.1111/j.1600-0609.2010.01461.x","title":"Meeting the Unmet Needs in Anticoagulant Therapy","year":2010,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton General Hospital","funders":"","keywords":"Medicine; Warfarin; Vitamin k; Oral anticoagulant; Anticoagulant therapy; Intensive care medicine; Stroke (engine); Atrial fibrillation; Surgery; Internal medicine","score_opus":0.06126052380546305,"score_gpt":0.3252583767967769,"score_spread":0.26399785299131384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410461470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97724825,0.00027902683,0.00009533909,0.012837641,0.0006067993,0.000090548536,9.781593e-8,0.00000822308,0.008834097],"genre_scores_gemma":[0.99790895,0.00012752223,0.00064637983,0.00055682403,0.00055885,4.6579675e-8,4.1222523e-7,0.000013779551,0.00018725019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989696,0.0002783579,0.000444993,0.000050901996,0.0001305745,0.00012554663],"domain_scores_gemma":[0.999344,0.00015463737,0.000263513,0.00013803177,0.00005645929,0.00004337928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014803682,0.00007231603,0.00029688515,0.00021965627,0.000038248687,0.000013870069,0.00013566932,0.000018440138,0.000107823726],"category_scores_gemma":[0.0002647553,0.00003932501,0.000107374224,0.00017477108,0.000066158864,0.000044362274,0.000032228498,0.00031103278,0.000037880007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006167487,0.000046462737,0.91306233,0.000034390072,0.0002253301,0.007272386,0.0024347273,0.000048246642,0.04177673,0.011985897,0.003980363,0.018516378],"study_design_scores_gemma":[0.0058479803,0.00059288443,0.68223196,0.0001342428,0.00011739892,0.014084477,0.0013876517,0.00016498324,0.0053660837,0.0003894696,0.28948426,0.00019856838],"about_ca_topic_score_codex":0.0000016455596,"about_ca_topic_score_gemma":0.0000025717984,"teacher_disagreement_score":0.2855039,"about_ca_system_score_codex":0.0000041094845,"about_ca_system_score_gemma":0.000020737541,"threshold_uncertainty_score":0.16036274},"labels":[],"label_agreement":null},{"id":"W2530762184","doi":"10.1111/ejh.12819","title":"Novel G6B gene variant causes familial autosomal recessive thrombocytopenia and anemia","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"Biotechnology and Biological Sciences Research Council; Dasman Diabetes Institute; Kuwait Foundation for the Advancement of Sciences; National Institute for Health and Care Research","keywords":"Biology; Exome sequencing; Genetics; Haploinsufficiency; Gene; Mutation; Phenotype","score_opus":0.022334285162103562,"score_gpt":0.2633814345967427,"score_spread":0.24104714943463912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530762184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929217,0.0007106046,0.0014335958,0.0024154407,0.00030739605,0.00009341967,0.000012720757,0.000014694704,0.0020904308],"genre_scores_gemma":[0.99533063,0.00047263762,0.0034332692,0.00034984035,0.0001278067,4.8517524e-7,0.0000019623433,0.000028798027,0.00025458782],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99884754,0.00014952899,0.00045191147,0.00017434837,0.0001458398,0.00023079838],"domain_scores_gemma":[0.99912614,0.00009243156,0.00032990664,0.00015019038,0.0001188838,0.00018242656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023403285,0.00015915692,0.00066810125,0.00011179657,0.00006203844,0.000012223214,0.00010747789,0.000043665896,0.00010236924],"category_scores_gemma":[0.00015514912,0.00008899933,0.00007652614,0.00005726953,0.00015551825,0.00011499982,0.00006132158,0.00014342077,0.00006724249],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018720548,0.00084894174,0.020892136,0.00010534922,0.0010096282,0.59088033,0.0008360502,0.0000014789418,0.355542,0.0010892575,0.005095517,0.02182725],"study_design_scores_gemma":[0.020652462,0.0027742502,0.1555817,0.00053916255,0.0006039623,0.79431385,0.00014985651,0.0000075637927,0.017817615,0.0002930701,0.0069543836,0.00031216038],"about_ca_topic_score_codex":0.000004699277,"about_ca_topic_score_gemma":0.0000038339713,"teacher_disagreement_score":0.3377244,"about_ca_system_score_codex":0.000026570722,"about_ca_system_score_gemma":0.000096871394,"threshold_uncertainty_score":0.36292875},"labels":[],"label_agreement":null},{"id":"W2535960806","doi":"10.1111/ejh.12820","title":"Clinical evaluation of a hemochromatosis next‐generation sequencing gene panel","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University","funders":"Marine Biological Laboratory","keywords":"Hemochromatosis; DNA sequencing; Medicine; Gene; Genetics; Computational biology; Biology","score_opus":0.24135586912203447,"score_gpt":0.3652527442620009,"score_spread":0.12389687513996642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535960806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887268,0.0015168652,0.0063657505,0.0009986055,0.00061307923,0.00010636598,0.0000013392839,0.000007828459,0.0016633536],"genre_scores_gemma":[0.994585,0.00036773738,0.0043102778,0.00028039148,0.0003902283,5.2267615e-7,0.0000021771814,0.000019982099,0.000043712123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968131,0.001428635,0.0010816911,0.00013116229,0.00040279655,0.00014258393],"domain_scores_gemma":[0.9982406,0.00010219219,0.00071424025,0.00020973125,0.00061864447,0.000114603616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004238524,0.000097902506,0.00051998737,0.00015670503,0.000029000437,0.000005405913,0.00010625721,0.00004359471,0.00023268782],"category_scores_gemma":[0.0012668747,0.000060198163,0.0001782086,0.000084287516,0.00012910277,0.00012815918,0.000025688629,0.00011399073,0.00005162825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000392592,0.0002744319,0.017154325,0.00010925446,0.00017134426,0.0013230538,0.0005579741,0.00003025134,0.74464107,0.0006019572,0.00541895,0.22932479],"study_design_scores_gemma":[0.083769284,0.00782652,0.31548458,0.0023413203,0.008856862,0.11245654,0.0025410017,0.004562092,0.4497119,0.001809864,0.009323202,0.0013168192],"about_ca_topic_score_codex":0.0000014826214,"about_ca_topic_score_gemma":0.0000010321775,"teacher_disagreement_score":0.29833028,"about_ca_system_score_codex":0.000031605072,"about_ca_system_score_gemma":0.0002927014,"threshold_uncertainty_score":0.25477684},"labels":[],"label_agreement":null},{"id":"W2565235298","doi":"10.1111/ejh.12842","title":"IgG4‐related disease and lymphocyte‐variant hypereosinophilic syndrome: A comparative case series","year":2016,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Richmond Hospital; Vancouver General Hospital; Providence Health Care; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Hypereosinophilic syndrome; Eosinophilia; IgG4-related disease; Immunoglobulin E; Internal medicine; Gastroenterology; Rituximab; Immunology; Antibody; Disease; Lymphoma; Pathology","score_opus":0.017843012332464266,"score_gpt":0.24383983434328502,"score_spread":0.22599682201082075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565235298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99054307,0.0051341956,0.000037802773,0.0022159375,0.0002761715,0.00015416536,0.000018423176,0.000038913327,0.0015813475],"genre_scores_gemma":[0.9985807,0.0004192135,0.00015570386,0.00022433704,0.00006767522,0.0000011693493,0.000002372348,0.000033870772,0.00051496],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9980323,0.0005686334,0.00075646274,0.00020655956,0.00016643363,0.00026963552],"domain_scores_gemma":[0.9984364,0.00011850853,0.00040462564,0.00023764427,0.00020160954,0.0006012217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033987086,0.00022199894,0.000698929,0.0002251366,0.000121386096,0.0000192173,0.000103751656,0.00004377852,0.0002838],"category_scores_gemma":[0.0001940939,0.00013308486,0.00014703003,0.00011584314,0.0004433425,0.00027864004,0.000064676344,0.00018493799,0.00018664134],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015927634,0.00017527827,0.0028447653,0.00011370847,0.0004944826,0.9871199,0.00066857936,0.0000026021091,0.0013919466,0.0023232354,0.0014202083,0.0018525335],"study_design_scores_gemma":[0.0049788016,0.00089268805,0.014049369,0.00072634494,0.00056152884,0.973565,0.00033870345,0.000015475385,0.00023449883,0.0002243935,0.004228586,0.00018462981],"about_ca_topic_score_codex":0.0000010395946,"about_ca_topic_score_gemma":6.0010103e-7,"teacher_disagreement_score":0.013554917,"about_ca_system_score_codex":0.000046824236,"about_ca_system_score_gemma":0.00021407091,"threshold_uncertainty_score":0.54270434},"labels":[],"label_agreement":null},{"id":"W2572662326","doi":"10.1111/ejh.12828","title":"The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Novo Nordisk Pharma; Novartis Pharma; Grifols; Novo Nordisk; Bayer HealthCare; Swedish Orphan Biovitrum; Baxalta; CSL Behring; Wyeth; Bayer; Biogen; Baxter International; Pfizer; Women's Fund of Hawaii","keywords":"Haemophilia; Multidisciplinary team; Multidisciplinary approach; Medicine; Health care; Haemophilia B; Haemophilia A; Family medicine; Nursing; Pediatrics; Political science","score_opus":0.02305966482525357,"score_gpt":0.3205823300819092,"score_spread":0.2975226652566556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572662326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8063628,0.0023007933,0.000010324463,0.012342282,0.000980272,0.00016515488,0.0000011352736,0.000009771318,0.17782745],"genre_scores_gemma":[0.9576133,0.0003471229,0.0002896587,0.0002775444,0.00076831295,0.0000015510614,0.000001326117,0.000030185796,0.040671013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841374,0.00039344002,0.00050655636,0.00013527517,0.00026200066,0.00028898602],"domain_scores_gemma":[0.99815,0.00013153903,0.00059829286,0.00059642654,0.00030727623,0.0002164947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014642581,0.00013237691,0.00036576702,0.00011425675,0.00069149357,0.00009405162,0.0005079743,0.000041314008,0.000268228],"category_scores_gemma":[0.0005795531,0.00007291733,0.00016934551,0.000031889405,0.00031062952,0.00012332911,0.00010582996,0.00045043867,0.00042815626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00114216,0.0010841704,0.10307462,0.00035336547,0.0009596661,0.019987846,0.0018750235,8.63932e-7,0.009189121,0.0016618776,0.71608895,0.14458232],"study_design_scores_gemma":[0.002380132,0.00082658825,0.12517828,0.00039975348,0.00013837441,0.023216125,0.00035949203,0.000013199966,0.0033664047,0.00048830686,0.8434838,0.00014954591],"about_ca_topic_score_codex":0.0000023639395,"about_ca_topic_score_gemma":0.0000060402685,"teacher_disagreement_score":0.15125047,"about_ca_system_score_codex":0.0000334597,"about_ca_system_score_gemma":0.00037331582,"threshold_uncertainty_score":0.55032253},"labels":[],"label_agreement":null},{"id":"W2584962199","doi":"10.1111/ejh.12865","title":"Impact of osteoblast maturation on their paracrine growth enhancing activity on cord blood progenitors","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Ottawa","funders":"","keywords":"Progenitor cell; Haematopoiesis; Paracrine signalling; Cell biology; Osteoblast; Cord blood; Myelopoiesis; Stem cell; Myeloid; Biology; Immunology; Chemistry; In vitro; Biochemistry","score_opus":0.028778063821492703,"score_gpt":0.31193000045461866,"score_spread":0.28315193663312593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584962199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993912,0.000019589486,0.0006154865,0.00040771713,0.00033486422,0.00021082784,0.0000066952157,0.000013206104,0.004479622],"genre_scores_gemma":[0.999329,0.000036801466,0.0003390297,0.000029526625,0.00019369175,8.370466e-7,0.0000029475714,0.00003576974,0.000032423657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983051,0.00045734685,0.0006058551,0.00016062643,0.00026555583,0.00020553362],"domain_scores_gemma":[0.9977568,0.000228467,0.0012365073,0.00037698378,0.00025973958,0.00014151479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007068123,0.0001944925,0.0006338159,0.00019612207,0.00011502667,0.000024306493,0.00021312131,0.000047589867,0.000044136632],"category_scores_gemma":[0.00043976872,0.00013056157,0.00024780797,0.00004971359,0.000108918975,0.00013509137,0.000021088506,0.00036206067,0.00004177244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019434042,0.002086603,0.07966122,0.0011190732,0.0014792865,0.01983522,0.0023190451,0.000035720204,0.85923034,0.0006526275,0.00041169004,0.013735144],"study_design_scores_gemma":[0.0032966987,0.0077651446,0.34439337,0.0011243927,0.00025086835,0.020940289,0.00007087436,0.000021724069,0.6219555,0.000034313613,0.000016141157,0.0001306703],"about_ca_topic_score_codex":0.000006470475,"about_ca_topic_score_gemma":0.0000026958057,"teacher_disagreement_score":0.26473215,"about_ca_system_score_codex":0.000035878926,"about_ca_system_score_gemma":0.0000992507,"threshold_uncertainty_score":0.5324146},"labels":[],"label_agreement":null},{"id":"W2597273572","doi":"10.1111/ejh.12876","title":"Economic burden of relapsed or refractory multiple myeloma: Results from an international trial","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Absenteeism; Medicine; Indirect costs; Quality of life (healthcare); Multiple myeloma; Multivariate analysis; Clinical trial; Physical therapy; Randomized controlled trial; Family medicine; Internal medicine; Nursing","score_opus":0.06516772725094637,"score_gpt":0.358220158953896,"score_spread":0.2930524317029496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597273572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004847,0.000059648497,0.000034769855,0.0014664677,0.0012098289,0.00020361508,0.00010955373,0.000009782107,0.0068578594],"genre_scores_gemma":[0.99582326,0.00013622221,0.0023659198,0.00002851522,0.0010666661,0.000001005297,0.000052265397,0.000030099978,0.0004960558],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99787647,0.00044781456,0.0009823503,0.000224292,0.00026202618,0.00020706811],"domain_scores_gemma":[0.99710923,0.0003417766,0.0013930099,0.0006823762,0.00019879277,0.00027483812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083325,0.00014474917,0.000628814,0.0001935008,0.000107962696,0.000040266717,0.00064195006,0.00005438922,0.0003298899],"category_scores_gemma":[0.0030035896,0.00010096638,0.0001715113,0.000014653928,0.0002095554,0.0003188146,0.00012934805,0.00031798438,0.00013343505],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8169382,0.0014947744,0.031250358,0.00004405131,0.002480943,0.07373958,0.0019062784,0.00003981065,0.006381158,0.00011389315,0.0053855386,0.060225405],"study_design_scores_gemma":[0.5661523,0.014695169,0.36071473,0.0005846761,0.00034470373,0.007576812,0.0005210479,0.0014146751,0.005773507,0.00010456146,0.04177063,0.0003472104],"about_ca_topic_score_codex":0.00016324948,"about_ca_topic_score_gemma":0.000054394324,"teacher_disagreement_score":0.32946438,"about_ca_system_score_codex":0.000076993114,"about_ca_system_score_gemma":0.0002410719,"threshold_uncertainty_score":0.41172898},"labels":[],"label_agreement":null},{"id":"W2604146377","doi":"10.1111/ejh.12891","title":"Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and <scp>JAK</scp> inhibitors era?","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Myelofibrosis; Medicine; International Prognostic Scoring System; Ruxolitinib; Internal medicine; Univariate analysis; Transplantation; Autologous stem-cell transplantation; Oncology; Stem cell; Overall survival; Gastroenterology; Myeloid leukemia; Hematopoietic stem cell transplantation; Myelodysplastic syndromes; Multivariate analysis; Surgery; Bone marrow","score_opus":0.01402502677181484,"score_gpt":0.24811725934685375,"score_spread":0.23409223257503892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604146377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995207,0.001323898,0.00017702905,0.001648128,0.000103639795,0.00038872476,0.000043216936,0.0000054603097,0.0011029134],"genre_scores_gemma":[0.9979111,0.00065147644,0.0006695309,0.0003397975,0.000045930225,0.0000059216836,0.000012005088,0.000033711607,0.00033053817],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985505,0.00031424448,0.0005608274,0.00018504019,0.00019529973,0.00019413044],"domain_scores_gemma":[0.99815303,0.00033007172,0.0009474685,0.0002557526,0.00017757868,0.00013610611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005600226,0.0001787248,0.0005361343,0.00011469803,0.00018356297,0.000025704601,0.00016707474,0.000055780307,0.00003060178],"category_scores_gemma":[0.00008017998,0.00011277441,0.00017845276,0.000038235077,0.00024722336,0.00006298892,0.000035501227,0.00015030454,0.000020414704],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031491863,0.0010926019,0.50326985,0.0019116512,0.0038214477,0.013615405,0.016206406,0.00005462349,0.402142,0.00026396083,0.03216715,0.022305747],"study_design_scores_gemma":[0.00569861,0.0022429198,0.25662515,0.00035489775,0.0010432228,0.004976089,0.00023218586,0.00002780906,0.72510993,0.000023543304,0.0035814561,0.00008416848],"about_ca_topic_score_codex":0.0000024122216,"about_ca_topic_score_gemma":0.0000018434466,"teacher_disagreement_score":0.32296798,"about_ca_system_score_codex":0.000027867185,"about_ca_system_score_gemma":0.00005452784,"threshold_uncertainty_score":0.45988068},"labels":[],"label_agreement":null},{"id":"W2607976896","doi":"10.1111/ejh.12897","title":"Low <i>CREBBP</i> expression is associated with adverse long‐term outcomes in paediatric acute lymphoblastic leukaemia","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"National Natural Science Foundation of China","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.018810641628732427,"score_gpt":0.28862023617197735,"score_spread":0.26980959454324493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607976896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947702,0.00013229945,0.00086858746,0.0012334689,0.00034872722,0.00024958843,0.000012516026,0.000027570064,0.0023570342],"genre_scores_gemma":[0.9975886,0.00014601708,0.0005782943,0.0006122746,0.00016198914,0.0000024936555,0.000006888282,0.00009014974,0.000813301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965647,0.00059665664,0.0010186146,0.00035796754,0.00078109157,0.0006809719],"domain_scores_gemma":[0.99649096,0.00044932336,0.0014277803,0.00079211005,0.00039703667,0.000442784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001146923,0.0003546987,0.0012942493,0.00053828344,0.00021685474,0.00005865149,0.0008610451,0.00013350435,0.00016154666],"category_scores_gemma":[0.0018016287,0.00023654016,0.00024780256,0.00018981924,0.00041296764,0.00035527203,0.000349765,0.00077849795,0.00018093595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022566628,0.0005929464,0.72814995,0.00013445095,0.0006911601,0.2572158,0.0006931945,0.00002412817,0.0029024787,0.000012370672,0.006075432,0.0012513926],"study_design_scores_gemma":[0.029073179,0.0019961032,0.9231871,0.0018582818,0.0006118991,0.03610494,0.00010271825,0.00018122995,0.006328567,0.000019846952,0.00013758725,0.00039854576],"about_ca_topic_score_codex":0.0000051377447,"about_ca_topic_score_gemma":0.000009211948,"teacher_disagreement_score":0.22111087,"about_ca_system_score_codex":0.00055791903,"about_ca_system_score_gemma":0.0008127377,"threshold_uncertainty_score":0.96458274},"labels":[],"label_agreement":null},{"id":"W2608830349","doi":"10.1111/ejh.12899","title":"Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo‐<scp>HCT</scp>: 12‐year follow‐up data","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Lymphocytosis; Medicine; Internal medicine; Incidence (geometry); Immunology; Gastroenterology","score_opus":0.03552050049559737,"score_gpt":0.29805925365248,"score_spread":0.26253875315688263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608830349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649674,0.00006361801,0.0016055054,0.00020179739,0.0004763844,0.0002453645,0.00011079986,0.0000099711415,0.0007897945],"genre_scores_gemma":[0.9975596,0.00010190621,0.0018236525,0.0002023229,0.00007329175,0.0000014420867,0.000062307015,0.00004886093,0.00012660398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974045,0.000588199,0.0010206702,0.0003327411,0.0003256448,0.00032824633],"domain_scores_gemma":[0.9975096,0.00039415207,0.00087467383,0.00079510803,0.00019080576,0.00023565894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017807549,0.0002225155,0.0010515027,0.00013516347,0.00011165419,0.00005804874,0.0004271997,0.00007505624,0.000024008665],"category_scores_gemma":[0.0014103978,0.0001590283,0.00010229676,0.00003618911,0.00022431032,0.0002697301,0.00017966134,0.00036896078,0.00004232995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082329614,0.0003204063,0.9912023,0.00013010636,0.00020779534,0.006226444,0.00047694374,5.6019985e-8,0.000004942673,0.000032869983,0.00020380839,0.0003710493],"study_design_scores_gemma":[0.014202839,0.00068766344,0.9818675,0.00046579962,0.00040437598,0.0009689608,0.00014051344,0.000020579111,0.000020317431,0.000014089502,0.0011250946,0.000082256665],"about_ca_topic_score_codex":0.00000444559,"about_ca_topic_score_gemma":0.000020540152,"teacher_disagreement_score":0.013379542,"about_ca_system_score_codex":0.000027482503,"about_ca_system_score_gemma":0.000101808204,"threshold_uncertainty_score":0.6484986},"labels":[],"label_agreement":null},{"id":"W2614781853","doi":"10.1111/ejh.12903","title":"Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low‐dose dexamethasone: A pooled analysis","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Medicine; Neutropenia; Lenalidomide; Multiple myeloma; Dexamethasone; Internal medicine; Adverse effect; Bortezomib; Febrile neutropenia; Refractory (planetary science); Surgery; Toxicity; Gastroenterology","score_opus":0.019646255981155318,"score_gpt":0.291607620513063,"score_spread":0.27196136453190767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614781853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974564,0.00020620374,0.00038105823,0.000223914,0.00007652286,0.00042057058,0.0000044621634,0.000010256351,0.0012206538],"genre_scores_gemma":[0.9948658,0.0000807852,0.0047594286,0.00007135717,0.000029706842,0.0000038549797,0.000011338823,0.000035797788,0.000141975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759966,0.00056363706,0.0006879083,0.00030169034,0.00045148365,0.0003956086],"domain_scores_gemma":[0.99764925,0.00012658323,0.0011246518,0.0005726242,0.00019215657,0.00033471306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008502055,0.0002264805,0.00085671234,0.0007501409,0.00017384399,0.000037848557,0.00027166685,0.000041610994,0.00006528648],"category_scores_gemma":[0.0006519466,0.00016139551,0.00017949843,0.0001792941,0.00018599871,0.0002056336,0.000189306,0.00037265656,0.000022317372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008840354,0.0006418638,0.9132243,0.000107472704,0.0039134882,0.053382948,0.00036053508,0.000101224985,0.0000486691,0.000014791901,0.00004668104,0.019317668],"study_design_scores_gemma":[0.033281863,0.0010241176,0.96264017,0.00034444648,0.0012137431,0.0005143555,0.0001571106,0.000507934,0.000052143674,0.000004941631,0.00012505316,0.00013410485],"about_ca_topic_score_codex":0.000029030947,"about_ca_topic_score_gemma":0.00005757246,"teacher_disagreement_score":0.05286859,"about_ca_system_score_codex":0.00015010472,"about_ca_system_score_gemma":0.000063348816,"threshold_uncertainty_score":0.65815175},"labels":[],"label_agreement":null},{"id":"W2619649452","doi":"10.1111/ejh.12909","title":"Extramedullary disease at diagnosis of <scp>AML</scp> does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in <scp>CR</scp>1","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Univariate analysis; Multivariate analysis; Gastroenterology; Hematopoietic stem cell transplantation; Transplantation; Chemotherapy; Leukemia; Disease; Single Center; Surgery","score_opus":0.022036240563716364,"score_gpt":0.2794230375608566,"score_spread":0.2573867969971403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619649452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964818,0.0012971878,0.00006353813,0.0005406191,0.00026394226,0.00039292438,0.00006739793,0.000012906621,0.0008796801],"genre_scores_gemma":[0.99649626,0.0022700517,0.0005910093,0.00027607422,0.00006195546,0.000006348804,0.000011410799,0.000084952866,0.00020191673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952941,0.0008438836,0.0019645172,0.00039265593,0.0008169999,0.00068785966],"domain_scores_gemma":[0.99400043,0.0021053827,0.0019293389,0.000910664,0.00044788822,0.000606316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013529395,0.00036787923,0.0014433261,0.0005647017,0.00015265503,0.000028337055,0.0011062862,0.00011905351,0.000028950608],"category_scores_gemma":[0.0051833116,0.00027110163,0.000380288,0.0001559948,0.00067726645,0.00028938477,0.0003679054,0.0007853205,0.000050269304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002011978,0.00059465406,0.9746235,0.0017655763,0.0001459231,0.01617498,0.0015311136,0.00010669605,0.0041452735,0.00006571103,0.00051081163,0.0001345355],"study_design_scores_gemma":[0.0067012077,0.0008429483,0.9451747,0.0013903459,0.00033707116,0.0013394878,0.0003997045,0.00002777245,0.042863294,0.00006999908,0.00076793,0.00008553717],"about_ca_topic_score_codex":0.00001943936,"about_ca_topic_score_gemma":0.000034192315,"teacher_disagreement_score":0.03871802,"about_ca_system_score_codex":0.00019040551,"about_ca_system_score_gemma":0.00036685902,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W2752464581","doi":"10.1111/ejh.12961","title":"Post‐transplant consolidation plus lenalidomide maintenance vs lenalidomide maintenance alone in multiple myeloma: A systematic review","year":2017,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Lenalidomide; Multiple myeloma; Medicine; Internal medicine; Autologous stem-cell transplantation; Adverse effect; Maintenance therapy; Transplantation; Oncology; Surgery; Chemotherapy","score_opus":0.08682034022645548,"score_gpt":0.35746485631628944,"score_spread":0.270644516089834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752464581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019721434,0.9930107,0.00029759065,0.000941571,0.00040485262,0.0041106055,0.00013873099,0.000030046675,0.00086871645],"genre_scores_gemma":[0.0059670545,0.99142253,0.0007039197,0.00044744113,0.00017610629,0.00009932967,0.00017530726,0.00017564898,0.00083265756],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9881181,0.0046454677,0.0046816343,0.00067998545,0.0008104459,0.0010643351],"domain_scores_gemma":[0.9908196,0.0011281682,0.005218194,0.0013898544,0.00084151066,0.00060270086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004921565,0.00095139834,0.011134409,0.0009195803,0.00017948527,0.0000827297,0.0012130475,0.00021595399,0.00008268955],"category_scores_gemma":[0.0076579745,0.0006066056,0.0015918755,0.00027960475,0.00041046648,0.00025343988,0.0001800882,0.001699099,0.0006808266],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001275612,0.00024078062,0.00007409297,0.80060184,0.0015835469,0.17809623,0.00010178751,6.982781e-7,0.000004247084,0.00006167037,0.0017182071,0.016241286],"study_design_scores_gemma":[0.008270545,0.00052317063,0.000081370374,0.75418603,0.0038866815,0.16209328,0.000025747073,0.000015797157,0.0000051319475,0.0000061168084,0.07050185,0.00040429828],"about_ca_topic_score_codex":0.00003261697,"about_ca_topic_score_gemma":0.000049234775,"teacher_disagreement_score":0.06878364,"about_ca_system_score_codex":0.0006094761,"about_ca_system_score_gemma":0.0012719642,"threshold_uncertainty_score":0.99963856},"labels":[],"label_agreement":null},{"id":"W2765773896","doi":"10.1111/ejh.12989","title":"Longitudinal changes in <scp>LIC</scp> and other parameters in patients receiving different chelation regimens: Data from <scp>LICNET</scp>","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada)","funders":"","keywords":"Medicine; Serum ferritin; Chelation therapy; Chelation; Iron status; Ferritin; Wilcoxon signed-rank test; Gastroenterology; Hemochromatosis; Nuclear medicine; Internal medicine; Anemia; Iron deficiency; Thalassemia; Chemistry","score_opus":0.049976941634996754,"score_gpt":0.27902235131814074,"score_spread":0.229045409683144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765773896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431294,0.0016880736,0.00006566611,0.0008612694,0.00039668803,0.00020675267,0.000011667023,0.000010614413,0.0024463483],"genre_scores_gemma":[0.9982027,0.0008637741,0.00039365602,0.0002791939,0.00009036722,9.979049e-7,0.000024018864,0.00004515652,0.00010017023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979002,0.00046285798,0.000673698,0.0003566737,0.00023887435,0.0003677352],"domain_scores_gemma":[0.99784786,0.00037827514,0.00086693384,0.0006648525,0.000070128,0.00017195268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007799345,0.00023212189,0.00070749316,0.00030856355,0.00011248484,0.000061402374,0.00045274326,0.00012008593,0.000009520455],"category_scores_gemma":[0.0025006342,0.00017831456,0.0000543734,0.00007754389,0.0002463571,0.0002086812,0.00029832238,0.0006448359,0.000023820934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051394374,0.00024470428,0.98885626,0.000055475666,0.000130699,0.001815709,0.0017918549,0.000011655272,0.00014538903,0.000020172729,0.0028277822,0.0040489044],"study_design_scores_gemma":[0.0051172646,0.0005028596,0.9877554,0.00094373216,0.00010761778,0.00055556925,0.0009148678,0.00029746923,0.00019144184,0.000089006106,0.0034747068,0.000050046343],"about_ca_topic_score_codex":0.000059012575,"about_ca_topic_score_gemma":0.0001824922,"teacher_disagreement_score":0.0050658705,"about_ca_system_score_codex":0.000042833075,"about_ca_system_score_gemma":0.000029043158,"threshold_uncertainty_score":0.7271457},"labels":[],"label_agreement":null},{"id":"W2768941569","doi":"10.1111/ejh.13000","title":"Impact of comorbidities constituting the hematopoietic cell transplant (HCT)‐comorbidity index on the outcome of patients undergoing allogeneic HCT for acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Hematopoietic cell; Medicine; Comorbidity; Internal medicine; Oncology; Hematopoietic stem cell transplantation; Myeloid; Haematopoiesis; Transplantation; Stem cell; Biology","score_opus":0.05127480759335997,"score_gpt":0.33675227348287484,"score_spread":0.2854774658895149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768941569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366903,0.00015157243,0.0007957715,0.0012336083,0.0003183141,0.0005492787,0.0000802043,0.000008639868,0.003193595],"genre_scores_gemma":[0.9991207,0.0002252102,0.00021910772,0.00017646026,0.00011672709,0.0000031204318,0.000008308591,0.00004937144,0.000080973434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683225,0.00070649356,0.0012792394,0.0002052616,0.00051255553,0.0004642038],"domain_scores_gemma":[0.99499893,0.0015305142,0.0019800658,0.0008465409,0.000489128,0.00015481851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021899545,0.00028827004,0.0010943059,0.00019449534,0.00045040646,0.00003844171,0.0011439321,0.000079735684,0.000062977895],"category_scores_gemma":[0.0009957156,0.00014827574,0.000628218,0.000078512145,0.0011681459,0.000110057896,0.00017469072,0.00082097325,0.000012635351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044387626,0.000535092,0.9667634,0.0010297959,0.0027754544,0.003749089,0.0033517496,0.00040284955,0.0069657303,0.0027026688,0.0064175976,0.000867839],"study_design_scores_gemma":[0.0245897,0.009764144,0.89142036,0.0021691187,0.0022975514,0.013700715,0.0019092603,0.0006838475,0.051131707,0.00071107363,0.00092871155,0.00069380645],"about_ca_topic_score_codex":0.000034459004,"about_ca_topic_score_gemma":0.00001279324,"teacher_disagreement_score":0.075343005,"about_ca_system_score_codex":0.00023401428,"about_ca_system_score_gemma":0.00084000546,"threshold_uncertainty_score":0.6046509},"labels":[],"label_agreement":null},{"id":"W2774842751","doi":"10.1111/ejh.13015","title":"Outcome following second allogeneic hematopoietic cell transplantation: A single‐center experience","year":2017,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Single Center; Hematopoietic cell; Univariate analysis; Transplantation; Internal medicine; Retrospective cohort study; Surgery; Hematopoietic stem cell transplantation; Cohort; Multivariate analysis; Gastroenterology; Haematopoiesis; Stem cell","score_opus":0.045884300600459026,"score_gpt":0.30467172513053575,"score_spread":0.25878742453007675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774842751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96597326,0.00027777668,0.0067840107,0.00065926614,0.0009987239,0.00016891488,0.0000046494674,0.000023416995,0.02510999],"genre_scores_gemma":[0.9951061,0.000047505087,0.0038395368,0.00039791758,0.00012434297,0.0000018139868,0.000004973507,0.000051554678,0.00042622478],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9976197,0.00032934637,0.001130315,0.000241956,0.00035090302,0.00032778113],"domain_scores_gemma":[0.99822193,0.00011735176,0.0007812749,0.0005120229,0.00012096856,0.00024644172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007882208,0.00022934708,0.0007402846,0.00016627321,0.0002220226,0.00007454781,0.00045139622,0.0000616787,0.00036104713],"category_scores_gemma":[0.000101841055,0.00019241271,0.00036239016,0.000046891324,0.0001573117,0.00025250443,0.000030559204,0.00030301194,0.00015240395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071012,0.000713876,0.6576156,0.002080316,0.00033135276,0.19778171,0.01671524,0.0000065354684,0.12213636,0.00023857603,0.000535089,0.0011351975],"study_design_scores_gemma":[0.022335384,0.001938255,0.21635467,0.0024825956,0.0013651008,0.52999645,0.0026482604,0.000019384628,0.21242113,0.00012362954,0.009306113,0.0010090502],"about_ca_topic_score_codex":8.3203196e-7,"about_ca_topic_score_gemma":0.000003064877,"teacher_disagreement_score":0.44126096,"about_ca_system_score_codex":0.000031720232,"about_ca_system_score_gemma":0.000053462943,"threshold_uncertainty_score":0.78463626},"labels":[],"label_agreement":null},{"id":"W2789356670","doi":"10.1111/ejh.13059","title":"Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria: Expert consensus","year":2018,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Alexion Pharmaceuticals","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Differential diagnosis; Delphi method; Consensus conference; Pediatrics; Case finding; Algorithm; Family medicine; Intensive care medicine; Pathology; Internal medicine; Artificial intelligence; Computer science","score_opus":0.04960305646498333,"score_gpt":0.33262286750579234,"score_spread":0.28301981104080903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789356670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93348,0.010427709,0.0490277,0.0013264382,0.0047326684,0.0003820759,0.000057574394,0.00004176269,0.0005240701],"genre_scores_gemma":[0.9815309,0.00007179664,0.016858619,0.00053088233,0.0008383464,0.0000033547642,0.000009049008,0.000034444314,0.00012261592],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964439,0.0016440552,0.0012373467,0.00024921107,0.000048430757,0.0003770579],"domain_scores_gemma":[0.9961738,0.0024804173,0.0007491404,0.00020274021,0.00029742927,0.00009649359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016491878,0.00019670979,0.0006888382,0.00012495852,0.00021741405,0.000022038901,0.00031406913,0.000081368795,0.00031972086],"category_scores_gemma":[0.0015401595,0.0001592814,0.0002174617,0.00005102398,0.0008249359,0.000047567795,0.00014505416,0.0002803797,0.00010707705],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023575793,0.0007227268,0.05424984,0.00010316419,0.002823604,0.007855018,0.0013563767,0.0000027878718,0.0071221786,0.0011772086,0.50949115,0.41273838],"study_design_scores_gemma":[0.0336135,0.011721385,0.07466832,0.0010955746,0.0008881486,0.19126171,0.002420835,0.00024344683,0.008587299,0.0006816331,0.67363733,0.0011808312],"about_ca_topic_score_codex":0.000002599441,"about_ca_topic_score_gemma":0.000002685266,"teacher_disagreement_score":0.41155756,"about_ca_system_score_codex":0.000011707317,"about_ca_system_score_gemma":0.00006629228,"threshold_uncertainty_score":0.64953065},"labels":[],"label_agreement":null},{"id":"W2792382323","doi":"10.1111/ejh.13047","title":"Bacterial neuraminidase‐mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure","year":2018,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of Toronto; McMaster University; Canadian Blood Services","funders":"Canadian Blood Services","keywords":"Neuraminidase; Sialic acid; Sialidase; Phosphatidylserine; Ganglioside; Biology; Biochemistry; Red blood cell; Flow cytometry; Haptoglobin; Chemistry; Enzyme; Immunology; Phospholipid; Membrane","score_opus":0.018794752371457377,"score_gpt":0.24198941280747394,"score_spread":0.22319466043601655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792382323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885526,0.00033554426,0.0010812065,0.0005544268,0.0029809293,0.00018512119,0.000005272915,0.000054257333,0.0062506944],"genre_scores_gemma":[0.9935464,0.00011643248,0.0033142501,0.0008054123,0.0016921867,5.545605e-7,0.000028669785,0.000055436914,0.00044062923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997449,0.0008111021,0.0009125056,0.00025785193,0.00022950422,0.00034004307],"domain_scores_gemma":[0.99795157,0.00016563617,0.00077026477,0.00029324723,0.0005718646,0.0002473979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006219341,0.0002399951,0.00074020354,0.00017242879,0.00011512092,0.000021453754,0.0001773472,0.00011149536,0.00070334313],"category_scores_gemma":[0.00029370037,0.00019163084,0.00018022904,0.00021203572,0.0003417363,0.00014384676,0.000055746532,0.00042287138,0.0007738491],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062852465,0.0005353735,0.009080999,0.00019691295,0.00018599647,0.0059719947,0.0015229878,0.000019993662,0.9437859,0.00007204649,0.030488659,0.0018539084],"study_design_scores_gemma":[0.029385071,0.042347554,0.1877627,0.00056514854,0.000997183,0.08050002,0.0013194232,0.00035443992,0.42001587,0.00010013531,0.23540522,0.0012472396],"about_ca_topic_score_codex":0.0000026728994,"about_ca_topic_score_gemma":0.0000021899068,"teacher_disagreement_score":0.52377003,"about_ca_system_score_codex":0.000035735673,"about_ca_system_score_gemma":0.00017041067,"threshold_uncertainty_score":0.9946522},"labels":[],"label_agreement":null},{"id":"W2807801451","doi":"10.1111/ejh.13109","title":"Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery","year":2018,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"China Scholarship Council; Haematology Society of Australia and New Zealand","keywords":"Mean platelet volume; Platelet; Medicine; Thrombopoiesis; Aspirin; Internal medicine; Cardiology; Antithrombotic; Artery; Surgery; Haematopoiesis; Stem cell; Biology","score_opus":0.022959712417529546,"score_gpt":0.2644292603759885,"score_spread":0.24146954795845899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807801451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954185,0.0009958511,0.000043026535,0.0007459429,0.0014812221,0.00024650077,0.00000509678,0.000043192904,0.0010206818],"genre_scores_gemma":[0.9972209,0.00006995098,0.0016266308,0.00036141457,0.00060393906,0.0000032095443,0.000009920168,0.00007540785,0.000028667244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965021,0.0009766979,0.0013867965,0.00030580963,0.00042398903,0.00040462107],"domain_scores_gemma":[0.9972738,0.00026450405,0.0012067548,0.00038225437,0.0006220742,0.00025063142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002398955,0.00027815579,0.00090175954,0.0005712254,0.00010071557,0.000018247047,0.00019503731,0.00010919647,0.0003188192],"category_scores_gemma":[0.0011863267,0.0002364745,0.00035525774,0.00026814814,0.0005006716,0.00022877143,0.00009235891,0.00045078443,0.000107132386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07339802,0.00081350707,0.6086368,0.0017591618,0.0033941185,0.21748838,0.0013395824,0.0000026572275,0.0478645,0.000043298496,0.030738547,0.014521453],"study_design_scores_gemma":[0.0029080065,0.0012797158,0.71146554,0.0027896096,0.0006530115,0.21767995,0.0005871481,0.00003505384,0.05824496,0.00004937042,0.0038461746,0.0004614643],"about_ca_topic_score_codex":0.0000017999463,"about_ca_topic_score_gemma":0.0000015503487,"teacher_disagreement_score":0.10282876,"about_ca_system_score_codex":0.00005208202,"about_ca_system_score_gemma":0.00022838458,"threshold_uncertainty_score":0.96431506},"labels":[],"label_agreement":null},{"id":"W2810788093","doi":"10.1111/ejh.13128","title":"The burden of disease in pyruvate kinase deficiency: Patients’ perception of the impact on health‐related quality of life","year":2018,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Psychological intervention; Activities of daily living; Gerontology; Pyruvate kinase deficiency; Pediatrics; Pyruvate kinase; Psychiatry; Internal medicine","score_opus":0.030556991999468052,"score_gpt":0.31093282868735567,"score_spread":0.2803758366878876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810788093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965084,0.00024516956,0.00001968933,0.0021913259,0.00036148087,0.00015448738,0.000008564803,0.0000031118325,0.00050777534],"genre_scores_gemma":[0.9995718,0.00009292224,0.000023816167,0.00020688582,0.00006639122,2.6433034e-7,0.0000025592533,0.000011633079,0.000023747089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626815,0.0019911276,0.0012619448,0.000100937184,0.00021539045,0.00016242034],"domain_scores_gemma":[0.9974645,0.0002081626,0.0015293941,0.00029947938,0.000371627,0.00012683174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014027334,0.00010289693,0.0005686707,0.0001264904,0.00006184137,0.0000015558362,0.00018056473,0.00003079756,0.00008880047],"category_scores_gemma":[0.0010919592,0.00005023406,0.00022092018,0.0002122378,0.0005119163,0.000026953741,0.00004471912,0.00026090586,0.000013340432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057629317,0.004676427,0.80403745,0.0015133275,0.0005111629,0.00031554158,0.027616873,0.002701339,0.068177834,0.002985254,0.013633575,0.016201895],"study_design_scores_gemma":[0.0024325568,0.0039747665,0.9919821,0.00028146332,0.0000274822,0.000044197026,0.0006138805,0.000100081255,0.00021615105,0.0001662559,0.000113747396,0.00004730716],"about_ca_topic_score_codex":0.000091808324,"about_ca_topic_score_gemma":0.0000043330083,"teacher_disagreement_score":0.18794465,"about_ca_system_score_codex":0.00003697101,"about_ca_system_score_gemma":0.00024382853,"threshold_uncertainty_score":0.20484856},"labels":[],"label_agreement":null},{"id":"W2893654740","doi":"10.1111/ejh.13176","title":"How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry","year":2018,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Jewish General Hospital; Sunnybrook Health Science Centre; BC Cancer Agency; University of Calgary; Memorial University of Newfoundland; Hôpital Maisonneuve-Rosemont; University of Toronto; Western University; Université Laval; University of Alberta; Université de Montréal","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Statement (logic); Medicine; Pediatrics; Family medicine; Political science; Internal medicine; Law","score_opus":0.057367202817645783,"score_gpt":0.29934983634157303,"score_spread":0.24198263352392724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893654740","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027900084,0.9927578,0.000001872786,0.0033417612,0.0014679825,0.000628514,0.00030117808,0.0000032423225,0.0012186258],"genre_scores_gemma":[0.005962726,0.9926773,0.000053415166,0.0002632139,0.00021514182,0.0000050172275,0.000018985314,0.000036353187,0.00076786027],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918213,0.00547699,0.0019301533,0.00023424339,0.00017239543,0.00036489917],"domain_scores_gemma":[0.9937323,0.0004223839,0.004754207,0.0004707586,0.00054260856,0.000077790886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002047917,0.00036019448,0.0020505555,0.00012558982,0.0002360613,0.000018478106,0.0010692958,0.00013305251,0.00022238184],"category_scores_gemma":[0.0007104515,0.00018708903,0.0007277959,0.00021825077,0.0010142733,0.000024620687,0.00028092202,0.00058619457,0.00001458767],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000637084,0.00008054374,0.00042886683,0.050466042,0.0023555746,0.00038095386,0.00010031928,0.0000012124967,0.000009917245,0.0011743995,0.9296996,0.015238842],"study_design_scores_gemma":[0.00048174016,0.00011384192,0.000117738,0.07152711,0.0011277578,0.021867303,0.000025789403,6.300151e-8,0.000010048861,0.000044654855,0.9045493,0.0001346727],"about_ca_topic_score_codex":0.00011134485,"about_ca_topic_score_gemma":0.0011364804,"teacher_disagreement_score":0.025150334,"about_ca_system_score_codex":0.00017954338,"about_ca_system_score_gemma":0.0019053178,"threshold_uncertainty_score":0.76292694},"labels":[],"label_agreement":null},{"id":"W2912419506","doi":"10.1111/ejh.13216","title":"Influence of <i>FLT3‐ITD</i> and <i>NPM1 </i>status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"NPM1; Medicine; Internal medicine; Proportional hazards model; Cumulative incidence; Transplantation; Hematopoietic stem cell transplantation; Oncology; Biology; Gene; Karyotype; Genetics","score_opus":0.005951508004904088,"score_gpt":0.22412590677303704,"score_spread":0.21817439876813294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912419506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754536,0.00016295203,0.00003095342,0.00032905172,0.000043314878,0.00031551448,0.000009947193,0.000006389684,0.0015565017],"genre_scores_gemma":[0.9984712,0.00012138709,0.0008098905,0.0004820237,0.000011747193,8.4512436e-7,0.0000038023172,0.00004280986,0.000056295514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976411,0.00039384834,0.0008114543,0.0002286533,0.00047554495,0.0004494324],"domain_scores_gemma":[0.9986514,0.00019886756,0.00035669698,0.0002943742,0.00022992685,0.00026874433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004994075,0.00021737089,0.0008857688,0.00033262055,0.000020939822,0.000007995997,0.0002353688,0.00005554707,0.000039311795],"category_scores_gemma":[0.00006681237,0.00014585182,0.00008263609,0.00016106322,0.00022325946,0.0000768097,0.000063637024,0.0005550503,0.000054992128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023224896,0.0003614195,0.9879352,0.0002747976,0.000085014326,0.0036179556,0.00055748085,0.00037794176,0.0042076833,0.0000571232,0.000045333407,0.00015756597],"study_design_scores_gemma":[0.010485387,0.0049953363,0.97463125,0.0003862266,0.00008489542,0.0022877932,0.00006340918,0.0000075322937,0.0066917157,0.0000072655657,0.00020426938,0.00015494667],"about_ca_topic_score_codex":0.000004975469,"about_ca_topic_score_gemma":0.000002931109,"teacher_disagreement_score":0.013303973,"about_ca_system_score_codex":0.00005078747,"about_ca_system_score_gemma":0.00020490002,"threshold_uncertainty_score":0.59476644},"labels":[],"label_agreement":null},{"id":"W2913349186","doi":"10.1111/ejh.13213","title":"Sequential liver and haematopoietic stem cell transplantation in a case of fulminant hepatitis associated liver failure and aplastic anaemia","year":2019,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Stem cell; Context (archaeology); Hematology; Fulminant hepatitis; Haematopoiesis; Immunosuppression; Hepatology; Hematopoietic stem cell transplantation; Internal medicine; Immunology; Hepatitis; Biology","score_opus":0.03132635471322488,"score_gpt":0.2861108854695674,"score_spread":0.25478453075634255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913349186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16828969,0.83029306,0.0005734225,0.000029822868,0.00012327045,0.0005149306,0.000079531856,0.000014216488,0.000082069055],"genre_scores_gemma":[0.12867264,0.8705563,0.00059466553,0.0000206007,0.000023014089,0.0000012842372,0.00002643061,0.00004932814,0.000055737182],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99728996,0.0008403017,0.001287521,0.00022666587,0.00015735299,0.0001982293],"domain_scores_gemma":[0.99817955,0.00030051626,0.001154406,0.00013278652,0.00011318862,0.0001195766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054184505,0.00030423616,0.0022208167,0.00053251453,0.000028349117,0.000014908892,0.00009422566,0.00018308836,0.000050489325],"category_scores_gemma":[0.00002381012,0.00023338062,0.00022965691,0.0001614223,0.000120361336,0.000083899606,0.000023386203,0.00055227475,0.000009176653],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017112015,0.00017518744,0.0035645852,0.16968416,0.00037104,0.7400296,0.002583373,7.107174e-7,0.00001677519,0.000108071086,0.00023012707,0.083065294],"study_design_scores_gemma":[0.0036258756,0.0016487897,0.0024699338,0.034982532,0.008138581,0.9371691,0.00019661017,0.000031716223,0.00016891184,0.0000052067107,0.011105979,0.00045676314],"about_ca_topic_score_codex":0.00002887914,"about_ca_topic_score_gemma":0.000077330435,"teacher_disagreement_score":0.19713955,"about_ca_system_score_codex":0.00004836979,"about_ca_system_score_gemma":0.0001439301,"threshold_uncertainty_score":0.95169854},"labels":[],"label_agreement":null},{"id":"W2928859997","doi":"10.1111/ejh.13230","title":"Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Fludarabine; Thymoglobulin; Cumulative incidence; Busulfan; Incidence (geometry); Graft-versus-host disease; Hematopoietic stem cell transplantation; Cyclophosphamide; Cohort; Surgery; Transplantation; Immunology; Chemotherapy; Tacrolimus","score_opus":0.00867137768890668,"score_gpt":0.2268223089696353,"score_spread":0.2181509312807286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928859997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708605,0.0016805116,0.0001751591,0.00022965996,0.000060500122,0.00026622327,0.000006499469,0.0000079472,0.00048744824],"genre_scores_gemma":[0.9977792,0.0011567653,0.00087238883,0.000040328632,0.000013263807,6.573525e-7,0.000004120744,0.00003421988,0.00009906393],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984978,0.00032508615,0.0006357119,0.00019433632,0.00013929149,0.00020779534],"domain_scores_gemma":[0.99921477,0.00013007024,0.0003275518,0.00011980107,0.0000694653,0.00013836959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004718059,0.00018460558,0.00078877754,0.00016318787,0.00001872686,0.000011925625,0.000067501394,0.000065735585,0.000060288356],"category_scores_gemma":[0.0000028892814,0.00013572024,0.000036072524,0.00009921481,0.00013971512,0.00009064548,0.000012367141,0.00027540582,0.000004307395],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035259211,0.00042335535,0.4749694,0.0073427907,0.0010934212,0.029990388,0.01883671,0.000034422963,0.46225813,0.00008250179,0.00001877632,0.0014241883],"study_design_scores_gemma":[0.047760583,0.006863512,0.33788997,0.0044385972,0.0023043172,0.17969477,0.0025428836,0.00044329336,0.4174534,0.000024963369,0.000038007234,0.000545705],"about_ca_topic_score_codex":0.000002992179,"about_ca_topic_score_gemma":0.00000551624,"teacher_disagreement_score":0.14970438,"about_ca_system_score_codex":0.000013636379,"about_ca_system_score_gemma":0.000077546436,"threshold_uncertainty_score":0.55345106},"labels":[],"label_agreement":null},{"id":"W2944731734","doi":"10.1111/ejh.13244","title":"Deferiprone exerts a dose‐dependent reduction of liver iron in adults with iron overload","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Deferiprone; Medicine; Gastroenterology; Adverse effect; Internal medicine; Neutropenia; Cohort; Thalassemia; Chemotherapy","score_opus":0.006068156558330796,"score_gpt":0.20767495292111826,"score_spread":0.20160679636278747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944731734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907722,0.0022008272,0.00003604703,0.00043874895,0.0002691453,0.0002383386,7.6224217e-7,0.000008025913,0.0060359016],"genre_scores_gemma":[0.9982788,0.00084415666,0.00045080704,0.000057606714,0.000041166415,4.5911625e-7,0.0000021786186,0.000027596576,0.0002972092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985519,0.0002528723,0.00059779466,0.00016021676,0.00023183993,0.00020537319],"domain_scores_gemma":[0.99911565,0.00001886831,0.0004614058,0.00019089013,0.00011604206,0.00009712831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040426632,0.00013499161,0.00052257505,0.00023227767,0.000015767271,0.0000038553753,0.000098522294,0.000065332366,0.00016531072],"category_scores_gemma":[0.00003371541,0.000092667375,0.0000816219,0.00014803308,0.0000933778,0.00008735395,0.00003100915,0.00040340438,0.000073004834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10740687,0.009636496,0.24178286,0.012533275,0.0013939574,0.19197151,0.062053356,0.0059866398,0.18206804,0.0018503825,0.00983395,0.17348267],"study_design_scores_gemma":[0.08812304,0.035812706,0.42680225,0.018047675,0.0010571367,0.38693595,0.01884678,0.00050601736,0.015409988,0.00008908635,0.0070240395,0.0013453232],"about_ca_topic_score_codex":0.000021854725,"about_ca_topic_score_gemma":0.000007125314,"teacher_disagreement_score":0.19496445,"about_ca_system_score_codex":0.000040992618,"about_ca_system_score_gemma":0.00007181885,"threshold_uncertainty_score":0.37788656},"labels":[],"label_agreement":null},{"id":"W2946234917","doi":"10.1111/ejh.13250","title":"Pregnancy and delivery in women with von Willebrand disease","year":2019,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Pregnancy; Von Willebrand disease; Von Willebrand factor; Desmopressin; Tranexamic acid; Amniocentesis; Miscarriage; Obstetrics; Vaginal delivery; Abortion; Gynecology; Immunology; Internal medicine; Surgery; Fetus; Platelet; Prenatal diagnosis","score_opus":0.028005730707816267,"score_gpt":0.27689654052219,"score_spread":0.24889080981437373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946234917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054172605,0.9444564,0.0000038647017,0.000053418928,0.00008180297,0.0003371169,0.0000068365352,0.00000464744,0.0008832889],"genre_scores_gemma":[0.005495035,0.9940836,0.00008186932,0.000060417482,0.00002564002,0.0000034553907,0.000007229069,0.000054563618,0.00018820693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998467,0.000360954,0.00060034054,0.00019974436,0.00012918182,0.00024275441],"domain_scores_gemma":[0.9989194,0.000072715426,0.00053686724,0.00018720585,0.000046162982,0.0002376321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018350952,0.0002684048,0.0023349328,0.00031233646,0.000018274279,0.000011582317,0.00010343012,0.000047876587,0.00003425304],"category_scores_gemma":[0.000037244394,0.0001578512,0.000121664925,0.000108266715,0.0000731032,0.00006637043,0.000042430125,0.0003676626,0.000046496833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005587285,0.00018491637,0.0008380685,0.0119436765,0.00050943054,0.2948098,0.00013091184,2.7879722e-7,4.8196576e-8,0.000010603559,0.00016945433,0.6908441],"study_design_scores_gemma":[0.0071045677,0.0020338397,0.001486574,0.12871647,0.002385315,0.11859789,0.000057011115,9.831855e-7,8.571541e-8,0.000024231045,0.73926866,0.0003243442],"about_ca_topic_score_codex":4.2940542e-7,"about_ca_topic_score_gemma":5.6825087e-7,"teacher_disagreement_score":0.7390992,"about_ca_system_score_codex":0.00005150476,"about_ca_system_score_gemma":0.00025757772,"threshold_uncertainty_score":0.6436985},"labels":[],"label_agreement":null},{"id":"W2948813254","doi":"10.1111/ejh.13272","title":"Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; London Health Sciences Centre; Queen's University; Canadian Electricity Association; University of Ottawa; Kingston Health Sciences Centre; Western University","funders":"European Hematology Association","keywords":"Fusion gene; DNA sequencing; Hematologic Neoplasms; Medicine; Gene; Oncology; Internal medicine; Computational biology; Genetics; Biology; Cancer","score_opus":0.07699446865798654,"score_gpt":0.3604213250905318,"score_spread":0.2834268564325453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948813254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487174,0.00009126141,0.0042995736,0.00017237493,0.00005162836,0.00045624768,0.000012739109,0.000007456935,0.000036979196],"genre_scores_gemma":[0.9631507,0.000022740775,0.036644187,0.00009432704,0.0000252082,9.134523e-7,0.000027780214,0.000026683718,0.0000074958834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781793,0.00051206717,0.001009592,0.00017506708,0.00027556333,0.00020975625],"domain_scores_gemma":[0.99758905,0.0002931117,0.001018692,0.00019153435,0.00078622974,0.000121390345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001457723,0.000120182056,0.000745664,0.00022840379,0.000032882966,0.0000053887097,0.00013569451,0.00004429116,0.00006130577],"category_scores_gemma":[0.00023324208,0.00008282056,0.00008899697,0.0001221298,0.00016524165,0.00010378664,0.000054068674,0.00021105354,0.000001421813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003981188,0.00017483985,0.94641024,0.00052907865,0.00019189143,0.0008472896,0.00043306095,0.00002517434,0.043477543,0.00011131956,0.00010269368,0.0037156597],"study_design_scores_gemma":[0.018659582,0.011186299,0.91880566,0.00041054544,0.00021885837,0.0023857735,0.002086473,0.00075326115,0.045263145,0.000018752988,0.000071614675,0.00014006003],"about_ca_topic_score_codex":0.000008169949,"about_ca_topic_score_gemma":0.0000032906587,"teacher_disagreement_score":0.032344613,"about_ca_system_score_codex":0.00003831365,"about_ca_system_score_gemma":0.00024649085,"threshold_uncertainty_score":0.33773246},"labels":[],"label_agreement":null},{"id":"W2966006629","doi":"10.1111/ejh.13309","title":"Epstein‐Barr virus associated post‐transplant lymphoproliferative disorder mimicking acute graft versus host disease","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Diarrhea; Differential diagnosis; Immune surveillance; Disease; Post-transplant lymphoproliferative disorder; Epstein–Barr virus infection; Lymphoproliferative disease; Epstein–Barr virus; Virus; Graft-versus-host disease; Presentation (obstetrics); Immune system; Immunology; Pathology; Gastroenterology; Surgery","score_opus":0.011031200839543063,"score_gpt":0.2531761141374302,"score_spread":0.24214491329788712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966006629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887554,0.0019501208,0.0001364494,0.0034118544,0.0013118765,0.00028836395,0.00007868318,0.00004672269,0.004020535],"genre_scores_gemma":[0.99713415,0.0005778162,0.000077626064,0.0015837357,0.00010735338,0.0000017777274,0.00005389263,0.00007842791,0.0003852297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973998,0.00059268647,0.0007744841,0.00029286993,0.00042421266,0.0005159144],"domain_scores_gemma":[0.99808973,0.00013112997,0.000720569,0.00026507257,0.00039128494,0.00040222835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005217321,0.0003132195,0.000902963,0.00024005151,0.00012490105,0.000036490746,0.00026267886,0.00008554508,0.00037949072],"category_scores_gemma":[0.00027175221,0.00025395458,0.00041216656,0.00022854705,0.000122057645,0.00018710742,0.000050872808,0.00049874035,0.00029078312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07623562,0.0035580944,0.6727616,0.00060666737,0.015512282,0.14531632,0.013061276,0.000504133,0.045360424,0.0018727469,0.021210276,0.0040005655],"study_design_scores_gemma":[0.20291276,0.023372306,0.6988676,0.004070292,0.011389622,0.01584455,0.007137327,0.0009979178,0.0036316174,0.00033412545,0.028119687,0.0033222067],"about_ca_topic_score_codex":0.00002114136,"about_ca_topic_score_gemma":0.000030016055,"teacher_disagreement_score":0.12947178,"about_ca_system_score_codex":0.00017447582,"about_ca_system_score_gemma":0.0003614112,"threshold_uncertainty_score":0.9999913},"labels":[],"label_agreement":null},{"id":"W2968198730","doi":"10.1111/ejh.13314","title":"Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cerebrospinal fluid; Internal medicine; Central nervous system; Myeloid leukemia; Cumulative incidence; Incidence (geometry); Pathological; Oncology; Leukemia; Gastroenterology; Transplantation","score_opus":0.01665544431114275,"score_gpt":0.29888103237909525,"score_spread":0.2822255880679525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968198730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977615,0.00022371135,0.00019685327,0.0001725919,0.0001492289,0.00041186388,0.0000433748,0.000006311918,0.0010345911],"genre_scores_gemma":[0.9992326,0.0001220165,0.0005241249,0.00004531991,0.00002291991,0.0000013355566,0.000005724884,0.000026184076,0.000019811476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997084,0.0006974888,0.0011452154,0.00021068146,0.0004706393,0.0003919415],"domain_scores_gemma":[0.99877584,0.00012830795,0.0004161288,0.00030483239,0.00015744232,0.00021745263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012207513,0.0002114271,0.0011386182,0.0003338545,0.00001273403,0.0000063517577,0.00020325801,0.000057783072,0.00012896852],"category_scores_gemma":[0.000027269482,0.00013893784,0.00025449178,0.000108908505,0.00013690839,0.00006708497,0.000045898734,0.00052882684,0.000006998161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041231383,0.00035407834,0.9767393,0.0016966669,0.0003997205,0.009628031,0.00074197614,0.00004474188,0.005774163,0.00014445603,0.0000787952,0.00027491536],"study_design_scores_gemma":[0.005064236,0.0037013604,0.9833625,0.0013647218,0.000110578265,0.004702036,0.00021365182,0.00046297337,0.0009017475,0.0000027491174,0.000018999972,0.00009444098],"about_ca_topic_score_codex":0.00006871425,"about_ca_topic_score_gemma":0.00000964007,"teacher_disagreement_score":0.006623189,"about_ca_system_score_codex":0.0002184606,"about_ca_system_score_gemma":0.0003348543,"threshold_uncertainty_score":0.56657207},"labels":[],"label_agreement":null},{"id":"W2970258757","doi":"10.1111/ejh.13321","title":"Reduced intensity allogeneic stem cell transplant with anti‐thymocyte globulin and post‐transplant cyclophosphamide in acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cumulative incidence; Anti-thymocyte globulin; Cyclophosphamide; Internal medicine; Gastroenterology; Incidence (geometry); Hematopoietic stem cell transplantation; Myeloid leukemia; Graft-versus-host disease; Surgery; Globulin; Immunology; Transplantation; Chemotherapy","score_opus":0.008846231724032474,"score_gpt":0.21579802800732908,"score_spread":0.2069517962832966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970258757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954302,0.0010414405,0.00072562264,0.0006360922,0.0003046087,0.00040191997,0.000019615127,0.000027754662,0.001412767],"genre_scores_gemma":[0.9960829,0.0018703578,0.0013531396,0.00043979025,0.00003733347,0.0000010390614,0.000020190007,0.00006387036,0.00013138262],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99734426,0.00046106667,0.001047474,0.00037223694,0.00034056007,0.0004343847],"domain_scores_gemma":[0.99864626,0.00015246413,0.00043059528,0.00028572997,0.00020462502,0.00028033392],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096754957,0.0003316722,0.001184775,0.0003109692,0.000040787505,0.00001863577,0.00021386582,0.00010184444,0.000044141474],"category_scores_gemma":[0.000006221943,0.00024635615,0.00012645847,0.00019839524,0.00013595386,0.0001264072,0.000019074825,0.00061953394,0.000087046195],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009800889,0.00021800946,0.34078577,0.0014057806,0.00054764975,0.16061929,0.0076579466,0.00016050789,0.47752407,0.00008177058,0.00006679915,0.0011315214],"study_design_scores_gemma":[0.01201347,0.0025448352,0.5586763,0.00267168,0.0009220357,0.2565446,0.00088492496,0.00008400496,0.16489907,0.000007650535,0.00025901682,0.00049245305],"about_ca_topic_score_codex":0.000015212498,"about_ca_topic_score_gemma":0.00000963765,"teacher_disagreement_score":0.31262502,"about_ca_system_score_codex":0.00008704569,"about_ca_system_score_gemma":0.0002645135,"threshold_uncertainty_score":0.99999887},"labels":[],"label_agreement":null},{"id":"W2972452355","doi":"10.1111/ejh.13327","title":"Reduced‐intensity conditioning allogeneic transplant with dual T‐cell depletion in myelofibrosis","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Cumulative incidence; Cyclophosphamide; Gastroenterology; Graft-versus-host disease; Incidence (geometry); Surgery; Transplantation; Bone marrow; Chemotherapy","score_opus":0.011424199007215082,"score_gpt":0.22568699275825554,"score_spread":0.21426279375104046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972452355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451756,0.00022400977,0.0002119769,0.001070474,0.00015912608,0.00020641969,0.0000034725545,0.000010214037,0.0035967578],"genre_scores_gemma":[0.99791056,0.00010548475,0.0014663495,0.0003267801,0.000055733555,0.0000020510572,0.000015718582,0.000026477222,0.00009081774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986308,0.00029066447,0.0004957848,0.0001852069,0.00018793254,0.0002096074],"domain_scores_gemma":[0.9992089,0.000076199205,0.00029403743,0.00013696839,0.00016369892,0.00012018935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035270234,0.00015889507,0.00060077576,0.0001907137,0.000038032267,0.000011274512,0.000059369442,0.000034595938,0.00017439091],"category_scores_gemma":[0.000019654304,0.00010897422,0.000097145705,0.00010288612,0.00006326873,0.000069452726,0.000012970453,0.0002618313,0.00012460655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018178741,0.00051666825,0.9212874,0.00011214705,0.00021547437,0.033069815,0.0014394239,0.00015080023,0.04041196,0.00027693328,0.00047846252,0.0002230008],"study_design_scores_gemma":[0.007129458,0.0039963806,0.84682024,0.0007675106,0.00023298709,0.07017922,0.00045805675,0.000026142008,0.069652766,0.00001755557,0.0005415514,0.00017812061],"about_ca_topic_score_codex":0.000006015105,"about_ca_topic_score_gemma":0.000012337004,"teacher_disagreement_score":0.07446719,"about_ca_system_score_codex":0.0000589957,"about_ca_system_score_gemma":0.000081908984,"threshold_uncertainty_score":0.44438398},"labels":[],"label_agreement":null},{"id":"W2975041764","doi":"10.1111/ejh.13332","title":"Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; CD34; Hematopoietic stem cell transplantation; Cumulative incidence; Stem cell; Transplantation; Internal medicine; Urology; Gastroenterology; Surgery; Biology","score_opus":0.019091064159130776,"score_gpt":0.2748290739479072,"score_spread":0.2557380097887764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975041764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873648,0.00010142949,0.0014518045,0.00016823258,0.00037218383,0.00031989696,0.000009141353,0.000024089715,0.010188413],"genre_scores_gemma":[0.99880385,0.00006456943,0.0006214391,0.000088261644,0.000056346962,7.5782634e-7,0.000020454658,0.000053950753,0.0002903424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99720865,0.0006298707,0.0011838508,0.00024807896,0.00043542602,0.0002941081],"domain_scores_gemma":[0.99792004,0.00032151944,0.0008515295,0.00031660107,0.00036427734,0.00022602442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009802226,0.00024250952,0.0009621655,0.00035907948,0.000040510047,0.000016180398,0.00018347069,0.00008538046,0.00029883985],"category_scores_gemma":[0.000025055202,0.000195379,0.0003929682,0.00017110523,0.000111271685,0.00012749832,0.000014556852,0.0004736994,0.0003845716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010468968,0.001948375,0.052043386,0.0058619855,0.0007261809,0.032104608,0.019541323,0.0008384675,0.87309676,0.00079531764,0.0020825064,0.00049209176],"study_design_scores_gemma":[0.018415902,0.009621948,0.16652921,0.003945713,0.001494748,0.08195873,0.0027030483,0.0002853657,0.7142602,0.00014586054,0.000041681742,0.000597546],"about_ca_topic_score_codex":0.000004002636,"about_ca_topic_score_gemma":2.0400284e-7,"teacher_disagreement_score":0.15883654,"about_ca_system_score_codex":0.000077404955,"about_ca_system_score_gemma":0.00015896963,"threshold_uncertainty_score":0.7967325},"labels":[],"label_agreement":null},{"id":"W2983490569","doi":"10.1111/ejh.13353","title":"Allogeneic stem cell transplant in myelodysplastic syndrome‐factors impacting survival","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Cumulative incidence; Myelodysplastic syndromes; Incidence (geometry); Oncology; Survival analysis; Transplantation; Ferritin; Bone marrow; Surgery","score_opus":0.022544785628342813,"score_gpt":0.2615934662579578,"score_spread":0.239048680629615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983490569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936792,0.00036456456,0.0002064433,0.00033208932,0.0005986668,0.0002044934,0.000004248308,0.00001744824,0.0045928033],"genre_scores_gemma":[0.9990407,0.00009251199,0.00021032589,0.00007442203,0.00006299959,3.5553302e-7,0.000004332137,0.00006837882,0.00044594225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692374,0.00095172366,0.00091577746,0.00023621917,0.0004084396,0.00056412286],"domain_scores_gemma":[0.99838287,0.00052120606,0.00039095478,0.00027407144,0.00011915085,0.00031176192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001624208,0.00023273876,0.00097399566,0.00057690876,0.00003415458,0.000017043261,0.00034856127,0.00007361973,0.00027980594],"category_scores_gemma":[0.000073112904,0.00017312689,0.0001944965,0.00027575306,0.0000780748,0.000118206655,0.00006145277,0.0010609657,0.0004055806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014696269,0.00029744772,0.72492325,0.0006814043,0.00030639427,0.20923828,0.003020682,0.00030086827,0.058412205,0.00008359427,0.00037925164,0.0008869759],"study_design_scores_gemma":[0.018040072,0.005935916,0.6429537,0.0016121893,0.0003591759,0.30596474,0.0054722703,0.00040438064,0.016141668,0.000017957864,0.0023678176,0.00073012937],"about_ca_topic_score_codex":0.000008107688,"about_ca_topic_score_gemma":0.0000037945376,"teacher_disagreement_score":0.09672648,"about_ca_system_score_codex":0.0001910382,"about_ca_system_score_gemma":0.00032514846,"threshold_uncertainty_score":0.70599097},"labels":[],"label_agreement":null},{"id":"W2985042324","doi":"10.1111/ejh.13343","title":"Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Daratumumab; Hematopoietic cell; Pure red cell aplasia; Refractory (planetary science); Medicine; Transplantation; Hematopoietic stem cell transplantation; Aplasia; Cell; Oncology; Cancer research; Immunology; Haematopoiesis; Stem cell; Internal medicine; Bortezomib; Multiple myeloma; Bone marrow; Biology","score_opus":0.010680294613957201,"score_gpt":0.24082056424326742,"score_spread":0.23014026962931022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985042324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757986,0.0018353817,0.00040714044,0.00017352513,0.00025561557,0.00021672476,0.0000048573734,0.000015043133,0.021293132],"genre_scores_gemma":[0.99764043,0.00091251713,0.0008035565,0.00006728933,0.000054922275,0.0000028398354,0.0000040851814,0.00003967809,0.0004746907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835265,0.00035062394,0.0006801562,0.00017957065,0.00023515793,0.0002018697],"domain_scores_gemma":[0.9986831,0.00009435145,0.0006588069,0.00024191894,0.00021496526,0.00010688792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021287122,0.00020752313,0.00078925793,0.00024449313,0.000033527835,0.0000062522445,0.00008545181,0.000042901316,0.00029415288],"category_scores_gemma":[0.000007958944,0.00013957825,0.00016028562,0.00012596385,0.00011080286,0.000090186164,0.0000112456155,0.00016250109,0.00032967425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012979925,0.0025745467,0.85025775,0.002125423,0.0009373676,0.03943123,0.0071506673,0.00011702225,0.082152024,0.00003278784,0.0014853355,0.00075589604],"study_design_scores_gemma":[0.037822567,0.020791905,0.4095225,0.0011958664,0.003016047,0.10566603,0.0018767166,0.000008650875,0.3774015,0.000023515368,0.04187628,0.0007984022],"about_ca_topic_score_codex":0.0000026424414,"about_ca_topic_score_gemma":0.0000042181246,"teacher_disagreement_score":0.44073525,"about_ca_system_score_codex":0.00005707341,"about_ca_system_score_gemma":0.00008237514,"threshold_uncertainty_score":0.5691835},"labels":[],"label_agreement":null},{"id":"W2997945764","doi":"10.1111/ejh.13376","title":"Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease‐specific assessments","year":2019,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Biochemical Acid Research Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Agios Pharmaceuticals","keywords":"Pyruvate kinase; Medicine; Quality of life (healthcare); Disease; Patient-reported outcome; Population; Pyruvate kinase deficiency; Internal medicine; Environmental health","score_opus":0.018135464847422844,"score_gpt":0.2994349143009339,"score_spread":0.28129944945351104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997945764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912272,0.005739643,0.0007369328,0.00021372268,0.00023484122,0.0002060163,0.000014926782,0.0000046913833,0.0016220096],"genre_scores_gemma":[0.99691087,0.0007201757,0.0021345078,0.00007016817,0.000049297378,0.0000024620178,0.00000967536,0.000030164645,0.00007268813],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974955,0.00059391593,0.00072330626,0.00034313652,0.0004131013,0.00043106935],"domain_scores_gemma":[0.9984851,0.00005404981,0.00054623344,0.0004309515,0.00026165057,0.00022201109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012319953,0.00025442085,0.00040948403,0.00010626695,0.00015558199,0.00003159058,0.0006417981,0.000053298918,0.00003691808],"category_scores_gemma":[0.00017642364,0.0001594422,0.0002039076,0.0001845637,0.00040373925,0.000015295487,0.0007623422,0.00032537527,0.000013518825],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002647226,0.0003432891,0.060836904,0.00020209055,0.00014172657,0.00028908928,0.00015549989,0.000029477676,0.93277097,0.00023281608,0.0009585698,0.0037748464],"study_design_scores_gemma":[0.0035102705,0.0016447554,0.67509085,0.00051086233,0.0001282402,0.000529832,0.0006678389,0.00006535885,0.30444512,0.00028918215,0.012326618,0.0007910419],"about_ca_topic_score_codex":9.668366e-7,"about_ca_topic_score_gemma":7.2014933e-7,"teacher_disagreement_score":0.6283258,"about_ca_system_score_codex":0.0000404911,"about_ca_system_score_gemma":0.00031683766,"threshold_uncertainty_score":0.6501865},"labels":[],"label_agreement":null},{"id":"W3010183597","doi":"10.1111/ejh.13403","title":"Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Malignancy; Lymphoblastic Leukemia; Multivariate analysis; Oncology; Leukemia; Acute leukemia; Stem cell","score_opus":0.014139057552876103,"score_gpt":0.2486395751561109,"score_spread":0.23450051760323481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010183597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959556,0.00076020544,0.00093016186,0.0010781606,0.00013600309,0.00023754974,0.00001102848,0.000016250578,0.0008750297],"genre_scores_gemma":[0.99771327,0.00084860093,0.0005547647,0.0007081437,0.00004389138,0.0000021080198,0.000005918197,0.000055263936,0.000068056026],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9971696,0.0006221179,0.0012468387,0.00022657569,0.00041232855,0.00032254058],"domain_scores_gemma":[0.9986011,0.00025170558,0.0005061404,0.0001805886,0.00020105652,0.00025945413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045309664,0.00022036843,0.00091003586,0.000309525,0.00001771972,0.0000069273306,0.00028828968,0.00008591193,0.00014017307],"category_scores_gemma":[0.000058444482,0.00016153195,0.00021445872,0.00031559524,0.00014708718,0.00009760529,0.00004241032,0.00040294277,0.00009739324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05976972,0.00079987565,0.3835496,0.0028075431,0.002711552,0.42991117,0.034538858,0.0014831594,0.06622744,0.00012770374,0.00180069,0.016272685],"study_design_scores_gemma":[0.08636314,0.00944739,0.79496163,0.0017503893,0.000970756,0.053463057,0.0012932244,0.0033160702,0.04705479,0.000040926265,0.00063571404,0.0007029129],"about_ca_topic_score_codex":0.0000049769187,"about_ca_topic_score_gemma":0.0000017084874,"teacher_disagreement_score":0.41141203,"about_ca_system_score_codex":0.00025242634,"about_ca_system_score_gemma":0.0006199112,"threshold_uncertainty_score":0.65870816},"labels":[],"label_agreement":null},{"id":"W3010273422","doi":"10.1111/ejh.13405","title":"c‐MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide‐dexamethasone in myeloma","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; SAIT Polytechnic","funders":"Agence Nationale de la Recherche","keywords":"Lenalidomide; Medicine; Internal medicine; Oncology; Multiple myeloma; Hazard ratio; Dexamethasone; Placebo; Ixazomib; Autologous stem-cell transplantation; Confidence interval; Pathology; Carfilzomib","score_opus":0.04591443661562897,"score_gpt":0.2880934337399425,"score_spread":0.24217899712431354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010273422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638575,0.0004069572,0.00020905379,0.0024847693,0.000033982644,0.00019085096,0.000057286572,0.000010539092,0.00022081565],"genre_scores_gemma":[0.9962812,0.0000309539,0.0032306414,0.00033203096,0.00006063575,0.0000014238549,0.000024245264,0.000025045534,0.000013830901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829197,0.00043662018,0.000585569,0.00018881557,0.00029187047,0.00020517372],"domain_scores_gemma":[0.9986231,0.00027773296,0.00047234946,0.00012609742,0.00017485333,0.00032589133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036527117,0.0001462111,0.00078460784,0.0001664936,0.0000287455,0.000011630873,0.00011146033,0.000043600954,0.0001323762],"category_scores_gemma":[0.0010971978,0.0001007706,0.0000627559,0.00015715417,0.00006950014,0.00008976101,0.000075565236,0.0003243243,0.000016915312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01255515,0.00056301896,0.92261744,0.00018387304,0.0005262972,0.027270377,0.0020445895,0.000039793293,0.026710244,0.00003794902,0.0011211527,0.0063301246],"study_design_scores_gemma":[0.009398283,0.0014826729,0.9761758,0.0009822954,0.00008954624,0.0005443079,0.00036659668,0.00005680576,0.010599718,0.000056940487,0.00014288894,0.00010417437],"about_ca_topic_score_codex":0.000017514865,"about_ca_topic_score_gemma":0.00003063837,"teacher_disagreement_score":0.05355834,"about_ca_system_score_codex":0.000037083315,"about_ca_system_score_gemma":0.000031936965,"threshold_uncertainty_score":0.41093057},"labels":[],"label_agreement":null},{"id":"W3023296941","doi":"10.1111/ejh.13437","title":"Causes of hypereosinophilia in 100 consecutive patients","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Hypereosinophilia; Eosinophilia; Medicine; Granulomatosis with polyangiitis; Hypereosinophilic syndrome; Context (archaeology); Eosinophilic; Vasculitis; Dermatology; Pathology; Immunology; Internal medicine; Gastroenterology; Disease","score_opus":0.02915228858587913,"score_gpt":0.2550555463843551,"score_spread":0.225903257798476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023296941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940444,0.0006475336,0.000025823789,0.004179442,0.00012247491,0.00009439087,0.000004112891,0.000005426674,0.0055163824],"genre_scores_gemma":[0.99845946,0.00009196875,0.0002866912,0.001076249,0.0000330745,1.75083e-7,0.0000020609816,0.00001843436,0.00003187803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858844,0.00027852828,0.0007082031,0.00010944738,0.0001692282,0.00014614787],"domain_scores_gemma":[0.9991357,0.00005717854,0.00037335313,0.00009850143,0.00019684086,0.00013842438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021196039,0.000106233885,0.00066272286,0.00014894508,0.000013150403,0.0000032623432,0.00013007644,0.00002695373,0.00012084463],"category_scores_gemma":[0.0004411811,0.00008295098,0.00010725103,0.00015723593,0.0001541458,0.000049974926,0.00004295325,0.0002295129,0.000033228363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016817556,0.0014133396,0.92419255,0.00054528716,0.00039623183,0.032627273,0.011940783,0.000016546697,0.0033456592,0.0013184288,0.018545343,0.0039768093],"study_design_scores_gemma":[0.013967527,0.0087907165,0.94911623,0.00079765357,0.0002527432,0.010339772,0.0030558826,0.00003264469,0.0030271653,0.00025450098,0.010049273,0.00031589932],"about_ca_topic_score_codex":0.0000028076536,"about_ca_topic_score_gemma":0.000001136595,"teacher_disagreement_score":0.024923678,"about_ca_system_score_codex":0.000010213491,"about_ca_system_score_gemma":0.00007813932,"threshold_uncertainty_score":0.3382643},"labels":[],"label_agreement":null},{"id":"W3037528322","doi":"10.1111/ejh.13478","title":"Sickle cell trait and the potential risk of severe coronavirus disease 2019—A mini‐review","year":2020,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pandemic; Disease; Medicine; Sickle cell trait; Epidemiology; Asymptomatic; Pneumonia; Public health; Coronavirus; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Environmental health; Infectious disease (medical specialty); Internal medicine; Pathology","score_opus":0.019641937636184863,"score_gpt":0.28339515384703906,"score_spread":0.2637532162108542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037528322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010776381,0.9954435,0.00004774783,0.001611614,0.00034905935,0.0006521641,0.000086223605,0.0000087398375,0.0016931474],"genre_scores_gemma":[0.00032928694,0.9985654,0.00014555373,0.00049895357,0.00014648087,0.0000015384933,0.000019670337,0.000070775786,0.00022233774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951256,0.0024727865,0.0016585832,0.00023358718,0.00027948702,0.00022997825],"domain_scores_gemma":[0.99663347,0.00024311293,0.0022922861,0.00031552836,0.00013277543,0.0003828175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010994774,0.0003730197,0.0035594162,0.000102566504,0.00006633444,0.000009797537,0.00035498952,0.00010104064,0.00020932619],"category_scores_gemma":[0.00039605715,0.00019134517,0.0012172273,0.00017085594,0.0004740513,0.00003380306,0.00013238938,0.0012276212,0.000090095375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000513163,0.00017106802,0.000011698651,0.06496727,0.0011506275,0.02431075,0.00014305433,0.0000018996776,3.6313216e-7,0.00008821783,0.021274805,0.88736707],"study_design_scores_gemma":[0.0028079003,0.00030747644,0.00003470622,0.02799327,0.0141753135,0.029213123,0.00004708063,0.0000033947974,1.18109426e-7,0.000020129779,0.9252304,0.00016710225],"about_ca_topic_score_codex":0.000002965013,"about_ca_topic_score_gemma":1.7432421e-7,"teacher_disagreement_score":0.9039556,"about_ca_system_score_codex":0.000015475647,"about_ca_system_score_gemma":0.0004253208,"threshold_uncertainty_score":0.7802829},"labels":[],"label_agreement":null},{"id":"W3038486853","doi":"10.1111/ejh.13482","title":"Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Angina; Hematopoietic stem cell transplantation; Cohort; Retrospective cohort study; Stroke (engine); Anthracycline; Cardiomyopathy; Coronary artery disease; Transplantation; Cardiology; Surgery; Heart failure; Myocardial infarction","score_opus":0.05202972940087471,"score_gpt":0.2888122664873757,"score_spread":0.23678253708650096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038486853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905614,0.0041779727,0.0023396204,0.0018517652,0.00012769092,0.00031409078,0.000006678013,0.0000074951836,0.00061323517],"genre_scores_gemma":[0.99763596,0.0014143266,0.0003199489,0.0005386508,0.00005560759,0.0000010275068,0.0000016134051,0.000025692058,0.000007170465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621296,0.0013849528,0.001574411,0.00022040632,0.0004083444,0.00019891518],"domain_scores_gemma":[0.9986701,0.0004058746,0.0004142669,0.000272092,0.00007977686,0.00015786095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002927383,0.0001694485,0.0010045782,0.00009451934,0.000030105604,0.000004430212,0.0003068755,0.00005934783,0.000020933534],"category_scores_gemma":[0.00005301963,0.000112170186,0.00038309762,0.00015107715,0.0001350547,0.000050396156,0.000025471612,0.00042005512,0.00001865844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006044985,0.00032491822,0.9560766,0.006449583,0.0004434058,0.021398718,0.013428952,0.00008776458,0.00041526795,0.000092547896,0.00008512871,0.0005925659],"study_design_scores_gemma":[0.017563699,0.004724354,0.83394593,0.003416774,0.004420385,0.12368597,0.0030431007,0.000233606,0.0042349165,0.000042748394,0.0041135233,0.0005749825],"about_ca_topic_score_codex":0.0000016081549,"about_ca_topic_score_gemma":9.21608e-7,"teacher_disagreement_score":0.12213071,"about_ca_system_score_codex":0.00000893,"about_ca_system_score_gemma":0.000047503032,"threshold_uncertainty_score":0.45741674},"labels":[],"label_agreement":null},{"id":"W3041190648","doi":"10.1111/ejh.13485","title":"Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alexion Pharmaceuticals","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Hemoglobinuria; Bone marrow failure; Bone marrow; Internal medicine; Surgery; Pediatrics; Anemia; Immunology; Antibody","score_opus":0.016380195855437634,"score_gpt":0.23577955306504847,"score_spread":0.21939935720961085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041190648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178773,0.0020623945,0.00016325702,0.003327086,0.0015409756,0.0002705167,0.00028219266,0.000009619202,0.0005562207],"genre_scores_gemma":[0.9994365,0.00005890806,0.00012849348,0.0001028264,0.00010789788,0.0000013856009,0.000013854635,0.00002159901,0.00012851696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965521,0.0012244853,0.0016239209,0.00021018222,0.0001793137,0.0002099929],"domain_scores_gemma":[0.99640155,0.00042295005,0.002427275,0.00035279948,0.0003123631,0.00008305655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045870358,0.0001930922,0.0007830945,0.000107491825,0.00007450542,0.0000056997574,0.0010221286,0.00006199189,0.00028682122],"category_scores_gemma":[0.0017329599,0.00012700343,0.00042070143,0.00015521263,0.0004364289,0.000057875874,0.00022749882,0.00032093877,0.000009758218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05954265,0.001800678,0.022393385,0.0031424316,0.0028764936,0.0064010024,0.0046155513,0.00038718275,0.8284094,0.002925413,0.06375394,0.0037519075],"study_design_scores_gemma":[0.0554565,0.0053702174,0.27058074,0.006788046,0.0026388934,0.018156983,0.0021044917,0.000057944555,0.586618,0.00030619322,0.050917964,0.0010040177],"about_ca_topic_score_codex":0.000006404706,"about_ca_topic_score_gemma":0.0000096024505,"teacher_disagreement_score":0.24818736,"about_ca_system_score_codex":0.000023538298,"about_ca_system_score_gemma":0.00029104465,"threshold_uncertainty_score":0.51790494},"labels":[],"label_agreement":null},{"id":"W3044606577","doi":"10.1111/ejh.13496","title":"Maintenance therapy in transplant ineligible adults with newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Ottawa Hospital; University of Ottawa; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Meta-analysis; Confidence interval; Hazard ratio; Adverse effect; Randomized controlled trial; Internal medicine; Multiple myeloma; Maintenance therapy; MEDLINE; Relative risk; Surgery; Chemotherapy","score_opus":0.056808534067040915,"score_gpt":0.3254934137450504,"score_spread":0.2686848796780095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044606577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008200397,0.9960716,0.00012009401,0.00065047253,0.000017431345,0.0028871887,0.00005101068,0.000015927912,0.000104300525],"genre_scores_gemma":[0.0033258977,0.9950356,0.0009556338,0.00038015036,0.000025730755,0.00009728089,0.00004420749,0.00008605469,0.000049430637],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99383056,0.0027312413,0.0021051625,0.00046489618,0.00042282516,0.0004453089],"domain_scores_gemma":[0.9966669,0.0006771827,0.00149793,0.00046884685,0.00022976956,0.00045935568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011366382,0.000626662,0.01330272,0.0007969617,0.000039774703,0.000025994155,0.00036971454,0.00008249476,0.00007119112],"category_scores_gemma":[0.00044004244,0.00030907916,0.0016148719,0.0010607806,0.000118992866,0.00007552154,0.00004494296,0.000820673,0.00004464075],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005677547,0.00021928694,0.000086598884,0.6880198,0.14552915,0.15892571,0.00022389111,6.90288e-7,7.105233e-8,0.000006856636,0.00011855613,0.006301642],"study_design_scores_gemma":[0.007856142,0.0016109849,0.00005862381,0.2636398,0.65316826,0.05651256,0.000051759936,0.000016111826,7.4237755e-7,0.000001035355,0.016716782,0.00036721327],"about_ca_topic_score_codex":0.000015953985,"about_ca_topic_score_gemma":0.00005111473,"teacher_disagreement_score":0.5076391,"about_ca_system_score_codex":0.00006175065,"about_ca_system_score_gemma":0.00027342385,"threshold_uncertainty_score":0.9999361},"labels":[],"label_agreement":null},{"id":"W3047580662","doi":"10.1111/ejh.13504","title":"Single UM171‐expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Aplastic anemia; Fludarabine; Cord blood; Cyclophosphamide; Transplantation; Stem cell; Haematopoiesis; Anemia; CD34; Hematopoietic stem cell transplantation; Progenitor cell; Surgery; Immunology; Internal medicine; Gastroenterology; Bone marrow; Chemotherapy","score_opus":0.026500904094581043,"score_gpt":0.24085192664927413,"score_spread":0.21435102255469307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047580662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943331,0.0006196812,0.0019237528,0.0013962928,0.00018735265,0.00017431483,0.000014532304,0.00001886486,0.0013321369],"genre_scores_gemma":[0.9984478,0.00024967658,0.0008926188,0.00026737235,0.0000763995,6.7533284e-7,0.0000070382134,0.000038493148,0.000019958627],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9974068,0.00058032025,0.001182189,0.00021446717,0.0003100415,0.00030620716],"domain_scores_gemma":[0.998695,0.00021872127,0.00051402266,0.0001560431,0.00014977231,0.00026642642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007350023,0.00019869053,0.0009071608,0.00019077152,0.000027755026,0.000008366447,0.00022185977,0.00007653156,0.00009487536],"category_scores_gemma":[0.00020672678,0.00017064498,0.00012500216,0.00028582715,0.00011364234,0.000071691225,0.000015855565,0.0005457511,0.00002118388],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006196407,0.001212828,0.31812444,0.008637873,0.00043064915,0.20171618,0.027761448,0.0006535041,0.43260366,0.000573276,0.0006508637,0.001438866],"study_design_scores_gemma":[0.03853417,0.017779365,0.08850961,0.01596059,0.0025288658,0.5660132,0.0047479556,0.00066893303,0.2628414,0.0001724619,0.0009135272,0.0013298946],"about_ca_topic_score_codex":0.000010685695,"about_ca_topic_score_gemma":0.000025324118,"teacher_disagreement_score":0.36429703,"about_ca_system_score_codex":0.000024285435,"about_ca_system_score_gemma":0.00019354501,"threshold_uncertainty_score":0.69587004},"labels":[],"label_agreement":null},{"id":"W3091916167","doi":"10.1111/ejh.13531","title":"Prolactin, a potential biomarker for chronic GVHD activity","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Prolactin; Medicine; Biomarker; Internal medicine; Cohort; Hormone; Gastroenterology; Odds ratio; Endocrinology; Biology","score_opus":0.03621521186632647,"score_gpt":0.2819842436058146,"score_spread":0.2457690317394881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091916167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760008,0.0011764795,0.0105509255,0.009727988,0.0002696965,0.0002577906,0.0000063335883,0.000018334997,0.0019916634],"genre_scores_gemma":[0.9982878,0.0000397526,0.0008370251,0.0005480916,0.0002137788,0.0000013137607,0.0000040862997,0.000023011671,0.000045164434],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99917316,0.0001409664,0.00027383384,0.00012635239,0.00010246811,0.0001832053],"domain_scores_gemma":[0.9993571,0.000031476848,0.00023800199,0.000087205604,0.000092390284,0.00019384608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017247254,0.000111308174,0.0003967865,0.000059064198,0.000049221948,0.000008378316,0.00008437167,0.000024060357,0.00014636696],"category_scores_gemma":[0.00012141818,0.00007848929,0.00020155087,0.00006346757,0.000043777545,0.000073888215,0.000027295926,0.00013742805,0.000047038848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07851364,0.0041260836,0.067795455,0.0021426463,0.006439197,0.18979923,0.0021881093,0.000070493166,0.0609541,0.0004695623,0.115044035,0.47245744],"study_design_scores_gemma":[0.075774826,0.028107615,0.67260236,0.00024201325,0.0026726457,0.08700778,0.00034368286,0.0027243728,0.009230631,0.00037871208,0.12015474,0.00076062756],"about_ca_topic_score_codex":5.4421446e-7,"about_ca_topic_score_gemma":4.856754e-7,"teacher_disagreement_score":0.6048069,"about_ca_system_score_codex":0.000021273938,"about_ca_system_score_gemma":0.00011182255,"threshold_uncertainty_score":0.32007003},"labels":[],"label_agreement":null},{"id":"W3092252175","doi":"10.1111/ejh.13533","title":"Association of anticoagulation dose and survival in hospitalized COVID‐19 patients: A retrospective propensity score‐weighted analysis","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Propensity score matching; Medicine; Coronavirus disease 2019 (COVID-19); Retrospective cohort study; 2019-20 coronavirus outbreak; Internal medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Survival analysis; Virology; Disease","score_opus":0.06118369551701191,"score_gpt":0.35904077255986705,"score_spread":0.29785707704285513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092252175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877124,0.000063439154,0.0010294416,0.010720879,0.00005114539,0.00024978712,0.0000068747204,0.0000086276605,0.00015742765],"genre_scores_gemma":[0.99894446,0.000186411,0.00024439377,0.000550129,0.000041161944,4.9001414e-7,0.0000063207226,0.0000107944425,0.00001583614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968857,0.0012975658,0.000923997,0.00021006072,0.0005061144,0.00017655743],"domain_scores_gemma":[0.99680984,0.001043867,0.0009572541,0.00011534225,0.00081077754,0.0002629066],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0022009925,0.000109535154,0.0011611102,0.0003138327,0.000039239174,0.000009782602,0.000097103235,0.00004202414,0.000042079995],"category_scores_gemma":[0.05281058,0.00008401886,0.00017208027,0.00078289973,0.00013644622,0.000091278154,0.00013031464,0.00035216945,0.0000036789747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011984045,0.00020018287,0.9953197,0.00015978613,0.0008868433,0.0008483972,0.00082192686,0.000024588704,0.00013028,0.00004273708,0.00018173158,0.00018541478],"study_design_scores_gemma":[0.005170486,0.0013538111,0.99204594,0.000050137696,0.00058670394,0.0000073265774,0.00003598811,0.00046262454,0.000031653,0.00008754568,0.000102950915,0.000064848115],"about_ca_topic_score_codex":0.00001849458,"about_ca_topic_score_gemma":0.000012663976,"teacher_disagreement_score":0.050609585,"about_ca_system_score_codex":0.00018895509,"about_ca_system_score_gemma":0.0001453452,"threshold_uncertainty_score":0.955168},"labels":[],"label_agreement":null},{"id":"W3094933225","doi":"10.1111/ejh.13543","title":"Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms","year":2020,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Essential thrombocythemia; Polycythemia vera; Myelofibrosis; Pulmonary hypertension; Internal medicine; Myeloproliferative neoplasm; Bone marrow","score_opus":0.044727797251144424,"score_gpt":0.2880866734117881,"score_spread":0.2433588761606437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094933225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023301631,0.9743348,0.00010898799,0.00022972815,0.00020510882,0.0015169079,0.00013449645,0.000027144832,0.00014120752],"genre_scores_gemma":[0.010385027,0.9883896,0.0005776522,0.000062246916,0.00025411128,0.000031976688,0.00007471544,0.00013452265,0.000090140995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962696,0.0013408919,0.001199239,0.00051753427,0.00030234494,0.00037040198],"domain_scores_gemma":[0.9953134,0.0015305062,0.0021254215,0.00022927813,0.00042305986,0.00037833527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005402779,0.0006708074,0.0038399564,0.00024054205,0.0001762434,0.000034475455,0.00018262671,0.00016167667,0.000034717916],"category_scores_gemma":[0.0011488287,0.00037639966,0.0005199461,0.00019398228,0.00019927823,0.00009238897,0.00008053383,0.00087031367,0.000018105837],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015250824,0.0017292546,0.04787832,0.039737917,0.018154832,0.10383291,0.0010905382,0.000008158012,0.0000048231364,0.00032429214,0.003238517,0.78247535],"study_design_scores_gemma":[0.00731747,0.02276563,0.015186869,0.07462522,0.030356614,0.12558638,0.00009116028,0.00012667288,0.00005398184,0.00002903838,0.7226934,0.0011675552],"about_ca_topic_score_codex":0.0000015396188,"about_ca_topic_score_gemma":0.0000035976639,"teacher_disagreement_score":0.7813078,"about_ca_system_score_codex":0.00020664581,"about_ca_system_score_gemma":0.0006799394,"threshold_uncertainty_score":0.9998688},"labels":[],"label_agreement":null},{"id":"W3095174995","doi":"10.1111/ejh.13542","title":"Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantation","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Comorbidity; Transplantation; Depression (economics); Internal medicine; Cohort; Dyslipidemia; Quality of life (healthcare); Hematopoietic stem cell transplantation; Anxiety; Surgery; Pediatrics; Psychiatry; Disease","score_opus":0.022806511894719276,"score_gpt":0.2497925551750155,"score_spread":0.22698604328029623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095174995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892187,0.00027938452,0.0050271186,0.00095389166,0.0003138602,0.00024070874,0.000018243727,0.000026396388,0.0039216606],"genre_scores_gemma":[0.99578637,0.00020549665,0.0034163983,0.0003635066,0.00007668919,0.000001101856,0.000034495773,0.00005072148,0.000065229295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99743193,0.0006477709,0.0010676148,0.00020501303,0.0004105054,0.00023715617],"domain_scores_gemma":[0.99862134,0.0001838041,0.0005816112,0.00017038405,0.00018279627,0.0002600379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000589333,0.00018310604,0.0007690254,0.00013278314,0.000039616323,0.000006322191,0.00019812847,0.00006363116,0.00021782413],"category_scores_gemma":[0.00009222225,0.0001667209,0.0003182964,0.00019711205,0.00008509798,0.00007634431,0.000022513905,0.00026449058,0.00015395334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037726348,0.00073349837,0.24270748,0.008693682,0.00097611063,0.11524225,0.033835392,0.00021172652,0.58723396,0.0003927923,0.0048034647,0.0013970068],"study_design_scores_gemma":[0.016082931,0.003341007,0.09130423,0.0016975637,0.0026975297,0.05781771,0.0021346193,0.00020651895,0.82187784,0.000051578943,0.0020347743,0.0007536844],"about_ca_topic_score_codex":0.0000044301246,"about_ca_topic_score_gemma":0.0000060610964,"teacher_disagreement_score":0.23464389,"about_ca_system_score_codex":0.000026477808,"about_ca_system_score_gemma":0.000086957225,"threshold_uncertainty_score":0.6798681},"labels":[],"label_agreement":null},{"id":"W3106232974","doi":"10.1111/ejh.13552","title":"The impact of COVID‐19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single‐center experience","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Amyloidosis; Pandemic; Outbreak; AL amyloidosis; Coronavirus disease 2019 (COVID-19); Disease; Intensive care medicine; Internal medicine; Pediatrics; Immunology; Antibody; Infectious disease (medical specialty); Pathology","score_opus":0.02132332063777698,"score_gpt":0.29642383992898896,"score_spread":0.275100519291212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106232974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116594,0.00461281,0.00050037075,0.0033752727,0.000036720987,0.00013992337,0.000011909852,0.0000018400303,0.0001552453],"genre_scores_gemma":[0.99700755,0.0020354094,0.00029108813,0.0006195337,0.000020631524,0.0000041838903,0.0000059346116,0.0000122890915,0.0000033920678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985474,0.0005438616,0.00048382705,0.00014424062,0.0001294842,0.00015121822],"domain_scores_gemma":[0.99914706,0.000056991,0.00043068337,0.0002070816,0.00004690309,0.000111296344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029580275,0.00012712785,0.00023275953,0.00003252279,0.00005534118,0.000016652573,0.00035486813,0.000019418201,0.000007982449],"category_scores_gemma":[0.0001015808,0.000072269475,0.00016655316,0.0000865112,0.00021830232,0.0000076277915,0.00013540899,0.0000791614,0.0000013231476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061393706,0.0018949801,0.8234521,0.00038767743,0.0025665918,0.00681373,0.008872532,0.0006336312,0.1296161,0.0005596306,0.008793605,0.0102700535],"study_design_scores_gemma":[0.011666552,0.0074788886,0.9029098,0.00045489587,0.0005824775,0.0066038202,0.01086893,0.000099902885,0.046932444,0.0001163325,0.011638253,0.00064768293],"about_ca_topic_score_codex":0.0000058357477,"about_ca_topic_score_gemma":0.0000019446222,"teacher_disagreement_score":0.082683645,"about_ca_system_score_codex":0.000019630488,"about_ca_system_score_gemma":0.000034562363,"threshold_uncertainty_score":0.29470634},"labels":[],"label_agreement":null},{"id":"W3111386845","doi":"10.1111/ejh.13564","title":"One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Hemoglobinuria; Adverse effect; Internal medicine; Anemia; Immunology; Antibody","score_opus":0.02286949683580114,"score_gpt":0.2583178488033262,"score_spread":0.23544835196752506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111386845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376154,0.00152195,0.00048468515,0.0016753733,0.0006619606,0.0010448465,0.00008155536,0.000026223657,0.0007418734],"genre_scores_gemma":[0.998825,0.00006997444,0.00065254385,0.00021088652,0.00011920845,0.000008911633,0.000041720312,0.000043063203,0.000028677414],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9919466,0.004876104,0.0022705304,0.00035348136,0.00016059962,0.00039268183],"domain_scores_gemma":[0.9964469,0.0008718196,0.0020173106,0.00031699694,0.00022828522,0.00011865152],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010312612,0.00033744297,0.0027040879,0.00023170776,0.00006371985,0.000017854094,0.00068443874,0.00009624324,0.001485924],"category_scores_gemma":[0.0012211371,0.0002497604,0.00046501544,0.00017869115,0.0004211425,0.00012840774,0.00013479215,0.000550517,0.00012233817],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9862846,0.0008268099,0.0017823023,0.00011124225,0.0013730956,0.0016680202,0.0032578215,0.000017468523,0.0018630102,0.00013144927,0.0013729999,0.0013111451],"study_design_scores_gemma":[0.9881805,0.0035322064,0.0020439015,0.0006800313,0.0004048676,0.0005387717,0.0007871975,0.000013918097,0.0024405152,0.00006290219,0.0010474763,0.0002676681],"about_ca_topic_score_codex":0.00002472852,"about_ca_topic_score_gemma":0.000014651074,"teacher_disagreement_score":0.005063482,"about_ca_system_score_codex":0.000041760053,"about_ca_system_score_gemma":0.00022139376,"threshold_uncertainty_score":0.99999547},"labels":[],"label_agreement":null},{"id":"W3113677185","doi":"10.1111/ejh.13572","title":"Comorbidities and complications in adults with pyruvate kinase deficiency","year":2020,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Pyruvate kinase deficiency; Pyruvate kinase; Splenectomy; Internal medicine; Population; Cohort; Gastroenterology; Iron deficiency; Hemolytic anemia; Anemia; Glycolysis","score_opus":0.028732588243687605,"score_gpt":0.24465824352526333,"score_spread":0.21592565528157573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113677185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985461,0.000535916,0.0007675907,0.008001968,0.000057118163,0.0000692711,0.000001712542,0.000011673626,0.0050937515],"genre_scores_gemma":[0.9960675,0.00015212229,0.0011316667,0.002566235,0.000053780135,4.949384e-7,0.000002901048,0.000011299051,0.0000139833655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992486,0.0001817751,0.0002996659,0.00010214912,0.0000637544,0.000104031926],"domain_scores_gemma":[0.99949276,0.000050646882,0.00016720091,0.00007619703,0.0000915741,0.00012163013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118317796,0.00007442487,0.0002948525,0.00008845022,0.000031150616,0.0000040085342,0.00005781088,0.000015319192,0.000043979995],"category_scores_gemma":[0.000076973905,0.00005295403,0.000027777392,0.00011374416,0.00015622459,0.00003856304,0.000022832934,0.00022249947,0.000033087636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026027089,0.0023043496,0.5680774,0.0038734335,0.00043690356,0.16903917,0.050002273,0.0005300502,0.07331229,0.037343472,0.041488837,0.027564764],"study_design_scores_gemma":[0.017634677,0.01307909,0.8675044,0.0012462306,0.00017118592,0.063034244,0.006357936,0.0006056722,0.001307791,0.00022261114,0.028417177,0.00041897886],"about_ca_topic_score_codex":0.0000015548942,"about_ca_topic_score_gemma":0.0000029935036,"teacher_disagreement_score":0.29942703,"about_ca_system_score_codex":0.000006041853,"about_ca_system_score_gemma":0.000037722828,"threshold_uncertainty_score":0.21594027},"labels":[],"label_agreement":null},{"id":"W3120212210","doi":"10.1111/ejh.13576","title":"Refined hepatic grading system in chronic graft‐versus‐host disease improves prognostic risk stratification of long‐term outcomes","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Cutoff; Grading (engineering); Risk stratification; Bilirubin; Predictive value; Surgery","score_opus":0.02874996879369944,"score_gpt":0.2880799857745002,"score_spread":0.25933001698080077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120212210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445987,0.0011367354,0.002881048,0.00036514807,0.0004184321,0.00027818696,0.000008407341,0.000020550777,0.00043161315],"genre_scores_gemma":[0.9988198,0.00017544982,0.00083608605,0.000017131642,0.000058889378,0.0000033227234,0.00002291585,0.000033938322,0.000032432723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969829,0.0010044598,0.001284906,0.00020960504,0.00029322173,0.00022496122],"domain_scores_gemma":[0.9978429,0.0005034726,0.00090184336,0.0003051295,0.00025952613,0.00018713331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092763244,0.00017540804,0.00073373015,0.0002539218,0.000039225906,0.000015529562,0.00013587165,0.000039259827,0.000026586511],"category_scores_gemma":[0.00075010903,0.00014426412,0.00017499244,0.00023387728,0.00008579848,0.00009819481,0.000019510428,0.00029041205,0.000021106383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010125935,0.00034480946,0.9085706,0.0064510843,0.00041160584,0.04393933,0.00104028,0.0000416555,0.034681868,0.0012953368,0.00002217663,0.002188673],"study_design_scores_gemma":[0.004900117,0.00053135166,0.9779359,0.0024498221,0.00081893074,0.0049871826,0.00038101067,0.00035851882,0.007481222,0.00001509198,0.0000066255056,0.00013422473],"about_ca_topic_score_codex":0.000004115624,"about_ca_topic_score_gemma":0.000026884934,"teacher_disagreement_score":0.069365315,"about_ca_system_score_codex":0.00015734279,"about_ca_system_score_gemma":0.0004169826,"threshold_uncertainty_score":0.58829206},"labels":[],"label_agreement":null},{"id":"W3126448789","doi":"10.1111/ejh.13593","title":"Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Ruxolitinib; Medicine; Hemophagocytic lymphohistiocytosis; Cytokine storm; Cytokine release syndrome; Tocilizumab; Internal medicine; Immunology; Macrophage activation syndrome; Oncology; Immunotherapy; Immune system; Chimeric antigen receptor; Bone marrow; Myelofibrosis","score_opus":0.028086633971856026,"score_gpt":0.30637414547763986,"score_spread":0.27828751150578385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126448789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96788025,0.013846753,0.00044043336,0.002762674,0.00033020985,0.00025217098,0.000011810653,0.000023163142,0.014452547],"genre_scores_gemma":[0.99390525,0.0007935331,0.0012992879,0.0015685683,0.00020622036,0.000007507272,0.0000139898475,0.000060329203,0.0021453388],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979786,0.0005437027,0.0007587708,0.0001949328,0.00019794964,0.00032602216],"domain_scores_gemma":[0.99824494,0.0001560806,0.00034097707,0.00027041338,0.00081033615,0.00017726727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007568126,0.00017289695,0.00074284466,0.00017213564,0.00015361862,0.000027733617,0.00013127396,0.000051253155,0.0007420372],"category_scores_gemma":[0.00066268956,0.00014076411,0.00030416314,0.00014766342,0.00020407645,0.00017498044,0.000058828948,0.00034844174,0.000084259795],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058241845,0.0005140954,0.00070448406,0.00048593106,0.0010344265,0.9103701,0.0024533733,0.000006305777,0.007173751,0.003672079,0.015044767,0.05271646],"study_design_scores_gemma":[0.009461737,0.0023196633,0.0008339892,0.00014774199,0.00009214922,0.8434437,0.0033687379,0.000016034735,0.01660646,0.0003933154,0.12316917,0.00014732771],"about_ca_topic_score_codex":0.00000196627,"about_ca_topic_score_gemma":0.000001434999,"teacher_disagreement_score":0.1081244,"about_ca_system_score_codex":0.00006039548,"about_ca_system_score_gemma":0.0013536139,"threshold_uncertainty_score":0.8124787},"labels":[],"label_agreement":null},{"id":"W3127156187","doi":"10.1111/ejh.13596","title":"The impact of lenalidomide maintenance on second‐line chemotherapy in transplant eligible patients with multiple myeloma","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; University of Saskatchewan; Dalhousie University; University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital; Institute of Cancer Research; Saint John Regional Hospital; BC Cancer Agency; CancerCare Manitoba; Occupational Cancer Research Centre; Ottawa Hospital; Canadian Institutes of Health Research; McGill University; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Internal medicine; Oncology; Cohort; Maintenance therapy; Thalidomide; Chemotherapy; Surgery","score_opus":0.01508152340516909,"score_gpt":0.2850994780564227,"score_spread":0.2700179546512536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127156187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974634,0.0003550513,0.000093891824,0.00065744726,0.000047277277,0.00017897996,0.000020069394,0.000003982709,0.0011798793],"genre_scores_gemma":[0.9989625,0.00029112241,0.0004042481,0.00010146874,0.00003180327,0.0000012507091,0.000011263564,0.000028680362,0.00016762757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826086,0.00043372758,0.0005657643,0.00014321707,0.0002725597,0.00032389406],"domain_scores_gemma":[0.9986514,0.00029800658,0.00030963327,0.00024349744,0.000342461,0.00015501077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045112724,0.00015481892,0.00054848345,0.00013465255,0.000045013807,0.00001052715,0.00014688552,0.0000241043,0.00011401614],"category_scores_gemma":[0.0002194884,0.00007557406,0.00018272043,0.00016980268,0.000118795964,0.000046667883,0.000015407666,0.00031734945,0.000014710229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025071261,0.0015836448,0.9228576,0.00009240667,0.00096716225,0.033343278,0.0005662972,0.00013289141,0.0038152682,0.000057008227,0.0011599853,0.010353198],"study_design_scores_gemma":[0.025271146,0.004065743,0.9495854,0.0005484215,0.00002900002,0.0042923763,0.00007510444,0.000099083045,0.015356697,0.000023184664,0.0005666384,0.00008719917],"about_ca_topic_score_codex":0.000010186448,"about_ca_topic_score_gemma":0.000048640602,"teacher_disagreement_score":0.029050903,"about_ca_system_score_codex":0.000066423054,"about_ca_system_score_gemma":0.00020192203,"threshold_uncertainty_score":0.3081821},"labels":[],"label_agreement":null},{"id":"W3165184255","doi":"10.1111/ejh.13673","title":"Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pancytopenia; Cumulative incidence; Internal medicine; Bone marrow; Cohort; Transplantation; Gastroenterology; Incidence (geometry); Myeloid leukemia; Oncology; Hematopoietic stem cell transplantation","score_opus":0.024707375714897697,"score_gpt":0.24442332911963768,"score_spread":0.21971595340473998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165184255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994072,0.0024297263,0.0016391269,0.0008615377,0.00025611988,0.00035536414,0.00015403717,0.000017791828,0.00021428635],"genre_scores_gemma":[0.9960983,0.0017770816,0.0012060091,0.00018100093,0.00006944521,0.000003883659,0.00003625981,0.00008192554,0.00054613565],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9959786,0.0016960811,0.0009424221,0.0003848185,0.000460345,0.00053776783],"domain_scores_gemma":[0.9977673,0.0007970348,0.0006054995,0.000263675,0.00029141846,0.0002750458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030774246,0.00027607204,0.0012399337,0.0002454539,0.00010758254,0.00003439231,0.00018308248,0.00014000811,0.000028034987],"category_scores_gemma":[0.0003174848,0.00020121256,0.0002324838,0.00026028958,0.00010212919,0.00011006406,0.000039674003,0.0010912239,0.0000039913716],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015538433,0.0011250604,0.23098674,0.0011833321,0.0019463997,0.69892746,0.0019481346,0.00008692327,0.047014073,0.000023238097,0.0004472511,0.0007729126],"study_design_scores_gemma":[0.14664716,0.018363507,0.38188073,0.0118226865,0.010964778,0.2622172,0.0048611723,0.0011497448,0.15589906,0.00008345812,0.0038681685,0.0022423621],"about_ca_topic_score_codex":0.000010588951,"about_ca_topic_score_gemma":0.0002830313,"teacher_disagreement_score":0.4367103,"about_ca_system_score_codex":0.00013993906,"about_ca_system_score_gemma":0.0005833993,"threshold_uncertainty_score":0.820521},"labels":[],"label_agreement":null},{"id":"W3165778820","doi":"10.1111/ejh.13671","title":"A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Victoria Hospital; Hôtel-Dieu de Québec; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University of Toronto; Université Laval; University of Alberta; Queen's University","funders":"","keywords":"Medicine; Clinical trial; Regimen; Multiple myeloma; Carfilzomib; Internal medicine; Dexamethasone; Lenalidomide","score_opus":0.12795554083561045,"score_gpt":0.42214811278364356,"score_spread":0.2941925719480331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165778820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470484,0.0037441477,0.00020079785,0.00041044055,0.00022544904,0.0005062039,0.00002672342,0.000008554976,0.00017282802],"genre_scores_gemma":[0.9896874,0.0009150643,0.009061975,0.0000909983,0.00009596906,0.000006331846,0.00002449195,0.000035252284,0.00008254896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931428,0.0036697385,0.0018992167,0.00043033418,0.00047591524,0.00038199386],"domain_scores_gemma":[0.99550724,0.0020836212,0.0009807877,0.00034265837,0.0006142487,0.0004714548],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0038691165,0.00024268797,0.0019398591,0.000680537,0.00006606757,0.000022641489,0.00012676368,0.000103543905,0.00009722214],"category_scores_gemma":[0.010332461,0.0001969872,0.00031862681,0.000707122,0.00036703114,0.00010311443,0.00015368321,0.00075162726,0.0000050053886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24971129,0.005821688,0.4396066,0.00022977288,0.010747606,0.11731894,0.0026659516,0.00004123279,0.012063703,0.00006959752,0.00027184613,0.16145176],"study_design_scores_gemma":[0.36474222,0.014278094,0.6052328,0.00045636823,0.0036790424,0.004665073,0.0015114126,0.0033599054,0.0014904991,0.000041852716,0.00029010195,0.00025268036],"about_ca_topic_score_codex":0.000053858614,"about_ca_topic_score_gemma":0.000090461224,"teacher_disagreement_score":0.16562615,"about_ca_system_score_codex":0.0000838398,"about_ca_system_score_gemma":0.00042616946,"threshold_uncertainty_score":0.9980039},"labels":[],"label_agreement":null},{"id":"W3170905114","doi":"10.1111/ejh.13678","title":"Retrospective study of treatment patterns and outcomes post‐lenalidomide for multiple myeloma in Canada","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; University of Alberta; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Saskatchewan; Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Calgary; Vancouver General Hospital; Princess Margaret Cancer Centre; Occupational Cancer Research Centre; CancerCare Manitoba; Ottawa Hospital; Institute of Cancer Research; McGill University; Canadian Institutes of Health Research","funders":"Celgene","keywords":"Lenalidomide; Daratumumab; Medicine; Salvage therapy; Bortezomib; Pomalidomide; Multiple myeloma; Carfilzomib; Internal medicine; Oncology; Autologous stem-cell transplantation; Ixazomib; Combination therapy; Dexamethasone; Maintenance therapy; Surgery; Chemotherapy","score_opus":0.02875396049537949,"score_gpt":0.2991474922586249,"score_spread":0.27039353176324543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170905114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984997,0.00021540784,0.00003003181,0.0006358388,0.000093009854,0.00039076974,0.000041769017,0.0000021127494,0.00009139447],"genre_scores_gemma":[0.99934846,0.000059105267,0.0004095039,0.00006566074,0.000023184813,0.0000049627033,0.0000069874654,0.000019510717,0.00006260138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984748,0.00038985387,0.0005654922,0.00016620223,0.00018374572,0.00021991842],"domain_scores_gemma":[0.99886787,0.00022031377,0.00024773736,0.00016849225,0.00033428275,0.00016130132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022319079,0.00013485391,0.00079865917,0.00013809654,0.000030337002,0.000005806932,0.000063733074,0.000013632501,0.000028821214],"category_scores_gemma":[0.0005718581,0.000092988645,0.00008709077,0.000072106996,0.000026430218,0.000034500248,0.00004116573,0.0001153877,8.714029e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088885543,0.00065989804,0.9599955,0.00004964736,0.0005805545,0.033875115,0.0007392696,0.000004122501,0.00034364962,0.000008252398,0.000033329114,0.00282177],"study_design_scores_gemma":[0.018389387,0.0037365647,0.96891934,0.00007662228,0.00010495109,0.0036738547,0.0035986959,0.00003420302,0.0013313927,0.0000057806155,0.00007033756,0.00005889408],"about_ca_topic_score_codex":0.07418959,"about_ca_topic_score_gemma":0.5697692,"teacher_disagreement_score":0.4955796,"about_ca_system_score_codex":0.00038535913,"about_ca_system_score_gemma":0.000685526,"threshold_uncertainty_score":0.9319755},"labels":[],"label_agreement":null},{"id":"W3182316807","doi":"10.1111/ejh.13689","title":"Effect of pre‐transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Myelofibrosis; Incidence (geometry); Internal medicine; CD34; Gastroenterology; Transplantation; Calcineurin; Tacrolimus; Surgery; Stem cell; Bone marrow","score_opus":0.009999089130386468,"score_gpt":0.2669885512672627,"score_spread":0.25698946213687623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182316807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584115,0.0010069256,0.000020018764,0.0018050205,0.00019772889,0.00019791281,0.000017032835,0.0000064002043,0.00090781425],"genre_scores_gemma":[0.99859935,0.00080282986,0.00024412856,0.00022980681,0.000041468185,0.0000032303158,0.000006998919,0.000024752528,0.00004745813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976612,0.0009374267,0.0007614443,0.00020230796,0.00022660366,0.00021103842],"domain_scores_gemma":[0.9987339,0.000616791,0.00026182234,0.00015862007,0.000079527206,0.00014936952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066035736,0.00021818835,0.0011002299,0.00022049353,0.000029070898,0.0000090301455,0.00006602239,0.000047915226,0.00005602782],"category_scores_gemma":[0.00011698126,0.00013942849,0.00019136711,0.000112552436,0.000085732114,0.00004556567,0.000017059325,0.000282444,0.00001028443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034726425,0.00085609616,0.9176264,0.00063681614,0.0005529502,0.06202194,0.0021344703,0.00001982112,0.006887554,0.00028955447,0.00025006876,0.0052516866],"study_design_scores_gemma":[0.012512344,0.010081479,0.6461679,0.002617193,0.0005909267,0.023056742,0.000067211695,0.000011863771,0.30421865,0.000020029962,0.00046537057,0.00019031488],"about_ca_topic_score_codex":0.0000049394434,"about_ca_topic_score_gemma":0.0000100204925,"teacher_disagreement_score":0.2973311,"about_ca_system_score_codex":0.000025453603,"about_ca_system_score_gemma":0.000059890684,"threshold_uncertainty_score":0.5685729},"labels":[],"label_agreement":null},{"id":"W3196712864","doi":"10.1111/ejh.13705","title":"T cell–mediated autoimmunity in immune thrombocytopenia","year":2021,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"Health Canada; Government of Canada; Australian Government; Ministry of Health, Ontario; Canadian Blood Services; McMaster University","keywords":"Immune thrombocytopenia; Immunology; Autoimmunity; Autoantibody; Platelet; CD8; Medicine; Immune system; Cytotoxic T cell; T cell; Autoimmune thrombocytopenia; Biology; Antibody","score_opus":0.04948419544022473,"score_gpt":0.32872458900027757,"score_spread":0.2792403935600528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196712864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053839907,0.9863998,0.0000080585405,0.00010372436,0.00041212456,0.000280798,0.0000094533825,0.000012859152,0.007389165],"genre_scores_gemma":[0.0023668478,0.9966767,0.0003395653,0.00006710048,0.000048505015,0.0000019817546,0.00012736904,0.00008928164,0.00028267133],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955902,0.0018166064,0.0018135121,0.00022669528,0.00020841164,0.00034456444],"domain_scores_gemma":[0.99773854,0.00024385216,0.0012970121,0.00043209034,0.00013985371,0.00014864912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008723861,0.00040762522,0.00616292,0.0004948178,0.000044088796,0.00002001097,0.0003510712,0.00015921664,0.0003473878],"category_scores_gemma":[0.00025279442,0.00029138968,0.0007835596,0.00040843972,0.00010281955,0.00006133482,0.00015110809,0.0013810376,0.0003778057],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004699532,0.0010061441,0.00005029657,0.006249344,0.00086216675,0.7430028,0.00016819563,3.522979e-7,0.000006175448,0.000030482443,0.0020931351,0.24648392],"study_design_scores_gemma":[0.0025263568,0.00040437348,0.00015889996,0.015337269,0.0012270224,0.14847818,0.00005465594,5.926275e-7,0.000004035382,0.000005320603,0.83160025,0.00020304036],"about_ca_topic_score_codex":0.0000060679745,"about_ca_topic_score_gemma":0.0000017674819,"teacher_disagreement_score":0.8295071,"about_ca_system_score_codex":0.00011016077,"about_ca_system_score_gemma":0.0006583371,"threshold_uncertainty_score":0.9999538},"labels":[],"label_agreement":null},{"id":"W3197669971","doi":"10.1111/ejh.13706","title":"Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Fleurimont; Centre Hospitalier Universitaire de Sherbrooke; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Bristol-Myers Squibb","keywords":"Medicine; Lenalidomide; Pomalidomide; Internal medicine; Hazard ratio; Bortezomib; Multiple myeloma; Dexamethasone; Clinical endpoint; Creatinine; Renal function; Gastroenterology; Progression-free survival; Surgery; Randomized controlled trial; Chemotherapy; Confidence interval","score_opus":0.03265644451244482,"score_gpt":0.3192080389079468,"score_spread":0.286551594395502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197669971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419415,0.0033152404,0.00014027274,0.0014119279,0.00009866694,0.00013448768,0.000032181826,0.000007889644,0.00066520297],"genre_scores_gemma":[0.9926258,0.0031020977,0.0035463818,0.00012708118,0.000059133607,0.0000013924338,0.000047895344,0.000040765506,0.00044950293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99562824,0.0015397561,0.0018089133,0.00032587908,0.00033442082,0.00036276816],"domain_scores_gemma":[0.99707574,0.0008234382,0.00084845384,0.00036531844,0.00044569082,0.00044137868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016955105,0.00022585774,0.0016476163,0.0003160799,0.000058060137,0.000016795075,0.00015199087,0.000099742545,0.00027036952],"category_scores_gemma":[0.0029595895,0.00018088489,0.00030946863,0.00035581423,0.00031135682,0.0000793456,0.00017497006,0.0005082658,0.000025257557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046930574,0.0010027778,0.8631529,0.00019527525,0.0013769798,0.11815859,0.00022405497,0.0000032667901,0.0036838264,0.000021322645,0.002613608,0.004874352],"study_design_scores_gemma":[0.02837826,0.0019164197,0.90888506,0.00070926454,0.0010751109,0.044147477,0.00021243528,0.00051615504,0.011144832,0.000017121183,0.002716179,0.00028165974],"about_ca_topic_score_codex":0.00001590708,"about_ca_topic_score_gemma":0.00003493002,"teacher_disagreement_score":0.07401111,"about_ca_system_score_codex":0.00008407571,"about_ca_system_score_gemma":0.00016079466,"threshold_uncertainty_score":0.73762715},"labels":[],"label_agreement":null},{"id":"W3201679150","doi":"10.1111/ejh.13714","title":"Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Cryopreservation; Medicine; Cyclophosphamide; Hematopoietic stem cell transplantation; Stem cell; Transplantation; Anti-thymocyte globulin; Cohort; Surgery; Incidence (geometry); Haematopoiesis; Internal medicine; Oncology; Chemotherapy; Biology","score_opus":0.03222355219946579,"score_gpt":0.27444041956172,"score_spread":0.2422168673622542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201679150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877688,0.002284608,0.006943909,0.0013526715,0.00048120544,0.00023894262,0.000026604272,0.000030150457,0.000873057],"genre_scores_gemma":[0.98667747,0.00030261127,0.01186241,0.0007919482,0.000101690996,7.440547e-7,0.0000103652455,0.000061923136,0.00019086245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970047,0.00070114306,0.0012621079,0.00030374865,0.00035704023,0.0003712758],"domain_scores_gemma":[0.9982386,0.00022409754,0.00037500123,0.0003006181,0.0004195405,0.00044212403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008569472,0.00026435117,0.0010007927,0.00021415688,0.00008138668,0.000045783396,0.00018894582,0.00007307132,0.000103857936],"category_scores_gemma":[0.00009950687,0.00022546799,0.00017055421,0.00017085229,0.00007858628,0.00014066634,0.0000690321,0.00034395832,0.00004979482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001230775,0.00030626252,0.5590798,0.0020502398,0.00032631695,0.15298967,0.005704955,0.00017251374,0.2767183,0.000093862436,0.0002347317,0.0010925418],"study_design_scores_gemma":[0.0074964673,0.0011588521,0.6282818,0.002440945,0.0012513975,0.17037243,0.0012812185,0.00011829127,0.18466316,0.000034102366,0.0023136951,0.0005876827],"about_ca_topic_score_codex":0.000009042845,"about_ca_topic_score_gemma":0.000006289282,"teacher_disagreement_score":0.09205514,"about_ca_system_score_codex":0.000037923062,"about_ca_system_score_gemma":0.00019239102,"threshold_uncertainty_score":0.91943175},"labels":[],"label_agreement":null},{"id":"W3205545929","doi":"10.1111/ejh.13717","title":"Use of midostaurin in mixed phenotype acute leukemia with <i>FLT3</i> mutation: A case series","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Midostaurin; Medicine; Discontinuation; Myeloid leukemia; Internal medicine; Oncology; Induction chemotherapy; Leukemia; Chemotherapy; Immunology","score_opus":0.03234183208156242,"score_gpt":0.27892429858555096,"score_spread":0.24658246650398855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205545929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954433,0.0004937095,0.0005207443,0.0021831908,0.000120685305,0.00012425923,0.000008532652,0.000010767193,0.0010948373],"genre_scores_gemma":[0.98187244,0.00014080353,0.01697445,0.00028708545,0.00007819143,0.0000010450437,0.000009832457,0.0000507249,0.0005854261],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99751776,0.0008670186,0.0008142797,0.00019672823,0.00030525198,0.00029894616],"domain_scores_gemma":[0.9981131,0.0002185757,0.00042013303,0.00032624378,0.0007351835,0.00018674422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059540063,0.00016904839,0.00076448434,0.00030703357,0.00003873053,0.000020994932,0.00013428346,0.000048809867,0.00012097256],"category_scores_gemma":[0.000468062,0.00012982462,0.000103552986,0.0004965424,0.0002603756,0.00025727568,0.00010249094,0.0006343681,0.000025494342],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023198416,0.00010792179,0.0036444482,0.00015871075,0.0003439525,0.9805339,0.0010061393,0.00010920956,0.0077335117,0.0003020133,0.0021713113,0.0015690682],"study_design_scores_gemma":[0.0043307263,0.0012728354,0.004722022,0.00032499657,0.00020345513,0.96104753,0.0012344833,0.00006169938,0.023208553,0.000027288595,0.003443151,0.00012325154],"about_ca_topic_score_codex":0.00001912953,"about_ca_topic_score_gemma":0.00010289491,"teacher_disagreement_score":0.019486334,"about_ca_system_score_codex":0.00017120372,"about_ca_system_score_gemma":0.0012565341,"threshold_uncertainty_score":0.5294094},"labels":[],"label_agreement":null},{"id":"W3211611146","doi":"10.1111/ejh.13726","title":"Kinetics of response to first‐ and second‐line therapies in multiple myeloma: Assessment by both M‐spikes and light chains","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Oncology; Medicine; Cohort; Multiple myeloma; Bortezomib; Internal medicine; Immunoglobulin light chain; Dexamethasone; Cyclophosphamide; Clearance; Melphalan; Complete response; Kinetics; Immunology; Chemotherapy; Urology; Antibody","score_opus":0.023104294104956746,"score_gpt":0.3006644771747745,"score_spread":0.2775601830698178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211611146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864155,0.0044233035,0.0003748586,0.008261135,0.000050459996,0.00014748506,0.000017042157,0.000004322713,0.00030586994],"genre_scores_gemma":[0.9940423,0.0005150483,0.004823859,0.00020463413,0.000027863969,0.0000015424175,0.000004218953,0.000021837828,0.00035874554],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982441,0.000679032,0.00050785835,0.0001657525,0.00018812252,0.00021514685],"domain_scores_gemma":[0.99889463,0.00037603415,0.00017389026,0.00016517154,0.00015370593,0.00023654172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058948575,0.00013130243,0.000545901,0.00022577507,0.000032322947,0.000014280071,0.000073162744,0.000030393103,0.000088762215],"category_scores_gemma":[0.0005379189,0.00009930691,0.000047721605,0.00012888436,0.000096436364,0.00004312924,0.000094403455,0.00020739983,0.000002611523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00777744,0.0015743817,0.33948365,0.00045262836,0.0005316048,0.058255114,0.0044992683,0.000009040294,0.57269156,0.00011383632,0.003757003,0.010854464],"study_design_scores_gemma":[0.01329717,0.005007253,0.8747924,0.00046749253,0.0000642461,0.012408616,0.0011300517,0.00012671578,0.069246165,0.00002314135,0.023272334,0.0001644045],"about_ca_topic_score_codex":0.000002999914,"about_ca_topic_score_gemma":0.00006280763,"teacher_disagreement_score":0.5353088,"about_ca_system_score_codex":0.000029341125,"about_ca_system_score_gemma":0.000058372934,"threshold_uncertainty_score":0.40496182},"labels":[],"label_agreement":null},{"id":"W4200189388","doi":"10.1111/ejh.13735","title":"Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cyclophosphamide; Internal medicine; Incidence (geometry); Immunology; Single Center; Gastroenterology; Transplantation; Anti-thymocyte globulin; Chemotherapy","score_opus":0.017022438706966903,"score_gpt":0.2681771097958236,"score_spread":0.2511546710888567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200189388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029726,0.0047392086,0.00100653,0.0026817254,0.00028275198,0.00022967526,0.000047051974,0.000028755756,0.0006870206],"genre_scores_gemma":[0.9911676,0.006878637,0.0008613322,0.00083362137,0.000065568995,0.0000010928137,0.000026299023,0.000054780976,0.000111084744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966455,0.0010572755,0.0012828393,0.00033271284,0.0003146492,0.00036698687],"domain_scores_gemma":[0.9980962,0.0003541222,0.0006482341,0.0003191729,0.00027822942,0.00030403875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014661846,0.00031200232,0.001048345,0.00011562072,0.00022640775,0.00008255736,0.00018648163,0.00009110264,0.00008948012],"category_scores_gemma":[0.00017349604,0.00021942334,0.00016186903,0.00013135726,0.00034760294,0.00010770692,0.000052506803,0.00061412307,0.000029135885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089091744,0.00016443028,0.73269665,0.0006766756,0.0007245046,0.045331944,0.005348111,0.000009657317,0.21168868,0.00041511428,0.0003994849,0.0016538104],"study_design_scores_gemma":[0.007984716,0.0005329019,0.7956473,0.0006967124,0.00094785925,0.102422945,0.0011886391,0.000029430172,0.08614474,0.000046260862,0.003978067,0.00038043197],"about_ca_topic_score_codex":0.000028814082,"about_ca_topic_score_gemma":0.00001319332,"teacher_disagreement_score":0.12554395,"about_ca_system_score_codex":0.000022507134,"about_ca_system_score_gemma":0.00011318305,"threshold_uncertainty_score":0.8947824},"labels":[],"label_agreement":null},{"id":"W4200239384","doi":"10.1111/ejh.13733","title":"Poor outcome after hematopoietic stem cell transplantation of patients with unclassified inherited bone marrow failure syndromes","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Janeway Children's Health and Rehabilitation Centre; McMaster University; London Health Sciences Centre; McMaster Children's Hospital; University of Alberta; Centre hospitalier universitaire de Québec; Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Queen's University; Centre Hospitalier Universitaire Sainte-Justine; Health Sciences Centre; CancerCare Manitoba; Izaak Walton Killam Health Centre; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre; University of Saskatchewan; Hospital for Sick Children; BC Children's Hospital; Montreal Children's Hospital; University of Toronto","funders":"","keywords":"Medicine; Cord blood; Hematopoietic stem cell transplantation; Transplantation; Stem cell; Bone marrow; Haematopoiesis; Internal medicine; Bone marrow failure; Surgery; Oncology; Biology","score_opus":0.01897387518674901,"score_gpt":0.2488259980760348,"score_spread":0.2298521228892858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200239384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960396,0.00049305253,0.00076698005,0.0017597737,0.00010131927,0.00017586874,0.000018492443,0.000013565401,0.00063132343],"genre_scores_gemma":[0.9962413,0.000038930393,0.0027802312,0.00026834346,0.000029773277,0.0000017459982,0.000024786581,0.000058974747,0.0005559289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731565,0.00069777283,0.0009758068,0.00020529292,0.0005152247,0.00029024432],"domain_scores_gemma":[0.99818736,0.000113749986,0.00052246446,0.00026981044,0.0007013736,0.00020525075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045074563,0.00019689504,0.00086596125,0.00027832566,0.00003207492,0.000014576423,0.00015448779,0.00006610617,0.00028124457],"category_scores_gemma":[0.000045298726,0.00014164366,0.00015725437,0.0003066644,0.00015192208,0.00011309014,0.000045116558,0.000528311,0.000049138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009104817,0.0013568194,0.6281719,0.0057377364,0.00074475154,0.32580528,0.004106432,0.000022623984,0.020197961,0.0001269107,0.003051061,0.0015736679],"study_design_scores_gemma":[0.032425757,0.004307599,0.77763,0.0017035118,0.0014472844,0.13227224,0.0028779653,0.000037343954,0.04345237,0.000027633982,0.0031792137,0.0006391017],"about_ca_topic_score_codex":8.8662887e-7,"about_ca_topic_score_gemma":0.0000036859922,"teacher_disagreement_score":0.19353305,"about_ca_system_score_codex":0.00006929433,"about_ca_system_score_gemma":0.00024072743,"threshold_uncertainty_score":0.5776061},"labels":[],"label_agreement":null},{"id":"W4200300045","doi":"10.1111/ejh.13731","title":"Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders","year":2021,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Perioperative; Hemostasis; Von Willebrand disease; Thrombosis; Surgery; Prospective cohort study; Von Willebrand factor; Internal medicine","score_opus":0.038627378290777406,"score_gpt":0.3312029643355121,"score_spread":0.2925755860447347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200300045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770415,0.0005736389,0.00002386518,0.0009774921,0.000019310877,0.0001930819,0.0000057662955,0.0000017698128,0.00050090754],"genre_scores_gemma":[0.9987084,0.00033465252,0.00085527904,0.000015699405,0.000008012257,0.0000011322292,0.0000128250795,0.000009826785,0.000054168624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920595,0.00022599257,0.00023273668,0.00011501745,0.00011710047,0.000103194696],"domain_scores_gemma":[0.99950904,0.00006889543,0.000067250454,0.000069237714,0.00018048068,0.000105084604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011312879,0.00008329812,0.00037152393,0.00012987849,0.000027441669,0.000009147098,0.000023015426,0.000012887625,0.000012414306],"category_scores_gemma":[0.00007809787,0.000047602967,0.00002299135,0.00009677836,0.00006354458,0.000062258856,0.000037140944,0.00007489125,5.6400484e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047662377,0.00028247648,0.98420775,0.000088161374,0.00009316175,0.0034058234,0.0026092017,0.000002626473,0.00008656475,0.000045231045,0.0000053323774,0.008697053],"study_design_scores_gemma":[0.018381944,0.0078310445,0.960872,0.00060616335,0.00016881574,0.0017602987,0.0061059482,0.000020520863,0.0024835549,0.0000021321746,0.0016441988,0.00012335902],"about_ca_topic_score_codex":0.000004208646,"about_ca_topic_score_gemma":0.000032740154,"teacher_disagreement_score":0.023335723,"about_ca_system_score_codex":0.000030258947,"about_ca_system_score_gemma":0.00008867364,"threshold_uncertainty_score":0.19411927},"labels":[],"label_agreement":null},{"id":"W4210777755","doi":"10.1111/ejh.13750","title":"Allogeneic hematopoietic stem cell transplantation in patients with therapy‐related hematologic malignancies developing after multiple myeloma","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Hematopoietic stem cell transplantation; Transplantation; Oncology; Monosomy; Population; Cohort; Gastroenterology; Karyotype; Chromosome; Biology","score_opus":0.017251799663774423,"score_gpt":0.23133553108340002,"score_spread":0.2140837314196256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210777755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997443,0.0012467866,0.00021029144,0.00029956698,0.00010023393,0.00043889807,0.000009801002,0.000019099965,0.00023231935],"genre_scores_gemma":[0.99840283,0.000120194636,0.0011354631,0.00017913924,0.000008629555,0.000020605246,0.000026806687,0.00004418271,0.00006216959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730414,0.0009048762,0.0007225812,0.00022712022,0.000459098,0.0003821642],"domain_scores_gemma":[0.9990525,0.0001171007,0.0003687589,0.00017894572,0.00014886404,0.00013382458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004950573,0.00021120164,0.0005833591,0.00039627653,0.00011114528,0.000012564301,0.00018561613,0.00003147032,0.00017355781],"category_scores_gemma":[0.000015891,0.00014923801,0.00010629221,0.0002936511,0.000081108934,0.00008977993,0.000054779422,0.00039308902,0.000029534947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005522918,0.00063904363,0.93872184,0.00018692853,0.00018429065,0.049988855,0.00216399,0.00008280753,0.00045292,0.00002877049,0.000036475594,0.0019911416],"study_design_scores_gemma":[0.01696757,0.0023666453,0.9633984,0.00018921749,0.000059754253,0.013059819,0.00053714385,0.00001668306,0.002933991,0.000020201467,0.00025662457,0.00019393617],"about_ca_topic_score_codex":0.0000024068418,"about_ca_topic_score_gemma":0.0000041700123,"teacher_disagreement_score":0.036929034,"about_ca_system_score_codex":0.00011846909,"about_ca_system_score_gemma":0.00014283622,"threshold_uncertainty_score":0.608575},"labels":[],"label_agreement":null},{"id":"W4210818981","doi":"10.1111/ejh.13752","title":"Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real‐world outcomes from a population‐based cohort","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Population; Residence; Demography; Socioeconomic status; Cohort; Rural area; Pediatrics; Gerontology; Internal medicine; Environmental health; Pathology","score_opus":0.014123140668207213,"score_gpt":0.2765303402350199,"score_spread":0.2624071995668127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210818981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634606,0.00013583456,0.00006854698,0.002432767,0.00012073553,0.00033866154,0.000022224482,0.000020210497,0.0005149553],"genre_scores_gemma":[0.9975472,0.000057820456,0.0013842636,0.00067656266,0.00004556033,0.0000066456164,0.000049632203,0.000054692035,0.00017761184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746174,0.0007716973,0.0007779945,0.000306968,0.0003582706,0.00032330828],"domain_scores_gemma":[0.9984919,0.0003949281,0.000533833,0.00028161725,0.00009273837,0.00020502305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088077417,0.00021307595,0.0008950606,0.0006277841,0.0001293628,0.000019214305,0.00029088603,0.000033991782,0.00062255125],"category_scores_gemma":[0.00009676879,0.00016249709,0.00010080664,0.00019987907,0.00012962594,0.00014508035,0.00019190494,0.0010982732,0.000016498516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010537166,0.000071238595,0.98081845,0.000025470821,0.00022709234,0.015733566,0.00087322475,0.00007946034,0.00007720272,0.00002878699,0.0007309733,0.0002808036],"study_design_scores_gemma":[0.0057591465,0.00044619132,0.9889731,0.00010343381,0.00013627879,0.0032721856,0.0007127379,0.0001990245,0.00009107602,0.000022446458,0.00013620805,0.00014818704],"about_ca_topic_score_codex":0.0005933198,"about_ca_topic_score_gemma":0.00029448973,"teacher_disagreement_score":0.01246138,"about_ca_system_score_codex":0.0005916169,"about_ca_system_score_gemma":0.0004022015,"threshold_uncertainty_score":0.6816499},"labels":[],"label_agreement":null},{"id":"W4220983498","doi":"10.1111/ejh.13762","title":"Systematic review of hematuria and acute renal failure with tranexamic acid","year":2022,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Pediatric Urology and Nephrology Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Mount Sinai Hospital; Foothills Medical Centre; University of Toronto; University of Calgary; St. Michael's Hospital","funders":"","keywords":"Medicine; Tranexamic acid; Randomized controlled trial; Urinary system; Surgery; Placebo; Renal function; Internal medicine; Urology; Pathology","score_opus":0.020828849043925263,"score_gpt":0.2812728447252225,"score_spread":0.2604439956812973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220983498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009637253,0.9977869,0.000032449876,0.0005232186,0.00012684776,0.0008418775,0.000016139289,0.000012838535,0.00056335883],"genre_scores_gemma":[0.000036728055,0.9985731,0.00046327818,0.00066532195,0.00010377327,0.000015628048,0.000017091053,0.000058954436,0.00006609206],"study_design_codex":"systematic_review","study_design_gemma":"case_report","domain_scores_codex":[0.9941739,0.0028276898,0.0021531396,0.000280484,0.00029212504,0.00027269375],"domain_scores_gemma":[0.99547917,0.00057081896,0.0032740068,0.00040299824,0.00014035623,0.0001326577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002156694,0.0004423891,0.007618801,0.00041767707,0.00008493308,0.0000033630013,0.00035551822,0.00013122622,0.00021188421],"category_scores_gemma":[0.0004834454,0.00025359594,0.0005903526,0.00029511302,0.000398393,0.000043330027,0.00013494189,0.0013972161,0.000017490986],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001447026,0.00007257913,0.0000024701703,0.94678926,0.009183259,0.0364974,0.00010017328,1.2601837e-8,0.0000013485669,0.000042785996,0.004988891,0.0021771085],"study_design_scores_gemma":[0.0008725743,0.0017478416,0.0000048049455,0.2874188,0.055514634,0.44702208,0.000025897603,5.0630042e-8,6.935655e-7,0.0000040210402,0.20721897,0.00016958306],"about_ca_topic_score_codex":1.0403304e-7,"about_ca_topic_score_gemma":4.7197472e-7,"teacher_disagreement_score":0.6593704,"about_ca_system_score_codex":0.000029955592,"about_ca_system_score_gemma":0.00031008036,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W4221007142","doi":"10.1111/ejh.13769","title":"Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"AbbVie","keywords":"Medicine; Myeloid leukemia; Intensive care medicine; Chemotherapy; Health care; Internal medicine","score_opus":0.041475496076281045,"score_gpt":0.33796020609165556,"score_spread":0.2964847100153745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221007142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495006,0.00017888946,0.0003364288,0.0027495374,0.0002466208,0.0012569388,0.00007088066,0.000018370956,0.00019227651],"genre_scores_gemma":[0.99773055,0.00010835052,0.00050866243,0.0004792826,0.00012253337,0.000061343584,0.00022217697,0.00008728758,0.0006798378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970559,0.0006996005,0.0009906748,0.00036468238,0.0005144655,0.00037471036],"domain_scores_gemma":[0.9974837,0.00015417718,0.0007297468,0.00027097875,0.001197494,0.00016393744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058927695,0.00026124847,0.0007901283,0.0009254017,0.00016214346,0.000021526641,0.000314098,0.000035797922,0.0001225593],"category_scores_gemma":[0.00018771243,0.00018163017,0.00012470748,0.0004600894,0.00006459742,0.00010605106,0.00014079874,0.00048577797,0.0000045301645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09937391,0.0030015688,0.74822813,0.0003680818,0.002709655,0.026297905,0.06424897,0.0012265171,0.000100213736,0.000013287926,0.0043278406,0.050103936],"study_design_scores_gemma":[0.25241336,0.15971988,0.3412998,0.0025543997,0.0014949598,0.033914547,0.16476355,0.0027423892,0.0007417314,0.0000058408204,0.039198987,0.0011505428],"about_ca_topic_score_codex":0.000049522536,"about_ca_topic_score_gemma":0.00011325852,"teacher_disagreement_score":0.40692833,"about_ca_system_score_codex":0.003008777,"about_ca_system_score_gemma":0.0005039616,"threshold_uncertainty_score":0.78678477},"labels":[],"label_agreement":null},{"id":"W4223439915","doi":"10.1111/ejh.13774","title":"Important questions for the malignant hematologist to consider when designing or evaluating a study with patient‐reported outcome measures (<scp>PROMs</scp>)","year":2022,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Patient-reported outcome; Hematologist; Medicine; Quality of life (healthcare); Cancer; MEDLINE; Health care; Medical physics; Physical therapy; Pathology; Nursing; Disease","score_opus":0.301061035879106,"score_gpt":0.42186651440669853,"score_spread":0.12080547852759255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223439915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004101646,0.9843308,0.00404402,0.00035891758,0.0013386216,0.005358902,0.000037243986,0.00006808034,0.00036178503],"genre_scores_gemma":[0.049718883,0.9248328,0.016596781,0.002771684,0.0010707116,0.0021184573,0.00009067445,0.0012372289,0.0015627787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99132764,0.0031561637,0.0034184353,0.0005591442,0.0009392402,0.0005993829],"domain_scores_gemma":[0.99109846,0.0033709677,0.0037113714,0.0007848863,0.0007204108,0.00031391488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006586934,0.0006158464,0.0036538024,0.00045405384,0.00045571194,0.000076211625,0.000530903,0.00008166831,0.00010625275],"category_scores_gemma":[0.0070243455,0.000306902,0.00071094505,0.00044573162,0.00015572496,0.000057625894,0.00024439726,0.001100997,0.000008226707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020532296,0.0019420821,0.017517265,0.019031089,0.016386168,0.28453475,0.02969779,0.000070713904,0.000009371898,0.0003282416,0.018112652,0.61031663],"study_design_scores_gemma":[0.0017981422,0.010286784,0.00009322563,0.006759681,0.011201729,0.17024446,0.015162352,0.000003379003,0.0000037425527,0.000022238055,0.78416324,0.00026102323],"about_ca_topic_score_codex":0.00003988138,"about_ca_topic_score_gemma":0.00029488018,"teacher_disagreement_score":0.7660506,"about_ca_system_score_codex":0.00019513941,"about_ca_system_score_gemma":0.0015500223,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W4224030651","doi":"10.1111/ejh.13779","title":"Validation of the <scp>HScore</scp> and the <scp>HLH</scp>‐2004 diagnostic criteria for the diagnosis of hemophagocytic lymphohistiocytosis in a multicenter cohort","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Hemophagocytic lymphohistiocytosis; Context (archaeology); Etiology; Cutoff; Internal medicine; Immunology; Disease","score_opus":0.022165643548159423,"score_gpt":0.28573249269383,"score_spread":0.2635668491456706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224030651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898553,0.006837125,0.00019133271,0.0012785144,0.00032267798,0.001065899,0.000014885992,0.000005442006,0.000428811],"genre_scores_gemma":[0.99814737,0.001084562,0.00007425905,0.00039358,0.00005504261,0.00008664001,0.0000044277053,0.00003815003,0.000115950475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99648863,0.0013934755,0.0011595391,0.0001810015,0.0004738025,0.00030354637],"domain_scores_gemma":[0.992689,0.005624021,0.0009223288,0.00042099084,0.00028135182,0.000062267216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034518917,0.0001730548,0.0007771788,0.00021074219,0.0002682824,0.000021218435,0.0005709195,0.00003472849,0.00004474503],"category_scores_gemma":[0.007887156,0.000093714894,0.00027460087,0.0003222324,0.0007248527,0.000085790656,0.00033456806,0.00043397027,0.0000036732172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051507965,0.0008023622,0.96395427,0.00082619855,0.00087522494,0.00086267455,0.011070156,0.0009125743,0.0020529295,0.0010197257,0.015013757,0.0020950506],"study_design_scores_gemma":[0.031074513,0.0020658888,0.8881739,0.0009150413,0.0015940397,0.006412378,0.014103038,0.003427119,0.023163036,0.0005217456,0.028451951,0.000097375385],"about_ca_topic_score_codex":0.000026736967,"about_ca_topic_score_gemma":0.0000029487933,"teacher_disagreement_score":0.07578039,"about_ca_system_score_codex":0.0000806792,"about_ca_system_score_gemma":0.0002188366,"threshold_uncertainty_score":0.9442232},"labels":[],"label_agreement":null},{"id":"W4229451231","doi":"10.1111/ejh.13786","title":"Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review","year":2022,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Tumor lysis syndrome; Hematology; Malignancy; Adverse effect; Incidence (geometry); Internal medicine; Hematologic malignancy; Oncology; Tyrosine kinase; Chemotherapy","score_opus":0.04386186007752226,"score_gpt":0.3017999458061116,"score_spread":0.25793808572858934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229451231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054225274,0.9921919,0.000009358062,0.00027379696,0.00047930467,0.0009821883,0.000014435583,0.000030005165,0.0005964867],"genre_scores_gemma":[0.0022044473,0.99651235,0.00041985823,0.00040613563,0.000074113945,0.00003467533,0.000027676264,0.00013977589,0.00018096018],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9904224,0.003846128,0.004032569,0.0006014334,0.00055683986,0.0005406192],"domain_scores_gemma":[0.9948966,0.00051864405,0.0033821182,0.00071203837,0.00012736188,0.00036323312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004164123,0.0007405379,0.009401766,0.0013481784,0.00008100821,0.000022607768,0.000560747,0.00010988343,0.0007716878],"category_scores_gemma":[0.0014432893,0.00052191457,0.0012141553,0.0012501067,0.00019474751,0.00008560403,0.00034206643,0.0015581595,0.00012396679],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003541536,0.00020568405,0.00011570302,0.2705362,0.0005489055,0.6669586,0.00006384059,2.8267797e-7,0.0000067601763,0.00014146302,0.0030487112,0.058338434],"study_design_scores_gemma":[0.0005827272,0.00040862846,0.000010626096,0.12668964,0.0023434265,0.53929085,0.000032882566,3.2773232e-7,7.011618e-7,0.000009616894,0.33040068,0.00022988474],"about_ca_topic_score_codex":0.0000018693396,"about_ca_topic_score_gemma":3.842965e-7,"teacher_disagreement_score":0.32735196,"about_ca_system_score_codex":0.00025848477,"about_ca_system_score_gemma":0.00046029818,"threshold_uncertainty_score":0.99972326},"labels":[],"label_agreement":null},{"id":"W4240708520","doi":"10.1111/ejh.12579","title":"Foreword","year":2015,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Stichting Haemophilia; Novo Nordisk Fonden","keywords":"Haemophilia; Medicine; Psychosocial; Life expectancy; Presentation (obstetrics); Quality of life (healthcare); Haemophilia A; Health care; Session (web analytics); Family medicine; Pediatrics; Nursing; Psychiatry; Surgery; Population","score_opus":0.0945526178501564,"score_gpt":0.34220438884995585,"score_spread":0.24765177099979946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240708520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484625,0.00082839,0.0003402236,0.006355509,0.0002587872,0.000057279445,5.009679e-7,0.000010499416,0.043686327],"genre_scores_gemma":[0.9953085,0.000031134925,0.002009624,0.00022064956,0.00024427,1.4803054e-7,9.541423e-7,0.000015556367,0.0021691548],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990602,0.00023783775,0.00028426634,0.000058769027,0.00020327076,0.00015561769],"domain_scores_gemma":[0.9992108,0.000034508634,0.000106724554,0.00011589582,0.00023510894,0.00029701038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078561745,0.00006247372,0.00028412594,0.00014001768,0.000017777707,0.000004345913,0.00009536021,0.00001792605,0.00008617218],"category_scores_gemma":[0.00027549468,0.000038439557,0.00008796752,0.00007924489,0.000076450626,0.00004068522,0.00003162572,0.00020539596,0.00041001913],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002652555,0.0008967829,0.13686508,0.0001463108,0.00073697296,0.43713808,0.0023030352,0.000008644816,0.0019581292,0.003352769,0.36057037,0.053371284],"study_design_scores_gemma":[0.020488374,0.011165545,0.038719185,0.00044276804,0.00038153995,0.44256005,0.0013496592,0.00012861838,0.007682455,0.0013372411,0.47543973,0.00030484487],"about_ca_topic_score_codex":3.6482413e-7,"about_ca_topic_score_gemma":2.1234939e-7,"teacher_disagreement_score":0.114869356,"about_ca_system_score_codex":0.000023531127,"about_ca_system_score_gemma":0.00012784444,"threshold_uncertainty_score":0.5270103},"labels":[],"label_agreement":null},{"id":"W4250808196","doi":"10.1111/ejh.12951","title":"Issue Information","year":2018,"lang":"en","type":"paratext","venue":"European Journal Of Haematology","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Citation; Computer science; Information retrieval; Library science; World Wide Web; Internet privacy","score_opus":0.017971164148900334,"score_gpt":0.3059243906027594,"score_spread":0.28795322645385907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250808196","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007047248,0.0014674171,0.00069388613,0.005753802,0.014080593,0.00009048171,0.000014432905,0.000008765307,0.9771859],"genre_scores_gemma":[0.15650389,0.009770103,0.0034810002,0.0038068893,0.038475834,0.0000030137815,0.00010695425,0.00012550186,0.7877268],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977452,0.0009691261,0.0006797922,0.00006904458,0.00030140698,0.00023539619],"domain_scores_gemma":[0.99796134,0.00007699074,0.0010549633,0.00012339615,0.0006699118,0.000113408],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012317433,0.00012750489,0.0004280439,0.00022103754,0.00050124485,0.00008077643,0.00037828548,0.00009625569,0.0061613806],"category_scores_gemma":[0.00027826967,0.00009892962,0.00016667531,0.00015612095,0.00052827405,0.00033814937,0.000077181045,0.0003349242,0.027892847],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011720881,0.000008722612,0.0000025689903,0.000024259329,0.00006440536,0.00018585111,0.0075650136,0.000005704039,3.603355e-7,0.0014521097,0.98854023,0.0021390407],"study_design_scores_gemma":[0.0001858831,0.00012255079,0.000028456947,0.00008543247,0.000040564708,0.000435764,0.00185558,6.376868e-7,0.0000030018907,0.00004028899,0.9970979,0.00010395307],"about_ca_topic_score_codex":0.000038723847,"about_ca_topic_score_gemma":0.000037655012,"teacher_disagreement_score":0.18945909,"about_ca_system_score_codex":0.00005353707,"about_ca_system_score_gemma":0.0002908619,"threshold_uncertainty_score":0.9947471},"labels":[],"label_agreement":null},{"id":"W4283746005","doi":"10.1111/ejh.13824","title":"Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Irish Research eLibrary","keywords":"Medicine; Internal medicine; CD38; Stage (stratigraphy); Cohort; Gastroenterology; Biology","score_opus":0.017552632825233675,"score_gpt":0.27480311968981974,"score_spread":0.25725048686458607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283746005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454707,0.0030690092,0.000020822372,0.0009811305,0.00023167892,0.00042902332,0.00002640329,0.000034105306,0.0006607421],"genre_scores_gemma":[0.99750304,0.00074582116,0.00031477245,0.00023154855,0.00014752729,0.000017434888,0.000026301956,0.00009510347,0.0009184556],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99497145,0.0024742687,0.000844109,0.00042162562,0.00066697755,0.0006215548],"domain_scores_gemma":[0.9974502,0.00075701217,0.0007782738,0.0005548506,0.00013836213,0.0003213011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013772252,0.00033605203,0.0011073761,0.0005108129,0.00019976454,0.000037689046,0.00045103376,0.000074650714,0.00036744942],"category_scores_gemma":[0.0010476437,0.00024070493,0.00015979019,0.00038851198,0.00027837048,0.00012474666,0.00036067807,0.00080221076,0.00000932933],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.020978289,0.0028494094,0.021892065,0.00077682297,0.0030363603,0.80098313,0.012243784,0.008868518,0.040223356,0.00022910295,0.067472726,0.020446427],"study_design_scores_gemma":[0.46224615,0.04192489,0.11660471,0.004626832,0.0014495205,0.2981381,0.0037326885,0.0030275732,0.06061047,0.00020225509,0.0060647996,0.0013720203],"about_ca_topic_score_codex":0.00028792338,"about_ca_topic_score_gemma":0.00016042797,"teacher_disagreement_score":0.50284505,"about_ca_system_score_codex":0.024210662,"about_ca_system_score_gemma":0.0067695105,"threshold_uncertainty_score":0.9988612},"labels":[],"label_agreement":null},{"id":"W4293312760","doi":"10.1111/ejh.13850","title":"Patient age and donor <scp>HLA</scp> matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups","year":2022,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University Health Network; University of Toronto; Hamilton Health Sciences; Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Confidence interval; Hematopoietic stem cell transplantation; Cohort; Human leukocyte antigen; Transplantation; Multivariate analysis; Oncology; Propensity score matching; Myeloid; Framingham Risk Score; Recursive partitioning; Scoring system; Immunology; Disease; Antigen","score_opus":0.01038637672080116,"score_gpt":0.2225755609359384,"score_spread":0.21218918421513722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293312760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994068,0.00046389853,0.002183239,0.00024134558,0.0004674284,0.00053220766,0.000021920137,0.00003249277,0.0019894326],"genre_scores_gemma":[0.9965934,0.00013540551,0.0026749184,0.00032617693,0.000048077778,0.000012320293,0.00009190861,0.00006951309,0.000048259768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645966,0.0011748967,0.0011406702,0.00030685047,0.00056209747,0.0003558393],"domain_scores_gemma":[0.99832076,0.00037194756,0.00068897015,0.00019664767,0.0001414253,0.0002802669],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007915193,0.00027380936,0.0006402378,0.0003202707,0.00024571473,0.00003487305,0.00017945773,0.00004657384,0.000069779366],"category_scores_gemma":[0.000079650395,0.00024994227,0.00013659903,0.0001884475,0.00010191487,0.00009655997,0.000055213168,0.00056646805,0.00002046102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012370859,0.0040853093,0.41999826,0.011642108,0.00095665624,0.2587088,0.23271433,0.0011216245,0.053058967,0.0018795589,0.0029952866,0.011601996],"study_design_scores_gemma":[0.027346682,0.017561618,0.6416111,0.0021372843,0.0037125614,0.2326827,0.037885595,0.00013177536,0.030116092,0.002291185,0.0034961721,0.0010272287],"about_ca_topic_score_codex":0.000009548043,"about_ca_topic_score_gemma":0.0000074040436,"teacher_disagreement_score":0.22161283,"about_ca_system_score_codex":0.00008056077,"about_ca_system_score_gemma":0.000109301225,"threshold_uncertainty_score":0.9999953},"labels":[],"label_agreement":null},{"id":"W4297909302","doi":"10.1111/ejh.13867","title":"The association of age and adverse events of <scp>PEG</scp>‐asparaginase in a pediatric tertiary care hospital; a retrospective review","year":2022,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Asparaginase; Pediatrics; Adverse effect; Retrospective cohort study; Population; Pancreatitis; Incidence (geometry); Internal medicine","score_opus":0.015411260933298978,"score_gpt":0.30008074341351026,"score_spread":0.2846694824802113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297909302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074526486,0.99021655,0.000005587363,0.00012908068,0.0002722394,0.0009328575,0.00002929783,0.0000049705127,0.0009567758],"genre_scores_gemma":[0.0039929454,0.9954893,0.000089299174,0.00004953819,0.00012083383,0.000013375914,0.000019269064,0.000064292115,0.00016113753],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934289,0.003145815,0.0019809823,0.0002760771,0.0008112918,0.0003569292],"domain_scores_gemma":[0.99354744,0.0017337711,0.003774574,0.00038874752,0.00040953673,0.00014595441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003134401,0.00030468593,0.0028642823,0.0005208587,0.00005878736,0.0000038682006,0.00049962365,0.000107267966,0.000020089936],"category_scores_gemma":[0.0071519683,0.0002007053,0.00055585953,0.00066244655,0.00012263336,0.00006423454,0.00035429315,0.001302461,0.000009932619],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016757469,0.0011535874,0.10975317,0.42828953,0.0039179875,0.17384362,0.0062190504,0.0000021059611,0.0000020609093,0.00018888409,0.050008032,0.22645439],"study_design_scores_gemma":[0.00621992,0.002605077,0.037307266,0.0670706,0.008517666,0.020112962,0.0012608363,0.0000028643226,0.0000019965562,0.00003912538,0.8565927,0.00026898462],"about_ca_topic_score_codex":0.0000052744263,"about_ca_topic_score_gemma":0.0000025026714,"teacher_disagreement_score":0.80658466,"about_ca_system_score_codex":0.0011668107,"about_ca_system_score_gemma":0.0011414837,"threshold_uncertainty_score":0.8562091},"labels":[],"label_agreement":null},{"id":"W4319060525","doi":"10.1111/ejh.13940","title":"Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Internal medicine; Medicine; NPM1; Myeloid leukemia; Cytogenetics; Hematopoietic stem cell transplantation; Transplantation; Oncology; Leukemia; Myeloid; Chemotherapy; Gastroenterology; Karyotype; Biology; Chromosome; Gene; Genetics","score_opus":0.009969441528545939,"score_gpt":0.2745431104625056,"score_spread":0.26457366893395967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319060525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989037,0.000120016004,0.00027943985,0.00019375856,0.000019089546,0.00029350078,0.000046647092,0.000009035243,0.00013480925],"genre_scores_gemma":[0.9985601,0.00034170027,0.00087739306,0.00005526292,0.000011052143,0.0000029078242,0.00006931281,0.000032084947,0.000050212864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997923,0.00044780123,0.00075217884,0.00022164134,0.00038871425,0.00026664807],"domain_scores_gemma":[0.9985614,0.00021681703,0.00047463604,0.00014730195,0.0004143932,0.00018546113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005038839,0.00019271157,0.00083772,0.0010657066,0.00004127032,0.0000112682255,0.00012397414,0.000052659263,0.00002749529],"category_scores_gemma":[0.000037464662,0.00013159435,0.00013694579,0.0007673761,0.00018611798,0.000091570546,0.000059304926,0.00029706824,0.000011030299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012883544,0.000072397794,0.9801114,0.0002802682,0.0015209287,0.011370064,0.0024658279,0.0005661656,0.0014249521,0.00001724531,0.000059902715,0.00082247605],"study_design_scores_gemma":[0.0068882,0.0012315572,0.9847869,0.00010531436,0.0010523241,0.004125138,0.00032117974,0.00038866408,0.0009730445,0.000011710291,0.0000014020275,0.00011454965],"about_ca_topic_score_codex":0.000018814406,"about_ca_topic_score_gemma":0.000014540924,"teacher_disagreement_score":0.0072449255,"about_ca_system_score_codex":0.00015574286,"about_ca_system_score_gemma":0.00039624775,"threshold_uncertainty_score":0.53662616},"labels":[],"label_agreement":null},{"id":"W4320857106","doi":"10.1111/ejh.13944","title":"<scp>VEXAS</scp> syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation","year":2023,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Bone marrow; Bone marrow aspirate; Myeloid cells; Myeloid; Pathology; Medicine; Biopsy; Cancer research","score_opus":0.05765889196432333,"score_gpt":0.3295710321045395,"score_spread":0.27191214014021614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320857106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060673147,0.98945427,0.000014762694,0.00031162836,0.0027554233,0.0005774431,0.000015661728,0.000036217203,0.0007672688],"genre_scores_gemma":[0.00006935776,0.99556917,0.0010303982,0.00011457247,0.00020235602,0.000004107295,0.000029005474,0.00013903237,0.002842014],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99334717,0.0010743735,0.0044899406,0.00037668968,0.0003625323,0.00034931337],"domain_scores_gemma":[0.9893925,0.00057180534,0.009132935,0.00033047347,0.0002864334,0.00028585657],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032210113,0.00043384187,0.0050006136,0.00065994955,0.000072475654,0.000025969013,0.00013839483,0.00019265532,0.000018317769],"category_scores_gemma":[0.0068112253,0.0003174817,0.0005199131,0.0004346669,0.00034646998,0.00010382613,0.0001428759,0.0009397529,0.000040138],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012381233,0.00009849818,0.00039125726,0.55870837,0.001214936,0.113671884,0.0004130202,5.3285287e-8,0.000038022637,0.000057233286,0.0361927,0.28920165],"study_design_scores_gemma":[0.00037489107,0.0004846834,0.00018160911,0.25402993,0.0019094569,0.32367074,0.00002471669,4.129634e-7,0.0000035763053,0.0000139911435,0.41923016,0.000075825585],"about_ca_topic_score_codex":0.0000013966061,"about_ca_topic_score_gemma":9.582126e-7,"teacher_disagreement_score":0.38303745,"about_ca_system_score_codex":0.000030362533,"about_ca_system_score_gemma":0.00028013758,"threshold_uncertainty_score":0.9999277},"labels":[],"label_agreement":null},{"id":"W4360946230","doi":"10.1111/ejh.13969","title":"Fatigue and health‐related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan <scp>PEGASUS</scp> trial data","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University Health Network","funders":"Swedish Orphan Biovitrum","keywords":"Medicine; Minimal clinically important difference; Quality of life (healthcare); Internal medicine; Physical therapy; Post-hoc analysis; Randomized controlled trial","score_opus":0.14049709640977695,"score_gpt":0.34853498259522875,"score_spread":0.2080378861854518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360946230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227256,0.004847503,0.000023319637,0.0010567767,0.0009483384,0.00033101576,0.00036006712,0.000015525935,0.00014490401],"genre_scores_gemma":[0.99949,0.00010351751,0.000029857514,0.000102957725,0.000027354878,0.0000012939794,0.00016530871,0.0000184144,0.00006126278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910759,0.00513867,0.0029405553,0.0003084449,0.00014876743,0.00038766564],"domain_scores_gemma":[0.9948003,0.0010815709,0.0030731126,0.0007694884,0.00019364785,0.000081875645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054988666,0.0002114777,0.0017419287,0.00073560985,0.00010905397,0.000013287445,0.0011716457,0.00009100974,0.000110816305],"category_scores_gemma":[0.0021501395,0.00015059118,0.00030810919,0.0010263454,0.00041021509,0.00012413587,0.0006199577,0.00046698566,0.00001794592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01978365,0.0017279645,0.84440786,0.0011615768,0.021528855,0.0017730807,0.0114380885,0.001153241,0.018195834,0.0037916307,0.07261622,0.0024219775],"study_design_scores_gemma":[0.03765055,0.0015238004,0.9521907,0.00032553117,0.0010926157,0.0014778757,0.004050057,0.0000922177,0.0002507397,0.00012342518,0.0010801987,0.00014227894],"about_ca_topic_score_codex":0.00015159429,"about_ca_topic_score_gemma":0.00039177763,"teacher_disagreement_score":0.107782826,"about_ca_system_score_codex":0.000028687537,"about_ca_system_score_gemma":0.00034196765,"threshold_uncertainty_score":0.614093},"labels":[],"label_agreement":null},{"id":"W4375955180","doi":"10.1111/ejh.13982","title":"<scp>PD‐L1</scp> expression predicts efficacy in the phase <scp>II SPiReL</scp> trial with <scp>MVP‐S</scp>, pembrolizumab, and low‐dose <scp>CPA</scp> in R/R <scp>DLBCL</scp>","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Health Sciences Centre; Sunnybrook Hospital; Baker Hughes (Canada); McGill University Health Centre; Sunnybrook Health Science Centre","funders":"Merck","keywords":"Medicine; Pembrolizumab; Internal medicine; Population; Oncology; Discontinuation; Gastroenterology; Immunotherapy; Cancer","score_opus":0.034535795403372906,"score_gpt":0.31449901093513066,"score_spread":0.27996321553175774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375955180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96771616,0.0049300017,0.00013669698,0.0006814289,0.0016293532,0.0037801461,0.00008085981,0.0003574517,0.020687893],"genre_scores_gemma":[0.97708106,0.0037484576,0.00046429032,0.0012254098,0.0028258422,0.0001424232,0.00017382427,0.0007667362,0.013571927],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97940725,0.0067289732,0.0043010837,0.0021315077,0.0035299598,0.0039012195],"domain_scores_gemma":[0.97562164,0.016597291,0.002545391,0.0023184945,0.00091090397,0.0020063035],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.010089566,0.0018908354,0.00407878,0.0036917122,0.0007930399,0.00047030515,0.0027885907,0.0008009998,0.000069098554],"category_scores_gemma":[0.025310094,0.001390473,0.0009630422,0.0038036692,0.0016198929,0.0009308767,0.0013537176,0.005913623,0.0005600016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007013968,0.01827087,0.018692033,0.002383996,0.0024084141,0.23777698,0.08504959,0.0010565511,0.14443585,0.00053939427,0.4695556,0.012816763],"study_design_scores_gemma":[0.37011492,0.03097143,0.043927375,0.005726569,0.0011966919,0.055637363,0.031593956,0.0016670122,0.0385102,0.00045620406,0.41987684,0.00032142986],"about_ca_topic_score_codex":0.00004781089,"about_ca_topic_score_gemma":0.000063178966,"teacher_disagreement_score":0.36310095,"about_ca_system_score_codex":0.00039160735,"about_ca_system_score_gemma":0.0012995338,"threshold_uncertainty_score":0.99938357},"labels":[],"label_agreement":null},{"id":"W4376133026","doi":"10.1111/ejh.13979","title":"Impact of secondary‐type mutations in <scp><i>NPM1</i></scp> mutated <scp>AML</scp>","year":2023,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Computer science; Computational biology; Genetics; Biology","score_opus":0.033359794818361786,"score_gpt":0.3206159618144294,"score_spread":0.28725616699606765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376133026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.930307,0.0017371499,0.00013110525,0.04755904,0.0013945303,0.00076569605,0.00017663528,0.000115998955,0.01781285],"genre_scores_gemma":[0.75612855,0.0040869205,0.0050061666,0.16976592,0.012913895,0.00003628522,0.0034954739,0.0031991885,0.045367595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916385,0.0026462101,0.0026704725,0.0006191049,0.0010641319,0.0013615855],"domain_scores_gemma":[0.99115664,0.0039527863,0.0021449872,0.00085490354,0.0014448952,0.00044581038],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023650904,0.00073890924,0.002816652,0.003177901,0.000093550756,0.00005561368,0.0011190986,0.00066261354,0.00022900836],"category_scores_gemma":[0.008743381,0.00060880533,0.0009103638,0.0017143919,0.00065019046,0.00020102652,0.00033674508,0.00863105,0.0012533393],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047667836,0.00011410979,0.0022267562,0.0005446995,0.0011398459,0.21086763,0.0013521884,0.00008064756,0.0012916324,0.000007671505,0.78194916,0.00037797447],"study_design_scores_gemma":[0.017277919,0.009335136,0.07155904,0.0033093214,0.0015512758,0.22248022,0.0025567147,0.0003107763,0.0023958092,0.00044917333,0.6683876,0.00038700903],"about_ca_topic_score_codex":0.000060481438,"about_ca_topic_score_gemma":0.000013286869,"teacher_disagreement_score":0.17417844,"about_ca_system_score_codex":0.00057989545,"about_ca_system_score_gemma":0.0031749867,"threshold_uncertainty_score":0.99963635},"labels":[],"label_agreement":null},{"id":"W4384126603","doi":"10.1111/ejh.14040","title":"Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the <scp>NuProtect</scp> study","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Institute for Clinical Evaluative Sciences; BC Children's Hospital; SickKids Foundation; McMaster University Medical Centre; Hospital for Sick Children; University of British Columbia","funders":"Octapharma","keywords":"Medicine; Adverse effect; Haemophilia; Incidence (geometry); Prophylactic treatment; Clinical endpoint; Internal medicine; Surgery; Clinical trial","score_opus":0.033717184442331065,"score_gpt":0.28183055437352506,"score_spread":0.24811336993119398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384126603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466556,0.00024751504,0.0000036051222,0.0019988965,0.000084465086,0.0017039119,0.000027980203,0.00003718182,0.0012308601],"genre_scores_gemma":[0.9989175,0.00014485404,0.00009381482,0.000094679985,0.00011812147,0.0000058665264,0.00005071537,0.000050662115,0.00052374846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962694,0.0014625702,0.000884365,0.0003633548,0.0005316251,0.00048865104],"domain_scores_gemma":[0.9974796,0.001243898,0.00036635948,0.00040843952,0.0002572964,0.00024436408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015939748,0.00026923913,0.00075319177,0.0002917973,0.00016366127,0.000035735924,0.000290471,0.00005829834,0.0000191071],"category_scores_gemma":[0.0015394348,0.00014147704,0.00007658281,0.0006214597,0.00021591366,0.00008735904,0.00016684695,0.0007380139,0.00012199801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055279336,0.0016184358,0.91592836,0.000056470668,0.00078106695,0.0506156,0.009236731,0.00007488661,0.000050105664,0.000008290271,0.005248186,0.010853959],"study_design_scores_gemma":[0.032792702,0.005152865,0.95701045,0.0004946285,0.00019750082,0.0014330109,0.0011195514,0.000028926552,0.00004147254,0.000024408022,0.001638497,0.00006597929],"about_ca_topic_score_codex":0.000037311773,"about_ca_topic_score_gemma":0.000055537403,"teacher_disagreement_score":0.04918259,"about_ca_system_score_codex":0.000054475648,"about_ca_system_score_gemma":0.00013634333,"threshold_uncertainty_score":0.5769266},"labels":[],"label_agreement":null},{"id":"W4384626056","doi":"10.1111/ejh.14041","title":"Influence of conditioning regimen intensity on outcomes post‐allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Univariate analysis; Transplantation; Myeloid leukemia; Hematopoietic stem cell transplantation; Regimen; Oncology; Myeloid; Cohort; Propensity score matching; Gastroenterology; Surgery; Multivariate analysis","score_opus":0.02923434032722486,"score_gpt":0.29421925522568576,"score_spread":0.2649849148984609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384626056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638,0.000029877408,0.0016747857,0.0009831245,0.0001222781,0.00035663633,0.00003150692,0.000033475906,0.00038832982],"genre_scores_gemma":[0.9972698,0.00013369959,0.0019485418,0.0004499441,0.000021282716,0.000003902411,0.00008623566,0.000032559008,0.000054053588],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99766934,0.00039920944,0.0011306332,0.00023180446,0.00029101004,0.00027800616],"domain_scores_gemma":[0.998115,0.0006270215,0.00060783955,0.00019464461,0.00032719126,0.00012827641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012340884,0.0001944052,0.0008957565,0.00046900407,0.0000560356,0.0000068168215,0.00018230664,0.000086796776,0.000021661306],"category_scores_gemma":[0.0002227732,0.00015342665,0.00018870726,0.00025494647,0.00012888106,0.00007815376,0.000018503837,0.00032343474,0.00004972073],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060318164,0.0002451604,0.0785993,0.002296294,0.00033250006,0.054909796,0.005404159,0.010728503,0.8397876,0.00061612093,0.0007659229,0.00028282768],"study_design_scores_gemma":[0.009049994,0.002677583,0.79728407,0.0022252183,0.00063084695,0.035294764,0.00079512293,0.00032091673,0.1509763,0.00033908352,0.00009164748,0.00031445894],"about_ca_topic_score_codex":0.000003683597,"about_ca_topic_score_gemma":9.557012e-7,"teacher_disagreement_score":0.7186848,"about_ca_system_score_codex":0.00008747014,"about_ca_system_score_gemma":0.00012412068,"threshold_uncertainty_score":0.6256558},"labels":[],"label_agreement":null},{"id":"W4384924021","doi":"10.1111/ejh.14056","title":"How can artificial intelligence help rehabilitation programs for people with hemophilia in the coming decades?","year":2023,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Coming out; Rehabilitation; Medicine; Pediatrics; Gerontology; Physical therapy; Sociology; Gender studies","score_opus":0.06936221222919448,"score_gpt":0.3225731496766002,"score_spread":0.25321093744740575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384924021","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11517451,0.00015405937,0.000534505,0.8825766,0.00027162454,0.0011544109,0.000007376389,0.00001882043,0.0001081356],"genre_scores_gemma":[0.9466885,0.000112858244,0.0071091484,0.03912687,0.004787057,0.00010095297,0.00021244757,0.00026963092,0.0015925466],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970004,0.0010082765,0.0006869788,0.00027856856,0.0005375056,0.00048830366],"domain_scores_gemma":[0.99747163,0.001321498,0.00045316666,0.0003156835,0.0003596322,0.000078387515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001986565,0.0002578855,0.0008585087,0.0005097465,0.000098477794,0.00009090833,0.0003949615,0.00016340544,0.0000072384837],"category_scores_gemma":[0.0008586166,0.00014103952,0.00023501743,0.00045221942,0.0002667143,0.000055257115,0.00003906077,0.0017391791,0.000018725132],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003057908,0.0008823678,0.017098695,0.005103586,0.0010074034,0.20490262,0.01804841,0.000021115642,0.00015874194,0.0008916027,0.6343064,0.11452116],"study_design_scores_gemma":[0.008827374,0.059591968,0.014551347,0.013921971,0.0026680056,0.15178487,0.037719294,0.0006501282,0.0012878841,0.014277169,0.6925118,0.0022081672],"about_ca_topic_score_codex":0.000005921174,"about_ca_topic_score_gemma":0.00010247,"teacher_disagreement_score":0.8434497,"about_ca_system_score_codex":0.00008778147,"about_ca_system_score_gemma":0.00021570091,"threshold_uncertainty_score":0.75559646},"labels":[],"label_agreement":null},{"id":"W4385264516","doi":"10.1111/ejh.14062","title":"Prognostic implication of pre‐transplant FEV<sub>1</sub> on long‐term outcomes following allogeneic hematopoietic stem cell transplantation","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Oncology; Multivariate analysis; Incidence (geometry); Retrospective cohort study; Cohort; Cutoff","score_opus":0.02744930365224022,"score_gpt":0.27834510158051234,"score_spread":0.2508957979282721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385264516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897414,0.00021582203,0.007837107,0.00045078786,0.0004639374,0.000617631,0.000020467109,0.00009036705,0.0005625073],"genre_scores_gemma":[0.9989486,0.00044829838,0.00023921806,0.000102479804,0.00004536889,0.000010015974,0.00007847113,0.00008958571,0.00003796337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638253,0.0006875965,0.0015682236,0.00033112522,0.00061085745,0.00041966472],"domain_scores_gemma":[0.99777836,0.00065944454,0.0008043796,0.00036148928,0.00017194459,0.00022439181],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013684664,0.00032763908,0.0010002848,0.0006086994,0.00008076095,0.00001735859,0.0002727905,0.000105113315,0.000013181655],"category_scores_gemma":[0.000038991417,0.00027090075,0.00045738686,0.00040443597,0.00008351596,0.00011866853,0.000014650861,0.0003481885,0.00017549645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092380843,0.0004904007,0.59735525,0.004492322,0.00053750235,0.024998615,0.0066573606,0.00021492795,0.3605571,0.0002256153,0.00008528629,0.0034617945],"study_design_scores_gemma":[0.002812536,0.00081942236,0.68543255,0.00150315,0.000960479,0.009829989,0.00014466335,0.000017326134,0.29824182,0.000027886303,0.000006433664,0.00020373125],"about_ca_topic_score_codex":9.1829304e-7,"about_ca_topic_score_gemma":0.0000022695654,"teacher_disagreement_score":0.08807731,"about_ca_system_score_codex":0.000042422158,"about_ca_system_score_gemma":0.00011999846,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W4385791443","doi":"10.1111/ejh.14082","title":"Outcome of carfilzomib/pomalidomide‐based regimens after daratumumab‐based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; University of British Columbia; Memorial University of Newfoundland; University of Saskatchewan; Queen Elizabeth II Health Sciences Centre; University of Ottawa; Dalhousie University; Saskatchewan Cancer Agency; Ottawa Hospital; CancerCare Manitoba; McGill University; London Health Sciences Centre; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of Calgary; BC Cancer Agency; McGill University Health Centre; Jewish General Hospital; Alberta Cancer Foundation; Canadian Institutes of Health Research; Juravinski Cancer Centre; Université de Montréal; Western University; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Pomalidomide; Daratumumab; Carfilzomib; Medicine; Multiple myeloma; Oncology; Internal medicine; Lenalidomide","score_opus":0.10225996986042807,"score_gpt":0.3763843437896896,"score_spread":0.27412437392926153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385791443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470747,0.00045960062,0.00009234618,0.0021928304,0.00012761241,0.00077988376,0.00019703533,0.000032999324,0.0014102119],"genre_scores_gemma":[0.9967102,0.00003342704,0.002171934,0.0001307538,0.00007417643,0.000046811285,0.00025605335,0.00008368097,0.0004929711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992513,0.0029960037,0.0016376497,0.0005584438,0.00097170786,0.0013231748],"domain_scores_gemma":[0.9957939,0.0009597884,0.00044232627,0.001028693,0.000652678,0.0011226203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038687398,0.00039151084,0.0016856705,0.0064843344,0.0001812789,0.00003530846,0.00043165186,0.00011491338,0.00029020972],"category_scores_gemma":[0.001611784,0.00030261264,0.0006270285,0.0034844,0.00040188347,0.000115573726,0.00011316729,0.0007491862,0.00023590788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054376014,0.0007329026,0.7330555,0.00020119139,0.0013787831,0.25550565,0.00043986147,0.00021995317,0.0013467005,0.000064361724,0.0008603157,0.0007571739],"study_design_scores_gemma":[0.029962428,0.0035142004,0.94977486,0.0003961649,0.0009555331,0.0012481699,0.0007771081,0.006543698,0.002988061,0.0000133859485,0.0034772062,0.00034919367],"about_ca_topic_score_codex":0.0110142855,"about_ca_topic_score_gemma":0.06912245,"teacher_disagreement_score":0.2542575,"about_ca_system_score_codex":0.0007811518,"about_ca_system_score_gemma":0.0009526169,"threshold_uncertainty_score":0.9999426},"labels":[],"label_agreement":null},{"id":"W4386208612","doi":"10.1111/ejh.14094","title":"Outpatient consolidation chemotherapy with intermediate dose cytarabine has similar survival and relapses rates in acute myeloid leukemia as compared to high dose cytarabine: A single center analysis","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Cytarabine; Medicine; Internal medicine; Regimen; Outpatient clinic; Chemotherapy; Oncology; Surgery","score_opus":0.029474219476904533,"score_gpt":0.2961845969885831,"score_spread":0.2667103775116786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386208612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891071,0.00009914664,0.0003661757,0.009416846,0.00018975676,0.00046039617,0.000021650443,0.000051443305,0.00028750068],"genre_scores_gemma":[0.9967315,0.0003874508,0.0013525095,0.0009754107,0.00010524105,0.0000068156596,0.000118235956,0.00008074838,0.0002420886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963694,0.0009598937,0.0011077701,0.00045118155,0.0005283042,0.00058344926],"domain_scores_gemma":[0.9978925,0.00032263095,0.0005136179,0.00039556643,0.0004395746,0.0004360996],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013684945,0.00035401422,0.0014102716,0.0017068372,0.00009489302,0.00008289497,0.00032261253,0.00007994436,0.00015113757],"category_scores_gemma":[0.00038610437,0.000264566,0.00016251768,0.00162298,0.00037090175,0.00018843352,0.00018743644,0.00070780324,0.00014550658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06426932,0.0019868915,0.62930596,0.0005348934,0.012585084,0.16004114,0.01843592,0.0063539194,0.06941625,0.00015499075,0.029093714,0.007821931],"study_design_scores_gemma":[0.05431851,0.012398121,0.8839359,0.0011565244,0.0020193944,0.01574136,0.0037956676,0.003514263,0.014761582,0.00008367562,0.0072302786,0.0010446905],"about_ca_topic_score_codex":0.0000682319,"about_ca_topic_score_gemma":0.000112149355,"teacher_disagreement_score":0.25463,"about_ca_system_score_codex":0.00043500765,"about_ca_system_score_gemma":0.00038557904,"threshold_uncertainty_score":0.9999806},"labels":[],"label_agreement":null},{"id":"W4386757545","doi":"10.1111/ejh.14080","title":"Long‐term effectiveness of eculizumab: Data from the International <scp>PNH</scp> Registry","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Alexion Pharmaceuticals; AstraZeneca","keywords":"Eculizumab; Medicine; Paroxysmal nocturnal hemoglobinuria; Internal medicine; Proportional hazards model; Hazard ratio; Renal function; Cohort; Hemoglobinuria; Gastroenterology; Surgery; Anemia; Confidence interval; Immunology; Complement system; Antibody","score_opus":0.0507329098349079,"score_gpt":0.2980045723555129,"score_spread":0.247271662520605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386757545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170625,0.0025529875,0.00045595417,0.0003345491,0.002721267,0.00013557305,0.0003357368,0.00003329987,0.0017244068],"genre_scores_gemma":[0.9989761,0.000092586735,0.000027744698,0.00006185782,0.00013225642,0.00000144436,0.0004757708,0.000024327981,0.00020792328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961716,0.0025200152,0.00073309883,0.00024342372,0.00010051639,0.0002313449],"domain_scores_gemma":[0.9955602,0.0026018482,0.0008267423,0.00081497803,0.00016651873,0.000029700113],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001929378,0.0001520619,0.0004678787,0.0001293625,0.000089004934,0.000020340423,0.0024649096,0.000047845777,0.00028637986],"category_scores_gemma":[0.0014531021,0.0001063446,0.00013815159,0.00013404002,0.00028690038,0.00011605235,0.00093216146,0.00028972767,0.00079522154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059513643,0.00034689464,0.44551226,0.00025071064,0.0034821932,0.0077288817,0.00087404036,0.000047474176,0.10072385,0.001239961,0.43745056,0.0017480522],"study_design_scores_gemma":[0.0033659076,0.00023226059,0.93346477,0.0007709638,0.00023710047,0.006075219,0.000741576,0.000008721903,0.011471053,0.00027004065,0.04326638,0.000095992276],"about_ca_topic_score_codex":0.000011487269,"about_ca_topic_score_gemma":0.000009464153,"teacher_disagreement_score":0.48795253,"about_ca_system_score_codex":0.000021678425,"about_ca_system_score_gemma":0.000084544015,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W4387115637","doi":"10.1111/ejh.14100","title":"Long‐term survivorship care after <scp>CAR‐T</scp> cell therapy","year":2023,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Chimeric antigen receptor; Cytokine release syndrome; Medicine; Tocilizumab; Survivorship curve; Population; CAR T-cell therapy; Immune system; Disease; Immunology; Intensive care medicine; Immunotherapy; Cell therapy; T cell; Bioinformatics; Cell; Internal medicine; Biology","score_opus":0.10031656807501967,"score_gpt":0.36828685148472,"score_spread":0.26797028340970036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387115637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0127384,0.97402275,0.000022832155,0.000057294055,0.0013441503,0.000918212,0.000026660027,0.00007602057,0.010793662],"genre_scores_gemma":[0.00096375233,0.98458517,0.0000825472,0.00016068314,0.0014434004,0.000017488514,0.000059000882,0.00054436707,0.012143598],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99138606,0.0041468763,0.002067064,0.0005770037,0.00088909717,0.00093388325],"domain_scores_gemma":[0.9951082,0.0012303715,0.0013872484,0.0010310048,0.0006278317,0.0006153768],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0024218562,0.0007998585,0.00450831,0.0012430548,0.00008213508,0.00008766283,0.0010596481,0.00033615463,0.0011131972],"category_scores_gemma":[0.00036122306,0.00056731014,0.0019964674,0.0006859377,0.00029173063,0.000080804755,0.00027153603,0.002680046,0.0021715797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022253126,0.0002831994,0.0013059871,0.04381523,0.0019746942,0.26457736,0.0028068875,3.3824637e-7,0.00004926823,0.00001074004,0.00744663,0.67750716],"study_design_scores_gemma":[0.0018413983,0.001277401,0.000578136,0.011992629,0.0008349432,0.03632629,0.00022039594,1.0746887e-7,0.00005423814,0.000004647265,0.94668746,0.0001823303],"about_ca_topic_score_codex":0.000003916208,"about_ca_topic_score_gemma":0.000011697786,"teacher_disagreement_score":0.9392409,"about_ca_system_score_codex":0.00020193725,"about_ca_system_score_gemma":0.00076735136,"threshold_uncertainty_score":0.9997999},"labels":[],"label_agreement":null},{"id":"W4387598782","doi":"10.1111/ejh.14117","title":"Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hematopoietic cell; Cytomegalovirus; Cohort; Internal medicine; Single Center; Univariate analysis; Cumulative incidence; Incidence (geometry); Transplantation; Human cytomegalovirus; Hematopoietic stem cell transplantation; Multivariate analysis; Immunology; Virus; Haematopoiesis; Viral disease; Herpesviridae; Stem cell","score_opus":0.08498975816963134,"score_gpt":0.31477752507409906,"score_spread":0.22978776690446773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387598782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296266,0.0002218326,0.00022192969,0.0020078686,0.0003509982,0.00049483404,0.00014892383,0.000023228382,0.003567714],"genre_scores_gemma":[0.9983439,0.00018139761,0.00044921078,0.0002832637,0.00016728022,0.0000051361812,0.00018973286,0.000068195055,0.00031191797],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751645,0.00035465538,0.0008579397,0.00034318437,0.00031096794,0.0006167929],"domain_scores_gemma":[0.9984714,0.00016629562,0.0002587805,0.0005357455,0.00018576044,0.00038201595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017902422,0.00018833105,0.0005947775,0.0012370003,0.000087533714,0.000037496895,0.000540801,0.000082543105,0.00008188496],"category_scores_gemma":[0.00024729696,0.00015879823,0.00012808188,0.0005241799,0.0000913981,0.00020409195,0.00008524756,0.00047860306,0.00021110201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010275819,0.0034137364,0.33049875,0.0026128334,0.0008504842,0.13955572,0.009117473,0.00012650063,0.33384115,0.0004178426,0.10102304,0.068266645],"study_design_scores_gemma":[0.026851378,0.0086560715,0.15679309,0.0023333707,0.0003139961,0.044604387,0.0011865926,0.0008286061,0.02624118,0.00026846988,0.7306341,0.0012887681],"about_ca_topic_score_codex":0.0005685858,"about_ca_topic_score_gemma":0.003422211,"teacher_disagreement_score":0.6296111,"about_ca_system_score_codex":0.00019272818,"about_ca_system_score_gemma":0.00038386273,"threshold_uncertainty_score":0.64756036},"labels":[],"label_agreement":null},{"id":"W4388574779","doi":"10.1111/ejh.14133","title":"Late‐onset <i>Pneumocystis jirovecii</i> pneumonia post‐allogeneic stem cell transplantation after time‐dependent discontinuation of prophylaxis","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Discontinuation; Internal medicine; Pneumonia; Transplantation; Interquartile range; Pneumocystis jirovecii; Immunosuppression; Surgery; Immunology","score_opus":0.00834889908734137,"score_gpt":0.22046299883279363,"score_spread":0.21211409974545226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388574779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996634,0.0003137489,0.0003110304,0.0008988921,0.00045519817,0.00037514113,0.000079933125,0.0000711267,0.00086094334],"genre_scores_gemma":[0.99775875,0.00030134595,0.00017147258,0.00014496593,0.00007952052,0.000008802675,0.000038346832,0.0000707138,0.0014260767],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996855,0.000728574,0.0012371427,0.00031163197,0.0005138557,0.0003537618],"domain_scores_gemma":[0.9981292,0.00015788159,0.00083712384,0.0003183837,0.00032874753,0.00022866669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007721032,0.00029972172,0.000827739,0.00060245814,0.00007060716,0.000023385626,0.00018721876,0.00008748877,0.000095896874],"category_scores_gemma":[0.000043055268,0.00023852175,0.0003243363,0.00038032242,0.000109618144,0.0001493402,0.00004617134,0.0003496474,0.0006581769],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004172057,0.0009782645,0.024881113,0.0007045496,0.0005178692,0.07021816,0.002419196,0.0003351509,0.8753052,0.000013319502,0.00029951753,0.020155642],"study_design_scores_gemma":[0.008869557,0.0107631385,0.7316055,0.00075920275,0.001178892,0.057534844,0.00042238465,0.00020401836,0.18721326,0.0000451595,0.00082456885,0.00057942624],"about_ca_topic_score_codex":0.0000044735807,"about_ca_topic_score_gemma":0.000005723731,"teacher_disagreement_score":0.70672446,"about_ca_system_score_codex":0.00007258634,"about_ca_system_score_gemma":0.000115549396,"threshold_uncertainty_score":0.9726635},"labels":[],"label_agreement":null},{"id":"W4390005460","doi":"10.1111/ejh.14143","title":"Determinants of durable humoral and T cell immunity in myeloma patients following <scp>COVID</scp>‐19 vaccination","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research; Janssen UK; Cancer Research UK; Myeloma UK; European Hematology Association","keywords":"Vaccination; Medicine; Antibody; Immunology; Immune system; Multiple myeloma; Immunity; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease","score_opus":0.028763906509255335,"score_gpt":0.3075254082450133,"score_spread":0.278761501735758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390005460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979065,0.0002536719,0.000011420617,0.000040852527,0.00013122786,0.00018535716,0.000004120895,0.000011903578,0.0014549532],"genre_scores_gemma":[0.9992669,0.00012532553,0.00031618826,0.000032536027,0.000017295357,0.0000012774036,0.00001051299,0.000023277262,0.00020668386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805415,0.0006153633,0.0006201843,0.00013172388,0.00026991157,0.00030865832],"domain_scores_gemma":[0.9988168,0.00031361752,0.00035812036,0.0001574275,0.0001341641,0.00021986222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009886314,0.00012403549,0.00051926484,0.00052562833,0.000069102876,0.000010749241,0.00013805005,0.000035291876,0.000014478015],"category_scores_gemma":[0.0013665961,0.0001006084,0.000103354476,0.0003033046,0.000038546976,0.00013164002,0.000108904605,0.00025556813,0.00003632331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011784151,0.00023921809,0.9779439,0.00020341788,0.000046371937,0.014790296,0.00090891944,0.000004485323,0.001288621,0.0000037608506,0.00038955378,0.004063605],"study_design_scores_gemma":[0.006830346,0.0009100591,0.98783,0.00014327344,0.000040884,0.0009081116,0.00044041604,0.00015519024,0.002489822,0.00004097498,0.00017688857,0.00003406271],"about_ca_topic_score_codex":0.000020355183,"about_ca_topic_score_gemma":0.000012921977,"teacher_disagreement_score":0.0138821835,"about_ca_system_score_codex":0.000049660866,"about_ca_system_score_gemma":0.000090901274,"threshold_uncertainty_score":0.41026914},"labels":[],"label_agreement":null},{"id":"W4390769807","doi":"10.1111/ejh.14167","title":"A post hoc analysis of <scp>PROTECT VIII</scp> kids assessing long‐term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia <scp>A</scp>","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Bayer","keywords":"Haemophilia; Medicine; Post-hoc analysis; Certolizumab pegol; Population; Subgroup analysis; Haemophilia A; Post hoc; Clinical trial; Internal medicine; Pediatrics; Tumor necrosis factor alpha","score_opus":0.021213001682114,"score_gpt":0.3042944079689858,"score_spread":0.28308140628687184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390769807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935135,0.003838897,0.00028832242,0.0005261645,0.000100560705,0.0005679149,0.000019982046,0.000021623948,0.0011230295],"genre_scores_gemma":[0.99873567,0.00039518529,0.0004102559,0.00005166721,0.00008907799,0.0000023336106,0.000016337057,0.00006847978,0.00023101277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962359,0.0009181347,0.0012632742,0.00041966455,0.0006501893,0.0005128353],"domain_scores_gemma":[0.9977817,0.0004992285,0.0005556327,0.00039633972,0.00041859306,0.0003484844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012232618,0.0003481154,0.0016336773,0.0018358135,0.000072674884,0.000056573488,0.00029830835,0.00011746466,0.000018600242],"category_scores_gemma":[0.0006987414,0.00023554356,0.00033793936,0.0013922462,0.0004043295,0.00021801295,0.00015709575,0.00087874476,0.0000124479575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014912799,0.0017647966,0.81656194,0.004879608,0.0071099536,0.13084286,0.0065272944,0.0001531367,0.015328457,0.00006790179,0.0005488038,0.014723993],"study_design_scores_gemma":[0.008642817,0.004098563,0.94801706,0.007736923,0.0030515932,0.023123039,0.0013541323,0.0003225187,0.003315433,0.000015703652,0.00022116424,0.00010108086],"about_ca_topic_score_codex":0.0000104630135,"about_ca_topic_score_gemma":0.000020907017,"teacher_disagreement_score":0.13145512,"about_ca_system_score_codex":0.00008281169,"about_ca_system_score_gemma":0.00033827097,"threshold_uncertainty_score":0.9605187},"labels":[],"label_agreement":null},{"id":"W4391932170","doi":"10.1111/ejh.14176","title":"Recombinant factor <scp>IX Fc</scp> for the treatment of hemophilia B","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Swedish Orphan Biovitrum; Sanofi","keywords":"Medicine; Factor IX; Hemostasis; Intensive care medicine; Clinical trial; Bleed; Distribution (mathematics); Pharmacology; Surgery; Internal medicine","score_opus":0.05814494965814852,"score_gpt":0.33350911914275355,"score_spread":0.275364169484605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391932170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97330284,0.01564149,0.00033403342,0.0065469355,0.0012877157,0.0005012324,0.000017296476,0.000022010858,0.0023464197],"genre_scores_gemma":[0.98832774,0.0038688274,0.0005187618,0.000053191885,0.00037485536,0.000005462371,0.0000054545644,0.000048762617,0.0067969165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852765,0.00022658316,0.0005783093,0.00015817706,0.00022082595,0.0002884765],"domain_scores_gemma":[0.99813205,0.0011267026,0.00016382513,0.00024365861,0.00018348683,0.00015030471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004862425,0.00016541194,0.00058230123,0.00021592293,0.00007239075,0.000020657233,0.00017122742,0.000040754356,0.00007608045],"category_scores_gemma":[0.00024112737,0.00007821489,0.00043350202,0.00014740562,0.00015854985,0.000044909204,0.000021854405,0.00018201937,0.00011602216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025771463,0.007410873,0.027945356,0.0036024887,0.013303574,0.14020804,0.023142658,0.000027468577,0.030033818,0.008518777,0.19362156,0.54960823],"study_design_scores_gemma":[0.0060196985,0.020548292,0.008732299,0.0006540663,0.0009094508,0.02318957,0.00076158356,0.00031172225,0.028277421,0.00043399792,0.91007334,0.00008857389],"about_ca_topic_score_codex":0.0000014402477,"about_ca_topic_score_gemma":9.573565e-7,"teacher_disagreement_score":0.71645176,"about_ca_system_score_codex":0.000068242065,"about_ca_system_score_gemma":0.00016125229,"threshold_uncertainty_score":0.31895107},"labels":[],"label_agreement":null},{"id":"W4392106791","doi":"10.1111/ejh.14180","title":"The <scp>EASEMENT</scp> study: <scp>A</scp> multicentre, observational, cross‐sectional study to evaluate patient preferences, treatment satisfaction, quality of life, and healthcare resource use in patients with multiple myeloma receiving injectable‐containing or fully oral therapies","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"Takeda Pharmaceuticals International","keywords":"Medicine; Observational study; Patient satisfaction; Family medicine; Cross-sectional study; Quality of life (healthcare); Internal medicine; Surgery; Nursing","score_opus":0.11404974343214659,"score_gpt":0.3636238877025933,"score_spread":0.24957414427044672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392106791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963675,0.0009393761,0.000023103032,0.00012675356,0.00017146888,0.0022676026,0.00005324476,0.00002610743,0.00002480313],"genre_scores_gemma":[0.9989353,0.0000742999,0.00062893867,0.00007433838,0.00004843969,0.000049392816,0.000023778364,0.000048265225,0.000117246454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99313706,0.0033243804,0.0015184407,0.0004735443,0.0010528195,0.0004937477],"domain_scores_gemma":[0.9938631,0.003907731,0.00063531334,0.0003245526,0.00088872993,0.00038056087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021587103,0.0003354295,0.00077134545,0.00038369565,0.00033661365,0.00019731911,0.0001615875,0.000038515853,0.000010471016],"category_scores_gemma":[0.0049686152,0.00018733599,0.00008980225,0.00042184643,0.00012875615,0.00029499555,0.00013085973,0.0003825689,0.0000063238213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032075846,0.001975145,0.96895474,0.00010018157,0.0014087305,0.0007449372,0.014386189,0.00015819422,0.000012432491,0.000007065498,0.00012326744,0.008921524],"study_design_scores_gemma":[0.012004558,0.019658342,0.95114386,0.0002573536,0.000098566445,0.00010714133,0.01614752,0.00010759522,0.000013771371,0.0000054424727,0.0004083389,0.000047483958],"about_ca_topic_score_codex":0.00087917555,"about_ca_topic_score_gemma":0.005688709,"teacher_disagreement_score":0.017810863,"about_ca_system_score_codex":0.00030564232,"about_ca_system_score_gemma":0.00048244648,"threshold_uncertainty_score":0.76393396},"labels":[],"label_agreement":null},{"id":"W4393315734","doi":"10.1111/ejh.14208","title":"Ocular adverse events following <scp>CAR‐T</scp> cell therapy: A pharmacovigilance study and systematic review","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacovigilance; Adverse effect; Medicine; Pharmacology; Intensive care medicine","score_opus":0.02932337168247901,"score_gpt":0.3358748212748156,"score_spread":0.3065514495923366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393315734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7693297,0.22658257,0.00009708798,0.00031739796,0.00044727352,0.001308354,0.0000011982861,0.00003686298,0.0018795196],"genre_scores_gemma":[0.97584236,0.020558493,0.00013342634,0.0008183951,0.00015241477,0.000010974729,0.0000013026532,0.000090688394,0.0023919707],"study_design_codex":"case_report","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956891,0.0021019108,0.0010153519,0.00028042195,0.0005801884,0.00033304302],"domain_scores_gemma":[0.99855375,0.0004116404,0.00030058384,0.00034594638,0.0001385563,0.0002494979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039463365,0.0002438883,0.0013645459,0.00028994255,0.00006249785,0.000022854949,0.00028767914,0.000027961807,0.00013034198],"category_scores_gemma":[0.00036625323,0.00016872722,0.00041649232,0.00032291652,0.00004922494,0.0001290944,0.00008853924,0.00063364836,0.00015528096],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025301508,0.0015797018,0.017280051,0.40640634,0.0072360747,0.47180653,0.008368501,0.000006357827,0.07268224,0.000033715176,0.012238766,0.0021087348],"study_design_scores_gemma":[0.038088083,0.015561669,0.0049537746,0.5617852,0.015063252,0.24928437,0.009200406,0.00055992504,0.011821371,0.000109287925,0.09269294,0.00087972666],"about_ca_topic_score_codex":8.810552e-7,"about_ca_topic_score_gemma":1.8638201e-7,"teacher_disagreement_score":0.22252214,"about_ca_system_score_codex":0.000051865347,"about_ca_system_score_gemma":0.000115332645,"threshold_uncertainty_score":0.6880496},"labels":[],"label_agreement":null},{"id":"W4394916661","doi":"10.1111/ejh.14211","title":"Sickle <scp>Cell Health Awareness, Perspectives,</scp> and <scp>Experiences</scp> (<scp>SHAPE</scp>) survey: <scp>Perspectives</scp> of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell disease","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Pfizer","keywords":"Medicine; Health professionals; Health care","score_opus":0.012048611198366596,"score_gpt":0.26143803542249,"score_spread":0.2493894242241234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394916661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90766233,0.086775914,0.000039345974,0.0026416327,0.0004929304,0.0009782433,0.00018991517,0.000047877602,0.0011718147],"genre_scores_gemma":[0.9853137,0.012925051,0.000097340184,0.000530185,0.00019518232,0.000010910853,0.000040616662,0.00012379001,0.0007631953],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9932688,0.0025585755,0.0014568623,0.0009202815,0.00089940074,0.0008960839],"domain_scores_gemma":[0.99324447,0.0025905152,0.0013642294,0.00052745274,0.001220918,0.0010524163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017142082,0.00066509936,0.0015917714,0.0005256977,0.0004604266,0.00007617131,0.00043359175,0.00021765479,0.000012272593],"category_scores_gemma":[0.00327297,0.0004600818,0.00029320706,0.000598976,0.0012550617,0.00023312903,0.00033417917,0.0014276226,0.0000141272185],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028460743,0.004012211,0.13034455,0.011288114,0.0009987867,0.0044688922,0.6736281,0.00010537548,0.00063608034,0.0028991792,0.16928858,0.0020455457],"study_design_scores_gemma":[0.0059162006,0.00434727,0.07511854,0.004433949,0.00039448,0.0009715787,0.8932062,0.00048209346,0.0010401489,0.00014417808,0.013824879,0.00012050174],"about_ca_topic_score_codex":0.00023365916,"about_ca_topic_score_gemma":0.000018375396,"teacher_disagreement_score":0.2195781,"about_ca_system_score_codex":0.00016142767,"about_ca_system_score_gemma":0.0010684106,"threshold_uncertainty_score":0.99978507},"labels":[],"label_agreement":null},{"id":"W4399326989","doi":"10.1111/ejh.14247","title":"Reviewing the impact of hydroxyurea on <scp>DNA</scp> methylation and its potential clinical implications in sickle cell disease","year":2024,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"DNA methylation; Epigenetics; Fetal hemoglobin; Methylation; Disease; Erythropoiesis; Hydroxycarbamide; Bioinformatics; Medicine; Downregulation and upregulation; Mechanism (biology); Gene; Biology; Cancer research; Immunology; Genetics; Gene expression; Anemia; Fetus; Internal medicine; Pregnancy","score_opus":0.0620446499275406,"score_gpt":0.38920067161508587,"score_spread":0.32715602168754526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399326989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015462478,0.98166025,0.00002435704,0.0005684291,0.00027974046,0.00053572224,0.000021375963,0.0000085836555,0.0014390579],"genre_scores_gemma":[0.060788814,0.93876064,0.000022915337,0.000060817776,0.00016662742,0.0000024038204,0.000016947033,0.000058240697,0.0001225922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954874,0.0018547655,0.0020074006,0.00025351497,0.0001701872,0.00022674668],"domain_scores_gemma":[0.9974884,0.0005467887,0.0012749166,0.00031642857,0.00012040679,0.00025305682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021504343,0.00030017676,0.002000587,0.0003643252,0.000048195845,0.000017430142,0.00023498709,0.00014537417,0.000011269484],"category_scores_gemma":[0.0010880461,0.00015112765,0.0011630552,0.00035309713,0.00012452505,0.000044382108,0.000092705595,0.0013970209,0.00007732122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017314062,0.0016442742,0.00063619687,0.054412153,0.003036037,0.020735627,0.0008311623,0.00018226456,0.000053696385,0.0014491298,0.025690665,0.89115566],"study_design_scores_gemma":[0.0032035585,0.0028291957,0.0042116186,0.07703464,0.018859003,0.020409722,0.0001555436,0.00024760954,0.0000058876076,0.00040409746,0.87228954,0.0003495925],"about_ca_topic_score_codex":0.0000013167155,"about_ca_topic_score_gemma":1.7687543e-7,"teacher_disagreement_score":0.8908061,"about_ca_system_score_codex":0.00004431014,"about_ca_system_score_gemma":0.00041832257,"threshold_uncertainty_score":0.6162807},"labels":[],"label_agreement":null},{"id":"W4399756908","doi":"10.1111/ejh.14251","title":"Impact of cytomegalovirus (<scp>CMV</scp>) seroconversion pre‐allogeneic hematopoietic cell transplantation on posttransplant outcomes","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Serostatus; Medicine; Seroconversion; Cumulative incidence; Cytomegalovirus; Internal medicine; Transplantation; Human cytomegalovirus; Immunology; Incidence (geometry); Gastroenterology; Serology; Cohort; Betaherpesvirinae; Hematopoietic stem cell transplantation; Antibody; Viral disease; Herpesviridae; Viral load; Virus","score_opus":0.023745147115366776,"score_gpt":0.31713125518623125,"score_spread":0.29338610807086446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399756908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914906,0.0018229486,0.00056963955,0.00028992986,0.000330613,0.00029055745,0.00006225753,0.0000425251,0.0051009418],"genre_scores_gemma":[0.9975239,0.0013838994,0.00021874816,0.00013231346,0.00010390485,0.0000014148962,0.000018591465,0.000077251294,0.0005399584],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997177,0.00046067798,0.0010271304,0.00029520394,0.0005920409,0.00044791642],"domain_scores_gemma":[0.9983832,0.00046023508,0.0003110977,0.0002930394,0.00021702984,0.00033536946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009382491,0.000313122,0.0009639669,0.00089420687,0.000065165645,0.000039774113,0.00029816205,0.00010381279,0.00020997996],"category_scores_gemma":[0.00007672336,0.00021327441,0.00073826255,0.00033555613,0.00017904113,0.00016066935,0.000029754116,0.00074487826,0.00035840162],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005932978,0.0026126166,0.2034412,0.010127484,0.0037255418,0.20953919,0.017849552,0.0007488191,0.52119815,0.00092678115,0.016103383,0.0077942885],"study_design_scores_gemma":[0.011438967,0.016110936,0.6621091,0.003682226,0.0017726414,0.09536961,0.00069289183,0.00022556336,0.19860528,0.00017199344,0.009370882,0.00044994734],"about_ca_topic_score_codex":0.000028088563,"about_ca_topic_score_gemma":0.0000028549612,"teacher_disagreement_score":0.45866784,"about_ca_system_score_codex":0.0001063787,"about_ca_system_score_gemma":0.0003327949,"threshold_uncertainty_score":0.8697078},"labels":[],"label_agreement":null},{"id":"W4399818339","doi":"10.1111/ejh.14253","title":"Childhood autoimmune hemolytic anemia: A scoping review","year":2024,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Observational study; Autoimmune hemolytic anemia; Rituximab; Intensive care medicine; MEDLINE; Randomized controlled trial; Pediatrics; Clinical trial; Anemia; Immunology; Internal medicine; Antibody","score_opus":0.03899514370309518,"score_gpt":0.34511991972104666,"score_spread":0.30612477601795146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399818339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010765302,0.9937188,0.000047237078,0.0008649559,0.0010040737,0.0009593283,0.000004028238,0.000047477788,0.0033433428],"genre_scores_gemma":[0.000026829826,0.9981328,0.00042689277,0.00058514037,0.00045500186,0.0000038946846,0.000018368595,0.00016717987,0.0001838453],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957162,0.0008462992,0.0024450645,0.00034004293,0.0003129588,0.00033942098],"domain_scores_gemma":[0.9979725,0.000117634685,0.0010801464,0.0004803677,0.00013238059,0.00021699151],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015191315,0.0005070143,0.0053096837,0.00042898767,0.00005460945,0.000026090704,0.00036716755,0.0001462442,0.00023770261],"category_scores_gemma":[0.00020849107,0.00031545095,0.0015502559,0.00042767348,0.00009208076,0.00005472824,0.000120530094,0.0019972925,0.00082939817],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006669905,0.000114668954,3.9709056e-7,0.47110382,0.00045357898,0.061120357,0.00003962784,1.5759825e-8,3.8431142e-7,0.000059411483,0.0039067185,0.46319434],"study_design_scores_gemma":[0.0003288941,0.00026300407,0.0000021059197,0.48688075,0.008273236,0.21334302,0.000002126896,7.2651424e-8,2.4583764e-7,0.000004509094,0.29077977,0.00012225719],"about_ca_topic_score_codex":3.9684969e-7,"about_ca_topic_score_gemma":2.750926e-7,"teacher_disagreement_score":0.4630721,"about_ca_system_score_codex":0.00004631058,"about_ca_system_score_gemma":0.0007760488,"threshold_uncertainty_score":0.99994856},"labels":[],"label_agreement":null},{"id":"W4399897699","doi":"10.1111/ejh.14258","title":"Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Immunosuppression; Cytomegalovirus; Internal medicine; Cohort; Single Center; Transplantation; Hematopoietic stem cell transplantation; Surgery; Immunology; Viral disease; Herpesviridae; Virus","score_opus":0.020473283917950582,"score_gpt":0.2875138084538746,"score_spread":0.26704052453592403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399897699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852676,0.0033844109,0.00068961625,0.0002674572,0.0004440557,0.00019773823,0.000014111958,0.000029390047,0.009705666],"genre_scores_gemma":[0.9982919,0.0005670535,0.00034687752,0.00021365249,0.0001767893,0.0000055712235,0.000004758044,0.00005436536,0.00033903608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780726,0.00037214227,0.00087063195,0.0002564551,0.00038958358,0.0003039486],"domain_scores_gemma":[0.99906284,0.000089015215,0.00021078867,0.00023054762,0.00020316248,0.00020367891],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052116904,0.000200934,0.00056371326,0.00056196627,0.0000463661,0.00005146861,0.00015902206,0.000072474075,0.0012367839],"category_scores_gemma":[0.000041129744,0.00015717189,0.00030758767,0.00030911353,0.00024548778,0.00022389139,0.000048325877,0.00059300027,0.0003181596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008076771,0.002195692,0.058792528,0.010998637,0.0007672448,0.28158742,0.02742975,0.000018263068,0.5531455,0.00031841168,0.0024295857,0.054240193],"study_design_scores_gemma":[0.007517556,0.013538943,0.058468055,0.0033003965,0.0005083846,0.36795315,0.0006421643,0.00003909252,0.39980698,0.00021243867,0.14719488,0.00081793807],"about_ca_topic_score_codex":0.00001233345,"about_ca_topic_score_gemma":0.0000067089527,"teacher_disagreement_score":0.15333852,"about_ca_system_score_codex":0.00006148004,"about_ca_system_score_gemma":0.00022121261,"threshold_uncertainty_score":0.9996762},"labels":[],"label_agreement":null},{"id":"W4400354929","doi":"10.1111/ejh.14260","title":"Aberrant early hematopoietic progenitor formation marks the onset of hematopoietic defects in Shwachman–Diamond syndrome","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University Health Network; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Haematopoiesis; Induced pluripotent stem cell; Biology; Bone marrow failure; Bone marrow; Stem cell; Embryonic stem cell; Progenitor cell; Diamond–Blackfan anemia; Transcriptome; Cell biology; Cancer research; Immunology; Genetics; Gene; Gene expression; Ribosome; RNA","score_opus":0.008332227450907352,"score_gpt":0.22825750956239999,"score_spread":0.21992528211149262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400354929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986837,0.011384397,0.00033420586,0.0003275697,0.00027901764,0.00019436055,0.0000076199963,0.000006323441,0.00062949746],"genre_scores_gemma":[0.99941987,0.00020242683,0.0001798284,0.000059410966,0.00003686714,0.0000052451664,0.000010978683,0.00003265982,0.0000527249],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99836457,0.00043042324,0.00064541306,0.0001724496,0.00015707343,0.00023010185],"domain_scores_gemma":[0.99932164,0.00004374454,0.00025659404,0.00024744033,0.00006639792,0.00006419044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005528789,0.00017192961,0.00034192362,0.00014391806,0.000042572472,0.000030092813,0.0002815161,0.000064951775,0.000018967694],"category_scores_gemma":[0.00004990236,0.000115799856,0.00020012746,0.00015591737,0.00012153894,0.000016661545,0.0000810016,0.0002005114,0.000032676795],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049392045,0.009420576,0.31489673,0.012728905,0.01007812,0.26581842,0.035364255,0.0008705311,0.21164285,0.01199895,0.083783135,0.038458336],"study_design_scores_gemma":[0.014367848,0.012870279,0.1197531,0.004002563,0.0017025409,0.49385,0.0034175594,0.00044075964,0.32073572,0.0060568587,0.020792518,0.0020102735],"about_ca_topic_score_codex":0.0000034587144,"about_ca_topic_score_gemma":0.000011776714,"teacher_disagreement_score":0.22803155,"about_ca_system_score_codex":0.000010765112,"about_ca_system_score_gemma":0.0000683066,"threshold_uncertainty_score":0.4722181},"labels":[],"label_agreement":null},{"id":"W4400460542","doi":"10.1111/ejh.14274","title":"Outcomes with low dose anti‐thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Anti-thymocyte globulin; Internal medicine; Gastroenterology; Regimen; Graft-versus-host disease; Univariate analysis; Hematopoietic stem cell transplantation; Transplantation; Multivariate analysis; Cumulative incidence; Immunology","score_opus":0.010951650076570426,"score_gpt":0.24401763495142595,"score_spread":0.23306598487485553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400460542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834399,0.002334012,0.010463996,0.0017477743,0.00078138383,0.0005576534,0.000039278395,0.00012100946,0.0005149912],"genre_scores_gemma":[0.9962649,0.00026452236,0.0028040728,0.00026851604,0.00008288996,0.0000108447275,0.00005645283,0.0001285924,0.0001192566],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99667925,0.00072935846,0.0011270152,0.00044359162,0.00057638396,0.00044441764],"domain_scores_gemma":[0.9981311,0.00043761393,0.00032451862,0.00037300753,0.00022821144,0.00050557056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000743616,0.00044385713,0.00090619863,0.00047244164,0.00006791374,0.000070209426,0.00022109639,0.00010521123,0.00024702022],"category_scores_gemma":[0.000057612324,0.0003106179,0.00035382042,0.00041152694,0.00019500215,0.00017430192,0.0000137268025,0.0005586612,0.0003166632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041613605,0.0015522335,0.12413366,0.020718265,0.0017666308,0.7726645,0.0058615343,0.00087050244,0.029241858,0.00016319632,0.00034469957,0.0010693404],"study_design_scores_gemma":[0.064753614,0.009365888,0.7532299,0.014670448,0.011399756,0.056849353,0.0009808576,0.0015423244,0.08311894,0.00005910871,0.0016449038,0.0023848594],"about_ca_topic_score_codex":0.0000030521135,"about_ca_topic_score_gemma":0.000004075886,"teacher_disagreement_score":0.7158151,"about_ca_system_score_codex":0.00007296619,"about_ca_system_score_gemma":0.0004207502,"threshold_uncertainty_score":0.9999346},"labels":[],"label_agreement":null},{"id":"W4400504061","doi":"10.1111/ejh.14267","title":"<scp>CRP</scp> and <scp>sCD25</scp> help distinguish between adult‐onset Still's disease and <scp>HLH</scp>","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; St. Paul's Hospital; BC Children's Hospital; University of British Columbia","funders":"BC Children's Hospital; Clinton Foundation","keywords":"Medicine; Ferritin; Macrophage activation syndrome; D-dimer; C-reactive protein; Internal medicine; Gastroenterology; Hemophagocytic lymphohistiocytosis; Immunology; Leukocytosis; Inflammation; Disease","score_opus":0.020321597052999213,"score_gpt":0.2825908087518603,"score_spread":0.2622692116988611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400504061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578226,0.028061148,0.00043616001,0.0011798084,0.00052489166,0.00043894644,0.0000685187,0.00014489226,0.011323004],"genre_scores_gemma":[0.99010247,0.0029388473,0.00036979464,0.0005581347,0.0008321509,0.00000744047,0.000056982626,0.00019421735,0.004939988],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946805,0.0011451598,0.0016105106,0.00070189644,0.0007935662,0.0010683254],"domain_scores_gemma":[0.9946029,0.0024084805,0.0006070469,0.0005753391,0.00056095375,0.0012452806],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019436713,0.0005898473,0.0015395137,0.0007583229,0.00031140257,0.0002824054,0.0005157617,0.00016787156,0.000032504013],"category_scores_gemma":[0.011433425,0.00048395403,0.00033786264,0.00048149607,0.00092468155,0.00036503005,0.00049693475,0.001653799,0.0002862397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009249083,0.0004466279,0.4571841,0.0042117,0.0020519882,0.12213152,0.009437102,0.000009753988,0.0010979638,0.0016370969,0.38361058,0.018089067],"study_design_scores_gemma":[0.0045358343,0.0017480471,0.4057289,0.00243113,0.0011716165,0.020656588,0.005727783,0.00038718927,0.00059231714,0.0009970153,0.5558797,0.00014386239],"about_ca_topic_score_codex":0.000008989894,"about_ca_topic_score_gemma":0.000003082545,"teacher_disagreement_score":0.17226912,"about_ca_system_score_codex":0.000058723854,"about_ca_system_score_gemma":0.00047831313,"threshold_uncertainty_score":0.9997612},"labels":[],"label_agreement":null},{"id":"W4400589592","doi":"10.1111/ejh.14271","title":"Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with <i>BCR</i>::<i>ABL1</i> digital <scp>PCR</scp> in chronic myeloid leukemia patients","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Discontinuation; Digital polymerase chain reaction; Imatinib; Myeloid leukemia; Medicine; Internal medicine; breakpoint cluster region; Tyrosine-kinase inhibitor; Cutoff; Oncology; Tyrosine kinase; Clinical endpoint; Gastroenterology; Immunology; Chemistry; Cancer; Polymerase chain reaction; Receptor; Clinical trial","score_opus":0.008593071422898032,"score_gpt":0.21905732001150868,"score_spread":0.21046424858861065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400589592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934419,0.0028610535,0.00037308407,0.00020751827,0.00041972008,0.00044840132,0.00004066018,0.000044915378,0.0021627555],"genre_scores_gemma":[0.9980741,0.0001807246,0.00027621243,0.00004531778,0.0003351532,0.000008288959,0.000103136634,0.000086311884,0.00089076854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973014,0.00024791172,0.0012025216,0.00035087316,0.00050230016,0.00039496706],"domain_scores_gemma":[0.99848735,0.00016992041,0.0005043741,0.00029680843,0.0003298018,0.00021173837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048768465,0.00031072195,0.000719693,0.0005203704,0.000034190263,0.000051426083,0.00014344437,0.00009123957,0.00003426959],"category_scores_gemma":[0.00042457395,0.00022119464,0.00016520893,0.00044927734,0.00016618866,0.000543228,0.00008656038,0.0005504868,0.00003250329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008484921,0.0037430173,0.6307009,0.006196891,0.00207335,0.13688698,0.008964459,0.0008702394,0.056444336,0.00039251978,0.038313042,0.106929354],"study_design_scores_gemma":[0.09550505,0.041317653,0.57647204,0.03925229,0.002626838,0.03451615,0.0025731528,0.0040215747,0.09246389,0.0002216522,0.11012758,0.00090211636],"about_ca_topic_score_codex":0.00000617912,"about_ca_topic_score_gemma":0.0000061331502,"teacher_disagreement_score":0.10602724,"about_ca_system_score_codex":0.0018437989,"about_ca_system_score_gemma":0.0011083076,"threshold_uncertainty_score":0.90200555},"labels":[],"label_agreement":null},{"id":"W4401431808","doi":"10.1111/ejh.14283","title":"Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1‐mutated AML","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"NPM1; Malignancy; Myeloid leukemia; Medicine; Internal medicine; Oncology; Myeloid; Biology; Genetics; Karyotype; Gene","score_opus":0.02174067340941448,"score_gpt":0.33769936050605315,"score_spread":0.31595868709663866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401431808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067396,0.002422709,0.0011957512,0.003619765,0.0011439119,0.00021704387,0.000043347925,0.00007232048,0.0006111639],"genre_scores_gemma":[0.9982243,0.00032301404,0.0003825335,0.000120643286,0.0005208791,0.0000016356032,0.000027143073,0.0000896753,0.00031017952],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9960584,0.001364834,0.0011048013,0.00037264117,0.00051531993,0.0005839976],"domain_scores_gemma":[0.9985044,0.0002898159,0.00026155365,0.00039374194,0.00020848765,0.0003420278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016721869,0.00029693404,0.0010571543,0.00080387405,0.000052896146,0.000068951995,0.0004079191,0.00009179537,0.0005498813],"category_scores_gemma":[0.0003776996,0.00018163302,0.00030397435,0.00038160433,0.00018121582,0.00033182534,0.0001313564,0.0011522976,0.00034294048],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034363584,0.00083446444,0.3423816,0.000598968,0.0019576056,0.4123656,0.003143528,0.0002753988,0.21350344,0.0011234453,0.0036145286,0.016765075],"study_design_scores_gemma":[0.008513807,0.00433934,0.9371417,0.0017966774,0.00034181483,0.028391404,0.0009134445,0.0042507187,0.011235206,0.0005066038,0.0020217572,0.0005475026],"about_ca_topic_score_codex":0.00019467414,"about_ca_topic_score_gemma":0.0001323949,"teacher_disagreement_score":0.5947601,"about_ca_system_score_codex":0.0011718851,"about_ca_system_score_gemma":0.00091092143,"threshold_uncertainty_score":0.74067795},"labels":[],"label_agreement":null},{"id":"W4401431914","doi":"10.1111/ejh.14287","title":"Recurrent venous thromboembolism and vaginal estradiol in women with prior venous thromboembolism: A nested case–control study","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"","keywords":"Venous thromboembolism; Medicine; Nested case-control study; Obstetrics; Case-control study; Internal medicine; Thrombosis","score_opus":0.022732654492614825,"score_gpt":0.30402862000731357,"score_spread":0.28129596551469876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401431914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893248,0.0077219685,0.000054448537,0.0011175885,0.00048054924,0.0008775165,0.000011999569,0.000037742142,0.00037336425],"genre_scores_gemma":[0.9988757,0.00019479488,0.00030399818,0.00031827408,0.00020691431,0.000009521054,9.4085186e-7,0.00007064994,0.000019209318],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9971124,0.0008242509,0.0008554461,0.00033046902,0.0002819333,0.00059551897],"domain_scores_gemma":[0.9986646,0.0001596252,0.00029231282,0.00025366823,0.000103783685,0.0005259875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012269742,0.00030821792,0.0015196167,0.00040767828,0.00010543215,0.00006173013,0.00011346347,0.000046370842,0.000057365825],"category_scores_gemma":[0.00007522031,0.00020251285,0.00002077956,0.00026085638,0.00011986524,0.00015001994,0.000031073647,0.0006914866,0.000026073027],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027000299,0.0031818831,0.0050103078,0.00055170787,0.0014649284,0.9248885,0.0185433,0.000009354137,0.00016813648,0.00013207611,0.0002059546,0.043143827],"study_design_scores_gemma":[0.0139078535,0.056743156,0.3341124,0.0010234483,0.00097124674,0.59052765,0.0015671906,0.0000430841,0.000006217732,0.000073471376,0.00082565885,0.00019859053],"about_ca_topic_score_codex":0.000027910242,"about_ca_topic_score_gemma":0.000020532601,"teacher_disagreement_score":0.33436084,"about_ca_system_score_codex":0.00017913211,"about_ca_system_score_gemma":0.00041171754,"threshold_uncertainty_score":0.8258234},"labels":[],"label_agreement":null},{"id":"W4402070861","doi":"10.1111/ejh.14295","title":"Idiopathic multicentric Castleman disease with marrow fibrosis and extramedullary hematopoiesis","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"Recordati Rare Diseases; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Clinton Foundation","keywords":"Extramedullary hematopoiesis; Medicine; Pathology; Haematopoiesis; Bone marrow; Fibrosis; Disease; Stem cell; Biology","score_opus":0.010580768580129973,"score_gpt":0.2420721591799359,"score_spread":0.23149139059980595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402070861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9409129,0.050960746,0.00061574456,0.0057056085,0.0002727129,0.00012992509,0.000005905648,0.000044873,0.0013515886],"genre_scores_gemma":[0.99779195,0.00090474385,0.00055785134,0.00042514544,0.00011196703,0.0000010612711,0.0000020660882,0.000048804926,0.00015640224],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99866694,0.00024625845,0.00042077343,0.00018990206,0.00022706146,0.00024908103],"domain_scores_gemma":[0.9991727,0.000062670144,0.00017842517,0.0001424786,0.000098056924,0.00034567987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043642966,0.00016492538,0.00047415638,0.0002365084,0.000064049535,0.000048024853,0.00008329299,0.00003294827,0.00008595926],"category_scores_gemma":[0.00014283946,0.00011434137,0.00012286342,0.00022149798,0.0001476949,0.00011262132,0.000032829455,0.00034118275,0.00003431653],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008314913,0.00088622386,0.10682629,0.008935707,0.00255544,0.76691294,0.006957561,0.00012481732,0.0036494802,0.003493565,0.05083179,0.040511288],"study_design_scores_gemma":[0.045698944,0.016457038,0.280505,0.03293302,0.013251007,0.4765982,0.013299309,0.005139262,0.0021505565,0.0021200785,0.10867891,0.0031686681],"about_ca_topic_score_codex":0.000002883584,"about_ca_topic_score_gemma":0.0000023514724,"teacher_disagreement_score":0.29031473,"about_ca_system_score_codex":0.000043307515,"about_ca_system_score_gemma":0.00018882564,"threshold_uncertainty_score":0.46627057},"labels":[],"label_agreement":null},{"id":"W4403735421","doi":"10.1111/ejh.14331","title":"Distance to <scp>CAR</scp>‐T Treatment Center Does Not Impede Delivery","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Apheresis; Refractory (planetary science); Internal medicine; Chimeric antigen receptor; Single Center; Referral; Gastroenterology; Surgery; Immunotherapy; Cancer","score_opus":0.02730334715386731,"score_gpt":0.30890125878051883,"score_spread":0.28159791162665154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403735421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97766703,0.002111943,0.00092031783,0.0038912788,0.0010026202,0.00023395335,0.000017691069,0.000046095058,0.0141090425],"genre_scores_gemma":[0.97716546,0.0008811786,0.00074547704,0.0007610571,0.0006575893,0.0000026460689,0.0000042744937,0.000078633915,0.019703671],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979657,0.00041886565,0.0005832781,0.00026264667,0.00034661102,0.0004229132],"domain_scores_gemma":[0.99871445,0.00032336861,0.000107511594,0.00030855477,0.00017313384,0.0003730092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006395852,0.000205475,0.0005832108,0.00034883534,0.00005086472,0.00006497816,0.00022382519,0.0000348962,0.0005677414],"category_scores_gemma":[0.00016928771,0.00012291469,0.0002981264,0.00019628671,0.000100013116,0.000085129876,0.000079122125,0.0003675259,0.0006073604],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018218713,0.0009363229,0.012083004,0.0006123792,0.0025054582,0.37757903,0.008770201,0.000027499626,0.3832412,0.0014684147,0.08281806,0.12813656],"study_design_scores_gemma":[0.0023370779,0.0027429564,0.0023356203,0.00050610217,0.00015723218,0.034417212,0.0005539027,0.00004983985,0.043367393,0.00004203736,0.91340846,0.000082139195],"about_ca_topic_score_codex":0.000005518802,"about_ca_topic_score_gemma":0.000010262988,"teacher_disagreement_score":0.8305904,"about_ca_system_score_codex":0.00019131789,"about_ca_system_score_gemma":0.00014132545,"threshold_uncertainty_score":0.78065914},"labels":[],"label_agreement":null},{"id":"W4404020293","doi":"10.1111/ejh.14341","title":"Daratumumab in the Management of Red Cell Aplasia Following Allogeneic Hematopoietic Stem Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Medicine; Pure red cell aplasia; Hematopoietic stem cell transplantation; Aplastic anemia; Oncology; Transplantation; Intensive care medicine; Internal medicine; Anemia; Multiple myeloma; Bone marrow; Bortezomib","score_opus":0.018197237845790984,"score_gpt":0.25904086327607617,"score_spread":0.2408436254302852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404020293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567412,0.0031540215,0.008163174,0.0006854778,0.00055884855,0.00035824018,0.0000034049872,0.00002181721,0.030313803],"genre_scores_gemma":[0.99728775,0.00065485045,0.0017500708,0.00007332216,0.000035228575,0.0000029709895,0.0000088722645,0.00004099681,0.00014590811],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9973007,0.0007470458,0.0010928579,0.00020160271,0.00042249903,0.00023531482],"domain_scores_gemma":[0.9991777,0.00021896158,0.0002530204,0.00023512632,0.000045819786,0.00006937982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001815021,0.00018261839,0.0005192526,0.00032834854,0.000036389447,0.000022383629,0.0002639543,0.000048668106,0.000032678392],"category_scores_gemma":[0.000002435367,0.00012801652,0.00026226218,0.0003429244,0.000049444534,0.00008707733,0.000012313826,0.00034149754,0.000051626586],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017471648,0.0012898084,0.0081238765,0.048125,0.0013500934,0.7700485,0.062339872,0.00044925173,0.090025835,0.0059259576,0.0022498528,0.008324795],"study_design_scores_gemma":[0.034804445,0.0055295005,0.06934533,0.03592521,0.013201905,0.40248656,0.046408895,0.0007168672,0.37731197,0.0010279096,0.011460282,0.0017811172],"about_ca_topic_score_codex":7.96191e-7,"about_ca_topic_score_gemma":9.858169e-7,"teacher_disagreement_score":0.36756194,"about_ca_system_score_codex":0.000030526844,"about_ca_system_score_gemma":0.000053196673,"threshold_uncertainty_score":0.5220362},"labels":[],"label_agreement":null},{"id":"W4404050519","doi":"10.1111/ejh.14317","title":"Maternal and Fetal Outcomes of Aplastic Anemia During Pregnancy and Delivery: Systematic Review and Meta‐Analysis","year":2024,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Meta-analysis; Preeclampsia; Aplastic anemia; Abortion; Publication bias; Cohort study; Retrospective cohort study; Prospective cohort study; Pediatrics; Internal medicine","score_opus":0.0446025269717282,"score_gpt":0.3138522281901661,"score_spread":0.26924970121843794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404050519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012385227,0.9976565,0.00009431348,0.0000752513,0.00006334679,0.0007489499,0.000030421803,0.00001116842,0.00008147473],"genre_scores_gemma":[0.004328919,0.9949845,0.0004342136,0.000022109229,0.0000120319955,0.0000075780445,0.0000049837304,0.000056779878,0.00014889568],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958928,0.0011583356,0.0022185508,0.00029039773,0.00025849204,0.00018138584],"domain_scores_gemma":[0.9975555,0.00041766008,0.0014873926,0.0002442578,0.00011389669,0.00018127836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081937935,0.000428484,0.00955478,0.00063688925,0.00003052523,0.000026515174,0.00013160927,0.00008149157,0.00004458343],"category_scores_gemma":[0.00013847789,0.0002465351,0.0009049625,0.00024994937,0.0001328877,0.000061048704,0.00007603945,0.0003919476,0.0000121725225],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006447205,0.000012021471,0.00010794367,0.92212576,0.06671607,0.0106049385,0.00007807075,5.4763074e-8,7.362871e-7,0.000027806655,0.000005305957,0.00031484742],"study_design_scores_gemma":[0.00022853316,0.00008111166,0.00008435103,0.25247893,0.63377273,0.113161825,0.000010668591,0.0000012383802,0.000001799604,0.0000021614594,0.00006450454,0.00011213789],"about_ca_topic_score_codex":0.0000014928992,"about_ca_topic_score_gemma":0.0000011402046,"teacher_disagreement_score":0.66964686,"about_ca_system_score_codex":0.000018205961,"about_ca_system_score_gemma":0.000061031446,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W4404473527","doi":"10.1111/ejh.14351","title":"Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; University of Ottawa; Joseph Brant Hospital; Lawson Health Research Institute; University of Toronto; Western University; Canadian Blood Services; SickKids Foundation; Hospital for Sick Children; London Health Sciences Centre; Queen's University; McMaster University; Saskatchewan Health Authority; Impact","funders":"Canadian Institutes of Health Research; Health Canada; Einstein Stiftung Berlin; Canadian Blood Services","keywords":"Immune thrombocytopenia; Medicine; Systematic review; Intensive care medicine; Immune system; Severe bleeding; MEDLINE; Pediatrics; Immunology; Platelet; Surgery","score_opus":0.0303647052277549,"score_gpt":0.33622915115524005,"score_spread":0.30586444592748513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404473527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067323586,0.9967142,0.0000036204756,0.00013934329,0.00017277045,0.0015770579,0.000017177643,0.000007695165,0.0006949436],"genre_scores_gemma":[0.0029373541,0.99665534,0.00015347087,0.000029607805,0.000019865549,0.000016062237,0.000030241215,0.000085045474,0.00007303222],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99579513,0.0009473062,0.0024654195,0.00023365629,0.00030053378,0.00025793153],"domain_scores_gemma":[0.99800956,0.00018494531,0.0010836018,0.0004039552,0.00019296711,0.00012497534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038675987,0.00047034986,0.01072341,0.00042855428,0.00001695346,0.000010388634,0.00019540102,0.00007873997,0.00004374017],"category_scores_gemma":[0.0001525158,0.00022802239,0.0007755349,0.00033075,0.00012950241,0.000049503135,0.000041661933,0.00034119494,0.00015075887],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061543215,0.00137517,0.000031415224,0.8980903,0.002415174,0.09102501,0.00006805846,1.7686427e-8,1.8759675e-8,0.00006536182,0.00007432653,0.006793607],"study_design_scores_gemma":[0.0025387711,0.00495359,0.00003320195,0.8851168,0.043233138,0.055074822,0.000014568159,1.8336904e-7,2.5531327e-7,0.000006694329,0.008853966,0.00017399699],"about_ca_topic_score_codex":0.0000015343019,"about_ca_topic_score_gemma":6.729272e-7,"teacher_disagreement_score":0.04081796,"about_ca_system_score_codex":0.00015923564,"about_ca_system_score_gemma":0.00026950153,"threshold_uncertainty_score":0.92984825},"labels":[],"label_agreement":null},{"id":"W4405308472","doi":"10.1111/ejh.14362","title":"<scp>BAY</scp> 81‐8973 Demonstrates Long‐Term Safety and Efficacy in Children With Severe Haemophilia A: Results From the <scp>LEOPOLD</scp> Kids Extension Study","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; McMaster University; McMaster Children's Hospital","funders":"Bayer","keywords":"Bay; Extension (predicate logic); Term (time); Medicine; Physics; Computer science; History","score_opus":0.022667379429618363,"score_gpt":0.285579327533637,"score_spread":0.26291194810401863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405308472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845065,0.006383307,0.000024932673,0.0019098725,0.00022699224,0.0008442934,0.000037437363,0.000053782584,0.0020687594],"genre_scores_gemma":[0.9971476,0.0010430379,0.00020059333,0.00013919246,0.0004096567,0.0000019591698,0.000041154468,0.0000804613,0.00093634345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995816,0.0013385863,0.0010863219,0.0005898404,0.00058464374,0.0005845981],"domain_scores_gemma":[0.9965649,0.0020501395,0.00028753022,0.00053140306,0.00019340416,0.00037258668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001956363,0.0004050576,0.00095460465,0.00037142035,0.00020674126,0.00012487218,0.00037787182,0.00010354329,0.000016898342],"category_scores_gemma":[0.0012058057,0.00021667688,0.0001561801,0.00049238116,0.0004546431,0.00017898243,0.00020785084,0.0012927696,0.00011442404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004956293,0.001077445,0.91121167,0.000058569927,0.0013659697,0.06702544,0.005453545,0.000023627435,0.0002651622,0.000038577473,0.006222273,0.006762071],"study_design_scores_gemma":[0.0093151275,0.0025981201,0.94931847,0.0009925959,0.00046973763,0.034873687,0.0013522267,0.000045517663,0.00020361869,0.000032740616,0.00073970936,0.000058467125],"about_ca_topic_score_codex":0.000025648804,"about_ca_topic_score_gemma":0.00005463604,"teacher_disagreement_score":0.038106762,"about_ca_system_score_codex":0.00006289488,"about_ca_system_score_gemma":0.00025704366,"threshold_uncertainty_score":0.8835827},"labels":[],"label_agreement":null},{"id":"W4405850856","doi":"10.1111/ejh.14376","title":"Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia","year":2024,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Chronic lymphocytic leukemia; Chemoimmunotherapy; Medicine; Clinical trial; Follicular lymphoma; Internal medicine; Oncology; Lymphoma; Cancer; Leukemia","score_opus":0.24920460784277412,"score_gpt":0.46771486865956996,"score_spread":0.21851026081679584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405850856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720236,0.011351123,0.0115463175,0.00039595691,0.0017366428,0.0009319355,0.000009721553,0.000048234528,0.0019564852],"genre_scores_gemma":[0.9953149,0.0011262688,0.0019609001,0.00015086684,0.0009103676,0.000010634429,0.000012810806,0.00010378924,0.0004094449],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99058783,0.0032749705,0.0045549814,0.00047675162,0.0005136443,0.00059182226],"domain_scores_gemma":[0.9920459,0.005694621,0.0010423474,0.0005068904,0.0003957988,0.000314478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016154075,0.0002889602,0.002176272,0.0009264839,0.000037747177,0.000045594243,0.00045574034,0.00017516562,0.00010362038],"category_scores_gemma":[0.007601019,0.00022605875,0.0009627827,0.00054780056,0.00042312033,0.00014487983,0.00013218401,0.00035022674,0.00010357697],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.03272102,0.0010473036,0.0026160418,0.025108807,0.0076273107,0.23120447,0.0050762515,0.018162468,0.015695205,0.017795797,0.04192538,0.6010199],"study_design_scores_gemma":[0.24229617,0.0104773175,0.0054171,0.009460109,0.0024356642,0.1655605,0.0011015701,0.52134967,0.0143125625,0.002985127,0.023700802,0.00090340065],"about_ca_topic_score_codex":0.00009050986,"about_ca_topic_score_gemma":0.000028566865,"teacher_disagreement_score":0.60011655,"about_ca_system_score_codex":0.046774045,"about_ca_system_score_gemma":0.06802484,"threshold_uncertainty_score":0.9568852},"labels":[],"label_agreement":null},{"id":"W4406108299","doi":"10.1111/ejh.14380","title":"Impact of Day 11 Methotrexate Dose Adjustments due to Mucositis on the Outcomes Following Allogeneic Stem Cell Transplant in the Setting of Anti Thymocyte Globulin (<scp>ATG</scp>) Based <scp>GVHD</scp> Prophylaxis","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Anti-thymocyte globulin; Mucositis; Methotrexate; Globulin; Stem cell; Immunology; Thymocyte; Medicine; T cell; Internal medicine; Biology; Toxicity; Immune system","score_opus":0.020312369967668192,"score_gpt":0.2887236746398868,"score_spread":0.26841130467221863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406108299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071246,0.00055753347,0.0043535638,0.00057605474,0.00034871316,0.0009119147,0.000045625795,0.000016489563,0.0024776533],"genre_scores_gemma":[0.9978051,0.000051300667,0.0014190024,0.000565703,0.000024103208,0.000007343119,0.000009994724,0.000052340903,0.000065093256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99260056,0.004132922,0.0017491463,0.00033590855,0.00065608835,0.0005253913],"domain_scores_gemma":[0.99341434,0.0047976384,0.0008988846,0.0005533289,0.00017659938,0.0001591885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005181527,0.00040491088,0.0014630257,0.0006349007,0.00009465886,0.000023830014,0.0006828724,0.00010486715,0.0000127141575],"category_scores_gemma":[0.000551319,0.00022669774,0.0007125445,0.0007226242,0.00009444379,0.00007410509,0.000039657258,0.0005732314,0.000017008795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028055088,0.0012428256,0.82678854,0.0018479807,0.0019002431,0.034259655,0.029834133,0.003080886,0.09513766,0.00024408397,0.0008482233,0.004535201],"study_design_scores_gemma":[0.004597461,0.0016405749,0.88134354,0.0015755934,0.00076424185,0.0015133263,0.0022355395,0.00012310514,0.106032535,0.00001782344,0.00008009119,0.0000761497],"about_ca_topic_score_codex":0.00003136919,"about_ca_topic_score_gemma":0.000012778223,"teacher_disagreement_score":0.054555003,"about_ca_system_score_codex":0.00008729256,"about_ca_system_score_gemma":0.000289966,"threshold_uncertainty_score":0.9244465},"labels":[],"label_agreement":null},{"id":"W4406926013","doi":"10.1111/ejh.14385","title":"Iron Overload, Oxidative Stress, and Somatic Mutations in <scp>MDS</scp>: What Is the Association?","year":2025,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Myelodysplastic syndromes; Oxidative stress; Bone marrow; International Prognostic Scoring System; Haematopoiesis; Myeloid; Medicine; Somatic cell; Bone marrow failure; Erythropoiesis; Progenitor cell; Bioinformatics; Cancer research; Internal medicine; Oncology; Stem cell; Biology; Genetics; Anemia; Gene","score_opus":0.024635990797010128,"score_gpt":0.33261495520361556,"score_spread":0.30797896440660544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406926013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018219858,0.9916732,0.000040347175,0.0023455746,0.0003016772,0.00071504334,0.00003177823,0.000010766626,0.0030596338],"genre_scores_gemma":[0.0003139896,0.99662143,0.000283072,0.00041878308,0.00016400983,0.00001020263,0.000032243304,0.000053628803,0.0021026626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99417627,0.0032248176,0.0014307487,0.00028258841,0.00047961815,0.00040592992],"domain_scores_gemma":[0.9921506,0.005411861,0.0016351587,0.000367654,0.00028428642,0.0001504278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021169134,0.00034338463,0.0022147105,0.00071309647,0.00011135388,0.00012689491,0.00046416346,0.00017613101,0.000052466792],"category_scores_gemma":[0.0039786464,0.00021567165,0.0003673137,0.0005091249,0.00018425327,0.00024346549,0.000233917,0.0018889959,0.00014346745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046118577,0.0006270794,0.0032072635,0.0719006,0.0036969257,0.03697051,0.011720443,0.000007065839,0.000006264073,0.00112129,0.08197014,0.78872633],"study_design_scores_gemma":[0.002575182,0.0004113961,0.0010169328,0.06681899,0.0029546667,0.013135386,0.004914192,0.000015253289,0.000012320782,0.00020799592,0.90776813,0.0001695642],"about_ca_topic_score_codex":0.0000036192687,"about_ca_topic_score_gemma":0.00000804711,"teacher_disagreement_score":0.825798,"about_ca_system_score_codex":0.00053630926,"about_ca_system_score_gemma":0.0011687173,"threshold_uncertainty_score":0.87948346},"labels":[],"label_agreement":null},{"id":"W4407570874","doi":"10.1111/ejh.14392","title":"Sustained Improvement in Health‐Related Quality of Life in Transplant‐Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: <scp>MAIA</scp> Final Analysis of Patient‐Reported Outcomes","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Janssen Research and Development; Johnson and Johnson; Janssen Scientific Affairs; National Cancer Institute; Kite Pharma; Celgene; Amgen","keywords":"Daratumumab; Lenalidomide; Medicine; Dexamethasone; Multiple myeloma; Internal medicine; Oncology; Quality of life (healthcare)","score_opus":0.030771107431434543,"score_gpt":0.3157290462354384,"score_spread":0.2849579388040039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407570874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691474,0.0014303733,0.00019171313,0.00046240442,0.000031785192,0.0006415845,0.00002927006,0.00001116151,0.00028695638],"genre_scores_gemma":[0.9986505,0.00029474925,0.0007934521,0.00009599601,0.0000035209325,0.000007611026,0.000050453826,0.000022218363,0.000081490965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941708,0.0015188013,0.0030650313,0.00033155992,0.0004371447,0.0004767031],"domain_scores_gemma":[0.995832,0.0014897627,0.0016672985,0.0003299735,0.00038772123,0.00029319187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017796025,0.00028882333,0.0024899235,0.002121496,0.000045730732,0.0000105993195,0.00015519165,0.00007493292,0.000015479869],"category_scores_gemma":[0.0023896804,0.0002049662,0.00025164383,0.0017048933,0.00021925196,0.0000921,0.000062692205,0.00038239258,5.0498215e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050229845,0.0011428111,0.9746801,0.00055825,0.003913911,0.00951668,0.0012577518,0.0003080421,0.00088589825,0.000043578577,0.000049259226,0.0026207224],"study_design_scores_gemma":[0.036005463,0.0019412081,0.9569077,0.0005323432,0.00056329963,0.00024178404,0.0013558489,0.00052861596,0.0018153604,0.000017848928,0.000017726077,0.0000727847],"about_ca_topic_score_codex":0.0014686149,"about_ca_topic_score_gemma":0.0014479307,"teacher_disagreement_score":0.030982478,"about_ca_system_score_codex":0.00011828399,"about_ca_system_score_gemma":0.00046844909,"threshold_uncertainty_score":0.8358279},"labels":[],"label_agreement":null},{"id":"W4408534942","doi":"10.1111/ejh.14411","title":"Daratumumab for Posttransplant Autoimmune Hemolytic Anemia","year":2025,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Daratumumab; Immunology; Hemolytic anemia; Anemia; Dermatology; Internal medicine; Antibody; Monoclonal antibody","score_opus":0.0169117475757505,"score_gpt":0.2570097166015386,"score_spread":0.2400979690257881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408534942","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010211126,0.005176794,0.0060778046,0.9603042,0.0033832733,0.00075217756,0.00009647157,0.000058757014,0.013939405],"genre_scores_gemma":[0.09179562,0.00120823,0.0074886265,0.8835391,0.0059335954,0.000007776305,0.0006205817,0.00032045692,0.009086006],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974611,0.00034829526,0.0011829612,0.0002904382,0.00028665178,0.00043057319],"domain_scores_gemma":[0.99834067,0.00025362516,0.00057846727,0.0004004988,0.00033389387,0.00009286507],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00061684346,0.00036614807,0.0015193017,0.00045231025,0.00010541457,0.00002269568,0.00037322473,0.0003378659,0.00010009273],"category_scores_gemma":[0.000081733924,0.0002800107,0.0006220133,0.00012657678,0.00012025746,0.000045167693,0.000032267366,0.0024992994,0.00003553873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006854599,0.00009617113,0.000035012454,0.0026202619,0.00046954342,0.13424052,0.00011983382,8.72594e-7,0.00069539994,0.0001062253,0.8592431,0.0016875971],"study_design_scores_gemma":[0.0051090843,0.001542632,0.00031730338,0.0023740903,0.0018746443,0.11206026,0.0000130742255,0.000009059882,0.00055458373,0.000076383694,0.87583655,0.00023230992],"about_ca_topic_score_codex":0.0000022901645,"about_ca_topic_score_gemma":5.124551e-7,"teacher_disagreement_score":0.0815845,"about_ca_system_score_codex":0.00003962892,"about_ca_system_score_gemma":0.00028562744,"threshold_uncertainty_score":0.9999652},"labels":[],"label_agreement":null},{"id":"W4408580322","doi":"10.1111/ejh.14416","title":"Central Nervous System Manifestations of Graft‐Versus‐Host Disease","year":2025,"lang":"en","type":"letter","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Graft-versus-host disease; Host (biology); Central nervous system; Disease; Medicine; Nervous system; Immunology; Pathology; Neuroscience; Biology; Internal medicine; Genetics","score_opus":0.0221753835575874,"score_gpt":0.2606632549026766,"score_spread":0.2384878713450892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408580322","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.079753175,0.003151201,0.02587051,0.7953595,0.01479253,0.0019827636,0.0006491463,0.00022181131,0.07821935],"genre_scores_gemma":[0.90317315,0.0004927389,0.0047798567,0.08272644,0.004147126,0.000008016239,0.000669476,0.00029059584,0.0037125954],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99608374,0.0011986146,0.0015571894,0.00024982163,0.0005156851,0.00039497312],"domain_scores_gemma":[0.9971014,0.000567862,0.0012312309,0.00042269618,0.0004441831,0.0002326259],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005227896,0.00031860947,0.0011755945,0.0005569131,0.000053144566,0.000015217045,0.00033208416,0.00016999675,0.00010243077],"category_scores_gemma":[0.00022585463,0.00027239096,0.00045407919,0.00018117574,0.00015476385,0.00005581708,0.00003365882,0.0012324044,0.00005413658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096443767,0.00009100107,0.0008554821,0.012691982,0.00078869396,0.5018044,0.00046755106,0.000018613671,0.000104712024,0.0006346265,0.48139712,0.00018136273],"study_design_scores_gemma":[0.021191146,0.002621975,0.03893571,0.036102246,0.019260673,0.35440022,0.0018613602,0.00019810129,0.0009650299,0.0000660154,0.52296966,0.0014278832],"about_ca_topic_score_codex":0.0000041210237,"about_ca_topic_score_gemma":9.56459e-7,"teacher_disagreement_score":0.82342,"about_ca_system_score_codex":0.0001090699,"about_ca_system_score_gemma":0.0005531548,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W4409741845","doi":"10.1111/ejh.14428","title":"Medical and Nutritional Outcomes Are Similar Among Autologous Transplant Patients on Enteral Nutrition When Compared to Parenteral Nutrition. A Randomized Pilot Study","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Parenteral nutrition; Malnutrition; Randomized controlled trial; Enteral administration; Internal medicine; Body mass index; Hematopoietic stem cell transplantation; Pediatrics; Transplantation","score_opus":0.03019671723004881,"score_gpt":0.31778961146729556,"score_spread":0.28759289423724677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409741845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722624,0.0003478171,0.00065941457,0.023851823,0.000689076,0.0017428614,0.00003863993,0.000044124663,0.00036388033],"genre_scores_gemma":[0.99209124,0.00016115462,0.0011043508,0.006346103,0.00014344265,0.000055860808,0.00004313065,0.000023055225,0.000031647905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99556065,0.0017374795,0.0014969204,0.00029869511,0.0005798465,0.00032644012],"domain_scores_gemma":[0.9980298,0.00052789215,0.00042217984,0.00016656218,0.00039678664,0.0004567251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001204372,0.00026443752,0.0016800157,0.00076230435,0.0001665949,0.000037122347,0.00019585123,0.00004909594,0.00015398329],"category_scores_gemma":[0.0004816824,0.00020768726,0.00020250317,0.0001378604,0.0002182815,0.000092742775,0.000049874077,0.00059693796,0.000015140826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13695963,0.025670417,0.79032207,0.0016258404,0.0007373513,0.015449857,0.0013468766,0.0000023226933,0.00002070367,0.0006918373,0.026792182,0.0003809412],"study_design_scores_gemma":[0.41339406,0.0054657063,0.567086,0.00766601,0.0003580779,0.00268762,0.0005889629,0.000099162506,0.000026864636,0.0006851034,0.0017206479,0.00022180243],"about_ca_topic_score_codex":0.000006656299,"about_ca_topic_score_gemma":0.000020116973,"teacher_disagreement_score":0.27643442,"about_ca_system_score_codex":0.00007418497,"about_ca_system_score_gemma":0.00006418481,"threshold_uncertainty_score":0.84692407},"labels":[],"label_agreement":null},{"id":"W4410143391","doi":"10.1111/ejh.14430","title":"Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Gastroenterology; Transplantation; Incidence (geometry); Cyclophosphamide; Myelodysplastic syndromes; Busulfan; Graft-versus-host disease; Anti-thymocyte globulin; Oncology; Chemotherapy; Bone marrow","score_opus":0.017156429193606337,"score_gpt":0.2918642025781279,"score_spread":0.27470777338452157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410143391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9496726,0.00050075434,0.04309834,0.0020190296,0.00039215607,0.00048182602,0.000020236035,0.000016590138,0.003798514],"genre_scores_gemma":[0.9929986,0.0001847639,0.005051842,0.00040742752,0.000053374883,0.000005688188,0.00000870612,0.000038075028,0.0012515225],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762994,0.0004480207,0.001102397,0.00020896712,0.0002904673,0.0003202134],"domain_scores_gemma":[0.99772584,0.0008090991,0.00053330127,0.00023377097,0.0005568022,0.00014117107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091964955,0.00021284648,0.0010244263,0.00046826547,0.00006822048,0.000012161255,0.00027841644,0.00007374669,0.00004259016],"category_scores_gemma":[0.00016117633,0.00016107301,0.00028533462,0.00021211868,0.00017489777,0.00008158399,0.000042806452,0.00037065527,0.00003106237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049018968,0.003509561,0.53460205,0.02576885,0.009650665,0.05769385,0.026178515,0.0016522642,0.17880037,0.038038827,0.044311337,0.03077473],"study_design_scores_gemma":[0.05640722,0.010230156,0.28053936,0.0028849368,0.004383303,0.05138278,0.006910749,0.0009794611,0.57355005,0.0014371853,0.010209501,0.0010852946],"about_ca_topic_score_codex":0.0000010425143,"about_ca_topic_score_gemma":0.0000014413306,"teacher_disagreement_score":0.39474967,"about_ca_system_score_codex":0.0000840712,"about_ca_system_score_gemma":0.0004953591,"threshold_uncertainty_score":0.6568366},"labels":[],"label_agreement":null},{"id":"W4410330493","doi":"10.1111/ejh.14434","title":"Genetic Landscape and Risk Stratification of <scp>AML</scp> With Hyperdiploid Karyotype","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"University Health Network","keywords":"Internal medicine; Myeloid leukemia; Karyotype; Oncology; Medicine; Confounding; Cohort; Cytogenetics; Risk stratification; Chromosome; Genetics; Gene; Biology","score_opus":0.010755976729565048,"score_gpt":0.25751127013321506,"score_spread":0.24675529340365002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410330493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98139834,0.0024495975,0.0022433123,0.0004866932,0.00006370949,0.00013262329,0.0000026670807,0.000009638606,0.013213388],"genre_scores_gemma":[0.9926551,0.0009843814,0.0057316343,0.00008503064,0.00006291004,6.797329e-7,0.0000019868237,0.000021210775,0.00045707502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851483,0.0004664272,0.0005024184,0.00014661436,0.00019180025,0.00017793544],"domain_scores_gemma":[0.99864054,0.00027613202,0.00038974677,0.00023967534,0.0003390604,0.00011486461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006611643,0.00011248313,0.00046002743,0.00031397323,0.000047738646,0.000011857975,0.00015876701,0.000039047212,0.000019118479],"category_scores_gemma":[0.00051232975,0.00007796865,0.000051143674,0.00023700288,0.00019876157,0.000047357997,0.000052698466,0.00042721882,0.000017126453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078930333,0.0002678428,0.93250906,0.0005850792,0.0011217839,0.008335607,0.0011003065,0.00008753017,0.01917244,0.00119164,0.019805146,0.015034239],"study_design_scores_gemma":[0.0052754697,0.0023843483,0.9550065,0.00038508856,0.0006259727,0.02126735,0.0010417491,0.00033550835,0.007260737,0.00021129606,0.0061391327,0.000066853216],"about_ca_topic_score_codex":0.0000033498056,"about_ca_topic_score_gemma":0.0000029703021,"teacher_disagreement_score":0.022497412,"about_ca_system_score_codex":0.000021005244,"about_ca_system_score_gemma":0.0002709117,"threshold_uncertainty_score":0.31794694},"labels":[],"label_agreement":null},{"id":"W4410873166","doi":"10.1111/ejh.14438","title":"Impact of Conditioning Intensity on Survival in Adult Patients (&lt; 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post‐Transplantation Cyclophosphamide Based <scp>GVHD</scp> Prophylaxis","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cyclophosphamide; Medicine; Myeloid leukemia; Globulin; Myeloid; Transplantation; Internal medicine; Immunology; Conditioning; Gastroenterology; Chemotherapy","score_opus":0.006431586956255188,"score_gpt":0.24237606289306218,"score_spread":0.235944475936807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410873166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504733,0.00004763307,0.0029559382,0.00006756555,0.00020320868,0.00028257046,0.000033637363,0.000015721927,0.001346387],"genre_scores_gemma":[0.9977942,0.00014693281,0.0018081934,0.00013069218,0.000016857635,0.0000010957586,0.000055216653,0.000028179507,0.000018636425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794364,0.00048298074,0.00080048735,0.00022758779,0.00030499144,0.00024030099],"domain_scores_gemma":[0.99818623,0.0004340323,0.00051644107,0.00015791674,0.00059142616,0.00011397647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006617905,0.0002068372,0.00071273703,0.00048604328,0.000044332668,0.000016391636,0.00010897444,0.00007345595,0.000013649543],"category_scores_gemma":[0.00038554968,0.0001649489,0.00010723642,0.0003207989,0.00014132394,0.00011804382,0.000013192334,0.0004101542,0.000006643235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003399431,0.00020630447,0.97096467,0.0007547625,0.00042277083,0.011638469,0.001808753,0.00050985866,0.007951405,0.0000835596,0.00007741617,0.0021826092],"study_design_scores_gemma":[0.0066405814,0.0026115535,0.9756733,0.0018912718,0.00024019658,0.0021803991,0.00015177872,0.00009717806,0.010428885,0.000012023088,0.0000036828446,0.000069157126],"about_ca_topic_score_codex":0.00003634753,"about_ca_topic_score_gemma":0.000014783803,"teacher_disagreement_score":0.00945807,"about_ca_system_score_codex":0.00014975248,"about_ca_system_score_gemma":0.00034416217,"threshold_uncertainty_score":0.67264205},"labels":[],"label_agreement":null},{"id":"W4410932907","doi":"10.1111/ejh.14443","title":"Efficacy and Safety of Bendamustine‐Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Bendamustine; Medicine; Internal medicine; Tolerability; Neutropenia; Rituximab; Rash; Gastroenterology; Adverse effect; Population; Lymphoma; Surgery; Chemotherapy","score_opus":0.011521212179555798,"score_gpt":0.2727653484747512,"score_spread":0.2612441362951954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410932907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861826,0.006604571,0.0019879686,0.002094131,0.00033999147,0.00043844437,0.000016453614,0.000011982952,0.0023239106],"genre_scores_gemma":[0.9930596,0.00063589675,0.005685135,0.00031632383,0.00007333418,0.0000037335074,0.000005968474,0.000023743049,0.00019628975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983337,0.00021130612,0.000895225,0.00019717193,0.00013499089,0.00022763184],"domain_scores_gemma":[0.998534,0.00036954958,0.00047713448,0.00023911291,0.00025656514,0.00012361899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060464826,0.00018351502,0.00095544657,0.0002444656,0.000069201305,0.000010311491,0.00013339886,0.00004580272,0.00002764791],"category_scores_gemma":[0.0003777225,0.00013317484,0.00020863747,0.00012224093,0.0001611855,0.000042262975,0.000076939934,0.000055013355,0.000007850005],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047310513,0.0113099,0.05031737,0.0033885788,0.0059088324,0.03510626,0.0024747723,0.000064652006,0.008324077,0.024091434,0.021730011,0.7899736],"study_design_scores_gemma":[0.26466,0.008299785,0.40104458,0.004485536,0.0039500766,0.05489281,0.00044158855,0.00036291403,0.05752199,0.0003860942,0.20344871,0.00050592533],"about_ca_topic_score_codex":0.000003590627,"about_ca_topic_score_gemma":9.587727e-7,"teacher_disagreement_score":0.7894677,"about_ca_system_score_codex":0.00011553398,"about_ca_system_score_gemma":0.00035352787,"threshold_uncertainty_score":0.5430712},"labels":[],"label_agreement":null},{"id":"W4410975252","doi":"10.1111/ejh.14426","title":"Sensitization of Non‐<scp>M3</scp> Acute Myeloid Leukemia Blasts to All‐<i>Trans</i> Retinoic Acid by the <scp>LSD1</scp> Inhibitor Tranylcypromine: <scp>TRANSATRA</scp> Phase I Study","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Deutschen Konsortium für Translationale Krebsforschung","keywords":"Retinoic acid; Tranylcypromine; Myeloid leukemia; Sensitization; Myeloid; Chemistry; Tretinoin; Cancer research; Pharmacology; Medicine; Immunology; Biochemistry; Gene; Enzyme","score_opus":0.006219842120234684,"score_gpt":0.25224893083010763,"score_spread":0.24602908870987295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410975252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96009666,0.0032019133,0.03189137,0.00036291266,0.0007405013,0.0007511667,0.00007023337,0.000026922862,0.002858306],"genre_scores_gemma":[0.99494314,0.00084790506,0.00068804156,0.0010577335,0.00043416643,0.000015555628,0.000093274684,0.00012201447,0.0017981925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99481994,0.0013387034,0.001742708,0.0007657398,0.0005352857,0.0007976323],"domain_scores_gemma":[0.9969131,0.00038965783,0.0009472379,0.00077297067,0.000650664,0.00032639693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017058512,0.00064936606,0.0010666099,0.00029775032,0.00024272197,0.00009610182,0.0012376748,0.0002916514,0.000005863034],"category_scores_gemma":[0.0010414683,0.00052606396,0.0004579742,0.0006052561,0.00045434182,0.00003869085,0.00018280964,0.0007889367,0.000022171604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008260904,0.00049993716,0.0006463943,0.00022306108,0.0008392147,0.00096084474,0.0026206456,0.00019901105,0.93212825,0.000017705715,0.06076831,0.0010140078],"study_design_scores_gemma":[0.005106159,0.0029809412,0.0003909195,0.00017847159,0.0006991451,0.002128594,0.001910691,0.000045042798,0.92967707,0.000032816006,0.05676043,0.000089744346],"about_ca_topic_score_codex":0.0000034328841,"about_ca_topic_score_gemma":0.0000066906186,"teacher_disagreement_score":0.03484644,"about_ca_system_score_codex":0.00006707365,"about_ca_system_score_gemma":0.0005054727,"threshold_uncertainty_score":0.9997191},"labels":[],"label_agreement":null},{"id":"W4413138559","doi":"10.1111/ejh.70020","title":"Renal Involvement in Chronic Graft‐Versus‐Host Disease","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Nephrotic syndrome; Membranous nephropathy; Hematopoietic stem cell transplantation; Internal medicine; Kidney disease; Minimal change disease; Immunosuppression; Proteinuria; Gastroenterology; Transplantation; Graft-versus-host disease; Disease; Complication; Kidney; Focal segmental glomerulosclerosis","score_opus":0.025050435843917456,"score_gpt":0.2919700022065511,"score_spread":0.26691956636263364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413138559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731584,0.00209456,0.004889154,0.0046948316,0.0007860254,0.00024574678,0.0000025806721,0.000018835066,0.01410985],"genre_scores_gemma":[0.9983919,0.00023382828,0.00061975047,0.00038382536,0.00008968081,0.000001475778,0.0000056491367,0.000016019243,0.00025786253],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9982998,0.00044810012,0.00071574474,0.00013944323,0.00018897203,0.00020797529],"domain_scores_gemma":[0.9992095,0.0001523792,0.0001993128,0.00018535696,0.00009559221,0.00015784122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082429434,0.000120059005,0.00039824488,0.00037920906,0.000027438435,0.000008766363,0.00013992105,0.000024989766,0.00013380138],"category_scores_gemma":[0.00014582384,0.00010010723,0.000112873844,0.00021357105,0.00007965722,0.000053018146,0.000027112354,0.00028182886,0.000069358925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028613884,0.0024544403,0.2138482,0.009281735,0.0023477871,0.5415823,0.0061994162,0.00075093046,0.09997027,0.046982896,0.032021053,0.015947059],"study_design_scores_gemma":[0.09515223,0.005606754,0.7232835,0.018052036,0.0028541712,0.017626693,0.001878865,0.0010984587,0.036627088,0.0011506813,0.095576495,0.0010930144],"about_ca_topic_score_codex":0.0000023327057,"about_ca_topic_score_gemma":0.000013717585,"teacher_disagreement_score":0.52395564,"about_ca_system_score_codex":0.00016707141,"about_ca_system_score_gemma":0.00042380564,"threshold_uncertainty_score":0.40822545},"labels":[],"label_agreement":null},{"id":"W4413270532","doi":"10.1111/ejh.70018","title":"The Clinicopathologic Spectrum of Rosai–Dorfman–Destombes Disease in Adults: An Analysis of 16 Cases","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"Victoria General Hospital Foundation","keywords":"Rosai–Dorfman disease; Medicine; Dermatology; Disease; Pathology","score_opus":0.014983610140978373,"score_gpt":0.3092551246069061,"score_spread":0.2942715144659277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413270532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391806,0.0031306017,0.00013706199,0.00070654583,0.00013061431,0.00009500596,0.000011894318,0.000004503245,0.0018657022],"genre_scores_gemma":[0.9991393,0.0004926341,0.00013508467,0.000093583476,0.000013127004,7.368857e-7,0.0000073439046,0.000008503088,0.00010966811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811375,0.0005404495,0.00093114254,0.00013246658,0.00013277374,0.00014942641],"domain_scores_gemma":[0.9986393,0.00028107266,0.0005594725,0.00030701002,0.00012046014,0.00009267691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006704066,0.00010738474,0.0007429098,0.00048034123,0.000039270835,0.0000048190577,0.00018344147,0.000021525948,0.00004391681],"category_scores_gemma":[0.00072764535,0.00006549929,0.00025283932,0.00048038195,0.00026121433,0.00003776184,0.000036807713,0.00014364395,0.0000037262637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002902703,0.0014055701,0.9604951,0.00014991454,0.0009394129,0.02587207,0.000472827,0.00020165338,0.000015280122,0.0021932176,0.00021884959,0.0051333797],"study_design_scores_gemma":[0.0045208805,0.002097574,0.98527306,0.00067514594,0.0033440324,0.00094101374,0.0012875255,0.00042588665,0.00010948355,0.00059774064,0.00063468394,0.000092943956],"about_ca_topic_score_codex":0.000030493562,"about_ca_topic_score_gemma":0.00015923564,"teacher_disagreement_score":0.024931056,"about_ca_system_score_codex":0.000035478635,"about_ca_system_score_gemma":0.00013695123,"threshold_uncertainty_score":0.26709837},"labels":[],"label_agreement":null},{"id":"W4417361914","doi":"10.1111/ejh.70081","title":"Eltrombopag in Treating Post‐Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug Tapering","year":2025,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Eltrombopag; Tapering; Cladribine; Context (archaeology); Hematopoietic stem cell transplantation; Cytopenia; Transplantation","score_opus":0.010716933284667876,"score_gpt":0.25623340128535077,"score_spread":0.24551646800068289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417361914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701434,0.0012013237,0.000073706666,0.00062185206,0.00006219355,0.00026121823,0.00000645216,0.000008178063,0.00075072615],"genre_scores_gemma":[0.99919194,0.00020775985,0.00038526373,0.000071117196,0.000005916004,0.0000014247986,0.0000031796087,0.00001854533,0.000114850605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982489,0.00048124278,0.0007822479,0.00017451649,0.00012437777,0.00018871189],"domain_scores_gemma":[0.998977,0.00038509115,0.00030807534,0.0001473466,0.00010226396,0.0000802265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007549998,0.00015367844,0.0007413818,0.0003379395,0.0000426652,0.000012362268,0.000106456646,0.00003561131,0.000011895637],"category_scores_gemma":[0.00005435709,0.00012650229,0.00009811362,0.00017109058,0.00007972744,0.000073303134,0.000030519765,0.00020011562,0.0000045189445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028623765,0.0021608272,0.6427396,0.0024483344,0.00059098896,0.11842466,0.02028764,0.00025861632,0.15512931,0.00040104953,0.000061389015,0.028873831],"study_design_scores_gemma":[0.014148471,0.0015404412,0.9345098,0.0015535969,0.00042108799,0.02051749,0.0014994855,0.00002029343,0.025473919,0.00006484208,0.00007275447,0.00017780953],"about_ca_topic_score_codex":0.000014913031,"about_ca_topic_score_gemma":0.000021659649,"teacher_disagreement_score":0.29177022,"about_ca_system_score_codex":0.000037676644,"about_ca_system_score_gemma":0.00007615211,"threshold_uncertainty_score":0.5158614},"labels":[],"label_agreement":null}]}